[S02DA03, antipyrine, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Antipyrine.]
[G03XB02, ulipristal, The metabolism of Ulipristal can be increased when combined with Magnesium sulfate.]
[J01GA01, streptomycin, The risk or severity of neuromuscular blockade can be increased when Magnesium sulfate is combined with Streptomycin.]
[L04AA27, fingolimod, Magnesium sulfate may increase the bradycardic activities of Fingolimod.]
[M03AB01, succinylcholine, The therapeutic efficacy of Succinylcholine can be increased when used in combination with Magnesium sulfate.]
[J01EC02, sulfadiazine, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Sulfadiazine.]
[J01EC01, sulfamethoxazole, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Sulfamethoxazole.]
[S01AB02, sulfisoxazole, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Sulfisoxazole.]
[M01AB02, sulindac, The risk or severity of hyperkalemia can be increased when Sulindac is combined with Magnesium sulfate.]
[N05AL01, sulpiride, The therapeutic efficacy of Sulpiride can be increased when used in combination with Magnesium sulfate.]
[N03AX03, sulthiame, The therapeutic efficacy of Sulthiame can be increased when used in combination with Magnesium sulfate.]
[A10BB04, glibornuride, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Glibornuride.]
[A10BC01, glymidine, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Glymidine.]
[M01AX04, apazone, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Azapropazone.]
[L01BB02, mercaptopurine, Magnesium sulfate may increase the excretion rate of Mercaptopurine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CD07, temazepam, The therapeutic efficacy of Temazepam can be increased when used in combination with Magnesium sulfate.]
[S01HA03, tetracaine, The therapeutic efficacy of Tetracaine can be increased when used in combination with Magnesium sulfate.]
[S03AA02, tetracycline, Magnesium sulfate can cause a decrease in the absorption of Tetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N05AE05, lurasidone, The therapeutic efficacy of Lurasidone can be increased when used in combination with Magnesium sulfate.]
[A04AD10, dronabinol, The therapeutic efficacy of Dronabinol can be increased when used in combination with Magnesium sulfate.]
[N04BC07, apomorphine, The therapeutic efficacy of Apomorphine can be increased when used in combination with Magnesium sulfate.]
[L04AX02, thalidomide, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.]
[R03DA07, theobromine, Magnesium sulfate may increase the excretion rate of Theobromine which could result in a lower serum level and potentially a reduction in efficacy.]
[R03DA04, theophylline, Magnesium sulfate may increase the excretion rate of Theophylline which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AD03, thiethylperazine, The therapeutic efficacy of Thiethylperazine can be increased when used in combination with Magnesium sulfate.]
[N05CA19, thiopental, The therapeutic efficacy of Thiopental can be increased when used in combination with Magnesium sulfate.]
[N05AB08, thioproperazine, The therapeutic efficacy of Thioproperazine can be increased when used in combination with Magnesium sulfate.]
[N05AC02, thioridazine, The therapeutic efficacy of Thioridazine can be increased when used in combination with Magnesium sulfate.]
[N05AF04, thiothixene, The therapeutic efficacy of Thiothixene can be increased when used in combination with Magnesium sulfate.]
[C01BB04, aprindine, Magnesium sulfate may increase the arrhythmogenic activities of Aprindine.]
[N05AL03, tiapride, The therapeutic efficacy of Tiapride can be increased when used in combination with Magnesium sulfate.]
[N02AX01, tilidine, The therapeutic efficacy of Tilidine can be increased when used in combination with Magnesium sulfate.]
[S01ED01, timolol, The risk or severity of adverse effects can be increased when Magnesium sulfate is combined with Timolol.]
[S01AA12, tobramycin, The risk or severity of neuromuscular blockade can be increased when Magnesium sulfate is combined with Tobramycin.]
[A10BB05, tolazamide, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Tolazamide.]
[M02AX02, tolazoline, The risk or severity of hypotension can be increased when Tolazoline is combined with Magnesium sulfate.]
[V04CA01, tolbutamide, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Tolbutamide.]
[M02AA21, tolmetin, The risk or severity of hyperkalemia can be increased when Tolmetin is combined with Magnesium sulfate.]
[M03BX04, tolperisone, The therapeutic efficacy of Tolperisone can be increased when used in combination with Magnesium sulfate.]
[N02AX02, tramadol, The therapeutic efficacy of Tramadol can be increased when used in combination with Magnesium sulfate.]
[N06AF04, tranylcypromine, The therapeutic efficacy of Tranylcypromine can be increased when used in combination with Magnesium sulfate.]
[N06AX05, trazodone, The therapeutic efficacy of Trazodone can be increased when used in combination with Magnesium sulfate.]
[C03DB02, triamterene, The risk or severity of adverse effects can be increased when Triamterene is combined with Magnesium sulfate.]
[N05CD05, triazolam, The therapeutic efficacy of Triazolam can be increased when used in combination with Magnesium sulfate.]
[C03AA06, trichlormethiazide, The risk or severity of adverse effects can be increased when Trichlormethiazide is combined with Magnesium sulfate.]
[A03AB12, mepenzolate, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Mepenzolate.]
[A16AX12, trientine, Magnesium sulfate can cause a decrease in the absorption of Triethylenetetramine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N05AB06, trifluoperazine, The therapeutic efficacy of Trifluoperazine can be increased when used in combination with Magnesium sulfate.]
[N05AD02, trifluperidol, The therapeutic efficacy of Trifluperidol can be increased when used in combination with Magnesium sulfate.]
[N05AA05, triflupromazine, The therapeutic efficacy of Triflupromazine can be increased when used in combination with Magnesium sulfate.]
[N04AA01, trihexyphenidyl, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Trihexyphenidyl.]
[A03AA05, trimebutine, Magnesium sulfate may increase the arrhythmogenic activities of Trimebutine.]
[S01ED04, metipranolol, Magnesium sulfate may increase the arrhythmogenic activities of Metipranolol.]
[R06AD01, trimeprazine, The therapeutic efficacy of Alimemazine can be increased when used in combination with Magnesium sulfate.]
[N03AC02, trimethadione, The therapeutic efficacy of Trimethadione can be increased when used in combination with Magnesium sulfate.]
[C02BA01, trimethaphan, The risk or severity of adverse effects can be increased when Magnesium sulfate is combined with Trimethaphan.]
[J01EA01, trimethoprim, The risk or severity of hyperkalemia can be increased when Trimethoprim is combined with Magnesium sulfate.]
[N06AA06, trimipramine, The therapeutic efficacy of Trimipramine can be increased when used in combination with Magnesium sulfate.]
[R06AX07, triprolidine, The therapeutic efficacy of Triprolidine can be increased when used in combination with Magnesium sulfate.]
[A03BB01, butylscopolamine, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Butylscopolamine.]
[N06AX24, vilazodone, The therapeutic efficacy of Vilazodone can be increased when used in combination with Magnesium sulfate.]
[S01FA06, tropicamide, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Tropicamide.]
[C09CA09, azilsartan medoxomil, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Azilsartan medoxomil.]
[M03AA02, tubocurarine, The therapeutic efficacy of Tubocurarine can be increased when used in combination with Magnesium sulfate.]
[A10BH05, linagliptin, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Linagliptin.]
[J05AP03, boceprevir, The serum concentration of Magnesium sulfate can be increased when it is combined with Boceprevir.]
[S01AA28, vancomycin, The risk or severity of neuromuscular blockade can be increased when Vancomycin is combined with Magnesium sulfate.]
[N03AX21, ezogabine, The therapeutic efficacy of Ezogabine can be increased when used in combination with Magnesium sulfate.]
[C08DA01, verapamil, Magnesium sulfate may increase the arrhythmogenic activities of Verapamil.]
[N06AX09, viloxazine, The therapeutic efficacy of Viloxazine can be increased when used in combination with Magnesium sulfate.]
[C03BA10, xipamide, The risk or severity of adverse effects can be increased when Xipamide is combined with Magnesium sulfate.]
[N05AF05, zuclopenthixol, The therapeutic efficacy of Zuclopenthixol can be increased when used in combination with Magnesium sulfate.]
[N03AX14, levetiracetam, The therapeutic efficacy of Levetiracetam can be increased when used in combination with Magnesium sulfate.]
[M05BA05, tiludronic acid, Magnesium sulfate can cause a decrease in the absorption of Tiludronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L01ED01, crizotinib, Crizotinib may increase the bradycardic activities of Magnesium sulfate.]
[H05BX03, doxercalciferol, The serum concentration of Magnesium sulfate can be increased when it is combined with Doxercalciferol.]
[M05BA06, ibandronic acid, Magnesium sulfate can cause a decrease in the absorption of Ibandronate resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[J01MA13, trovafloxacin, Magnesium sulfate can cause a decrease in the absorption of Trovafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N05AE04, ziprasidone, The therapeutic efficacy of Ziprasidone can be increased when used in combination with Magnesium sulfate.]
[G03AC10, drospirenone, The metabolism of Drospirenone can be increased when combined with Magnesium sulfate.]
[V03AC02, deferiprone, Magnesium sulfate can cause a decrease in the absorption of Deferiprone resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N02BA01, aspirin, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Acetylsalicylic acid.]
[L01EJ01, ruxolitinib, Ruxolitinib may increase the bradycardic activities of Magnesium sulfate.]
[G04BD07, tolterodine, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Tolterodine.]
[C07AB03, atenolol, Atenolol may increase the arrhythmogenic activities of Magnesium sulfate.]
[A11CC03, alfacalcidol, The serum concentration of Magnesium sulfate can be increased when it is combined with Alfacalcidol.]
[J02AC03, voriconazole, The therapeutic efficacy of Voriconazole can be increased when used in combination with Magnesium sulfate.]
[M03AC04, atracurium, The therapeutic efficacy of Atracurium can be increased when used in combination with Magnesium sulfate.]
[S01FA01, atropine, Atropine may increase the arrhythmogenic activities of Magnesium sulfate.]
[J01CA09, azlocillin, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Azlocillin.]
[M03BX01, baclofen, The therapeutic efficacy of Baclofen can be increased when used in combination with Magnesium sulfate.]
[A08AA11, lorcaserin, The therapeutic efficacy of Lorcaserin can be increased when used in combination with Magnesium sulfate.]
[A06AX04, linaclotide, The therapeutic efficacy of Linaclotide can be decreased when used in combination with Magnesium sulfate.]
[A02AA05, magnesium silicate, The risk or severity of hypotension can be increased when Magnesium silicate is combined with Magnesium sulfate.]
[N03AG01, valproic acid, The therapeutic efficacy of Valproic acid can be increased when used in combination with Magnesium sulfate.]
[J01MB04, pipemidic acid, Magnesium sulfate can cause a decrease in the absorption of Pipemidic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L01EX05, regorafenib, Magnesium sulfate may increase the bradycardic activities of Regorafenib.]
[N05CA04, barbital, The therapeutic efficacy of Barbital can be increased when used in combination with Magnesium sulfate.]
[C01AA01, acetyldigitoxin, Acetyldigitoxin may increase the arrhythmogenic activities of Magnesium sulfate.]
[S01GA07, brimonidine, Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Magnesium sulfate.]
[N04BD02, rasagiline, The therapeutic efficacy of Rasagiline can be increased when used in combination with Magnesium sulfate.]
[C08CA13, lercanidipine, Lercanidipine may increase the arrhythmogenic activities of Magnesium sulfate.]
[A03FA09, mosapride, The therapeutic efficacy of Mosapride can be increased when used in combination with Magnesium sulfate.]
[N06DA02, donepezil, The therapeutic efficacy of Donepezil can be increased when used in combination with Magnesium sulfate.]
[N03AX22, perampanel, The therapeutic efficacy of Perampanel can be increased when used in combination with Magnesium sulfate.]
[L04AA29, tofacitinib, Magnesium sulfate may increase the bradycardic activities of Tofacitinib.]
[N02CC03, zolmitriptan, The therapeutic efficacy of Zolmitriptan can be increased when used in combination with Magnesium sulfate.]
[R06AC06, thonzylamine, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Thonzylamine.]
[G04BD10, darifenacin, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Darifenacin.]
[N01AA01, ethyl ether, The therapeutic efficacy of Diethyl ether can be increased when used in combination with Magnesium sulfate.]
[H01CB05, pasireotide, Magnesium sulfate may increase the bradycardic activities of Pasireotide.]
[C04AX11, bencyclane, Magnesium sulfate may increase the arrhythmogenic activities of Bencyclane.]
[A10BH04, alogliptin, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Alogliptin.]
[C03AA01, bendroflumethiazide, The risk or severity of adverse effects can be increased when Bendroflumethiazide is combined with Magnesium sulfate.]
[L04AX06, pomalidomide, The therapeutic efficacy of Pomalidomide can be increased when used in combination with Magnesium sulfate.]
[N02BA10, benorilate, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Benorilate.]
[N05AD07, benperidol, The therapeutic efficacy of Benperidol can be increased when used in combination with Magnesium sulfate.]
[A10BK02, canagliflozin, The risk or severity of adverse effects can be increased when Canagliflozin is combined with Magnesium sulfate.]
[J01MA15, gemifloxacin, The absorption of Gemifloxacin can be decreased when combined with Magnesium sulfate.]
[A12CC09, magnesium orotate, The risk or severity of hypotension can be increased when Magnesium orotate is combined with Magnesium sulfate.]
[S01AE07, moxifloxacin, Magnesium sulfate can cause a decrease in the absorption of Moxifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A06AX06, tegaserod, The therapeutic efficacy of Tegaserod can be decreased when used in combination with Magnesium sulfate.]
[A10AE05, insulin detemir, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Insulin detemir.]
[R02AD01, benzocaine, The therapeutic efficacy of Benzocaine can be increased when used in combination with Magnesium sulfate.]
[A10BX05, pramlintide, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Pramlintide.]
[M01AH01, celecoxib, The risk or severity of hyperkalemia can be increased when Celecoxib is combined with Magnesium sulfate.]
[N02CC02, naratriptan, The therapeutic efficacy of Naratriptan can be increased when used in combination with Magnesium sulfate.]
[A12CC05, magnesium aspartate, The risk or severity of hypotension can be increased when Magnesium aspartate is combined with Magnesium sulfate.]
[N04AC01, benztropine, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.]
[R02AX03, benzydamine, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Benzydamine.]
[P03AX06, benzyl alcohol, The therapeutic efficacy of Benzyl alcohol can be increased when used in combination with Magnesium sulfate.]
[N06AX28, levomilnacipran, The therapeutic efficacy of Levomilnacipran can be increased when used in combination with Magnesium sulfate.]
[C08EA02, bepridil, Magnesium sulfate may increase the arrhythmogenic activities of Bepridil.]
[A10BJ03, lixisenatide, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Lixisenatide.]
[N06AX26, vortioxetine, The therapeutic efficacy of Vortioxetine can be increased when used in combination with Magnesium sulfate.]
[G03AC08, etonogestrel, The metabolism of Etonogestrel can be increased when combined with Magnesium sulfate.]
[N03AF04, eslicarbazepine, The therapeutic efficacy of Eslicarbazepine can be increased when used in combination with Magnesium sulfate.]
[N03AG04, vigabatrin, The therapeutic efficacy of Vigabatrin can be increased when used in combination with Magnesium sulfate.]
[A10BK01, dapagliflozin, The risk or severity of adverse effects can be increased when Dapagliflozin is combined with Magnesium sulfate.]
[C07AB04, acebutolol, Magnesium sulfate may increase the arrhythmogenic activities of Acebutolol.]
[N05CH03, tasimelteon, The therapeutic efficacy of Tasimelteon can be increased when used in combination with Magnesium sulfate.]
[S01ED02, betaxolol, Betaxolol may increase the arrhythmogenic activities of Magnesium sulfate.]
[A10BJ04, albiglutide, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Albiglutide.]
[L01ED02, ceritinib, Magnesium sulfate may increase the bradycardic activities of Ceritinib.]
[A03BA03, hyoscyamine, Hyoscyamine may increase the arrhythmogenic activities of Magnesium sulfate.]
[N01AX05, alfaxalone, The therapeutic efficacy of Alfaxalone can be increased when used in combination with Magnesium sulfate.]
[A10BK03, empagliflozin, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Empagliflozin.]
[D11AA01, glycopyrronium, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Glycopyrronium.]
[N05CM19, suvorexant, The therapeutic efficacy of Suvorexant can be increased when used in combination with Magnesium sulfate.]
[S01AA15, dihydrostreptomycin, The risk or severity of neuromuscular blockade can be increased when Magnesium sulfate is combined with Dihydrostreptomycin.]
[N05AA04, acepromazine, The therapeutic efficacy of Acepromazine can be increased when used in combination with Magnesium sulfate.]
[A06AB04, phenolphthalein, The therapeutic efficacy of Phenolphthalein can be decreased when used in combination with Magnesium sulfate.]
[A10BJ05, dulaglutide, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Dulaglutide.]
[A06AH03, naloxegol, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Naloxegol.]
[N04AA02, biperiden, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Biperiden.]
[A06AG02, bisacodyl, The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Magnesium sulfate.]
[S03AA06, gentamicin, The risk or severity of neuromuscular blockade can be increased when Magnesium sulfate is combined with Gentamicin.]
[N06AX11, mirtazapine, The therapeutic efficacy of Mirtazapine can be increased when used in combination with Magnesium sulfate.]
[A03AA09, difemerine, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Difemerine.]
[C01EB17, ivabradine, Magnesium sulfate may increase the bradycardic activities of Ivabradine.]
[A07DA06, eluxadoline, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Eluxadoline.]
[N05AX16, brexpiprazole, The therapeutic efficacy of Brexpiprazole can be increased when used in combination with Magnesium sulfate.]
[G02CX02, flibanserin, The therapeutic efficacy of Flibanserin can be increased when used in combination with Magnesium sulfate.]
[A06AD03, magnesium peroxide, The risk or severity of hypotension can be increased when Magnesium peroxide is combined with Magnesium sulfate.]
[N05AX15, cariprazine, The therapeutic efficacy of Cariprazine can be increased when used in combination with Magnesium sulfate.]
[A10BF01, acarbose, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Acarbose.]
[M02AA25, aceclofenac, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Aceclofenac.]
[M01AB11, acemetacin, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Acemetacin.]
[S01EC01, acetazolamide, The therapeutic efficacy of Acetazolamide can be increased when used in combination with Magnesium sulfate.]
[A10AE06, insulin degludec, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Insulin degludec.]
[N05AB07, acetophenazine, The therapeutic efficacy of Acetophenazine can be increased when used in combination with Magnesium sulfate.]
[J02AC05, isavuconazole, The therapeutic efficacy of Isavuconazole can be increased when used in combination with Magnesium sulfate.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be decreased when it is combined with Magnesium sulfate.]
[A10BB31, acetohexamide, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Acetohexamide.]
[G04CA01, alfuzosin, The risk or severity of hypotension can be increased when Alfuzosin is combined with Magnesium sulfate.]
[N05CA05, aprobarbital, The therapeutic efficacy of Aprobarbital can be increased when used in combination with Magnesium sulfate.]
[M01AE16, alminoprofen, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Alminoprofen.]
[N03AX23, brivaracetam, The therapeutic efficacy of Brivaracetam can be increased when used in combination with Magnesium sulfate.]
[N05BA08, bromazepam, The therapeutic efficacy of Bromazepam can be increased when used in combination with Magnesium sulfate.]
[N04BC01, bromocriptine, The therapeutic efficacy of Bromocriptine can be increased when used in combination with Magnesium sulfate.]
[A02AD05, aluminum magnesium silicate, The risk or severity of neuromuscular blockade can be increased when Magnesium sulfate is combined with Magnesium Aluminum Silicate.]
[A03AX08, alverine, The therapeutic efficacy of Alverine can be increased when used in combination with Magnesium sulfate.]
[R06AB01, brompheniramine, The therapeutic efficacy of Dexbrompheniramine can be increased when used in combination with Magnesium sulfate.]
[N06AA19, amineptin, The therapeutic efficacy of Amineptine can be increased when used in combination with Magnesium sulfate.]
[C08CA01, amlodipine, Amlodipine may increase the arrhythmogenic activities of Magnesium sulfate.]
[N06BX11, aniracetam, The therapeutic efficacy of Aniracetam can be increased when used in combination with Magnesium sulfate.]
[C03CA02, bumetanide, The risk or severity of adverse effects can be increased when Bumetanide is combined with Magnesium sulfate.]
[N01BB01, bupivacaine, The therapeutic efficacy of Bupivacaine can be increased when used in combination with Magnesium sulfate.]
[C07AA19, bupranolol, Magnesium sulfate may increase the arrhythmogenic activities of Bupranolol.]
[N07BC01, buprenorphine, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.]
[N05BE01, buspirone, The therapeutic efficacy of Buspirone can be increased when used in combination with Magnesium sulfate.]
[N06DA03, rivastigmine, Magnesium sulfate may increase the bradycardic activities of Rivastigmine.]
[N02AF01, butorphanol, The therapeutic efficacy of Butorphanol can be increased when used in combination with Magnesium sulfate.]
[J01MA09, sparfloxacin, Magnesium sulfate can cause a decrease in the absorption of Sparfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[R06AX09, azatadine, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Azatadine.]
[S01GX07, azelastine, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Azelastine.]
[A06AX07, plecanatide, The therapeutic efficacy of Plecanatide can be decreased when used in combination with Magnesium sulfate.]
[A07EC04, balsalazide, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Balsalazide.]
[R03DA08, bamifylline, Magnesium sulfate may increase the excretion rate of Bamifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[N02BF02, pregabalin, The therapeutic efficacy of Pregabalin can be increased when used in combination with Magnesium sulfate.]
[N03AX30, beclamide, The therapeutic efficacy of Beclamide can be increased when used in combination with Magnesium sulfate.]
[N06BC01, caffeine, Magnesium sulfate may increase the excretion rate of Caffeine which could result in a lower serum level and potentially a reduction in efficacy.]
[C09AA07, benazepril, The risk or severity of hyperkalemia can be increased when Benazepril is combined with Magnesium sulfate.]
[A10BX06, benfluorex, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Benfluorex.]
[S01HA02, benoxinate, The therapeutic efficacy of Oxybuprocaine can be increased when used in combination with Magnesium sulfate.]
[H05BX05, calcifediol, The serum concentration of Magnesium sulfate can be increased when it is combined with Calcifediol.]
[D05AX03, calcitriol, The serum concentration of Magnesium sulfate can be increased when it is combined with Calcitriol.]
[J01XX08, linezolid, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Linezolid.]
[A12AA01, calcium phosphate, Magnesium sulfate can cause a decrease in the absorption of Calcium Phosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N04BD03, safinamide, The therapeutic efficacy of Safinamide can be increased when used in combination with Magnesium sulfate.]
[J01MA23, delafloxacin, Magnesium sulfate can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[D01AC10, bifonazole, The therapeutic efficacy of Bifonazole can be increased when used in combination with Magnesium sulfate.]
[P03AC02, bioallethrin, Magnesium sulfate may increase the arrhythmogenic activities of Bioallethrin.]
[C07AB07, bisoprolol, The therapeutic efficacy of Magnesium sulfate can be increased when used in combination with Bisoprolol.]
[J05AG03, efavirenz, The therapeutic efficacy of Efavirenz can be increased when used in combination with Magnesium sulfate.]
[C07AA17, bopindolol, The risk or severity of bradycardia can be increased when Magnesium sulfate is combined with Bopindolol.]
[N04AA11, bornaprine, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Bornaprine.]
[N05AD06, bromperidol, The therapeutic efficacy of Bromperidol can be increased when used in combination with Magnesium sulfate.]
[N05CD09, brotizolam, The therapeutic efficacy of Brotizolam can be increased when used in combination with Magnesium sulfate.]
[C03DA03, canrenone, The risk or severity of adverse effects can be increased when Canrenone is combined with Magnesium sulfate.]
[M01AB07, bumadizone, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Bumadizone.]
[N05CA03, butobarbital, The therapeutic efficacy of Butobarbital can be increased when used in combination with Magnesium sulfate.]
[N06AA15, butriptyline, The therapeutic efficacy of Butriptyline can be increased when used in combination with Magnesium sulfate.]
[C01AA02, acetyldigoxins, Magnesium sulfate may increase the arrhythmogenic activities of Acetyldigoxin.]
[A10BJ06, semaglutide, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Semaglutide.]
[N01BX04, capsaicin, The risk or severity of methemoglobinemia can be increased when Magnesium sulfate is combined with Capsaicin.]
[A10BK04, ertugliflozin, The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Magnesium sulfate.]
[N05CA08, butylvinal, The therapeutic efficacy of Vinylbital can be increased when used in combination with Magnesium sulfate.]
[C09AA01, captopril, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Captopril.]
[N03AF01, carbamazepine, The therapeutic efficacy of Carbamazepine can be increased when used in combination with Magnesium sulfate.]
[A06AC08, calcium polycarbophil, The therapeutic efficacy of Calcium polycarbophil can be decreased when used in combination with Magnesium sulfate.]
[A03AA03, camylofine, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Camylofin.]
[R06AA08, carbinoxamine, The therapeutic efficacy of Carbinoxamine can be increased when used in combination with Magnesium sulfate.]
[C07AG02, carvedilol, Magnesium sulfate may increase the arrhythmogenic activities of Carvedilol.]
[N03AX24, cannabidiol, The therapeutic efficacy of Cannabidiol can be increased when used in combination with Magnesium sulfate.]
[J01GB14, plazomicin, The risk or severity of neuromuscular blockade can be increased when Magnesium sulfate is combined with Plazomicin.]
[C07AB08, celiprolol, Magnesium sulfate may increase the arrhythmogenic activities of Celiprolol.]
[N03AX17, stiripentol, The therapeutic efficacy of Stiripentol can be increased when used in combination with Magnesium sulfate.]
[J01AA14, sarecycline, Magnesium sulfate can cause a decrease in the absorption of Sarecycline resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[J01AA15, omadacycline, Magnesium sulfate can cause a decrease in the absorption of Omadacycline resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[S01GX12, cetirizine, The therapeutic efficacy of Cetirizine can be increased when used in combination with Magnesium sulfate.]
[N05CM04, carbromal, The therapeutic efficacy of Carbromal can be increased when used in combination with Magnesium sulfate.]
[A10BB06, carbutamide, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Carbutamide.]
[N01BA04, chloroprocaine, The therapeutic efficacy of Chloroprocaine can be increased when used in combination with Magnesium sulfate.]
[R06AA06, chlorphenoxamine, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Chlorphenoxamine.]
[M01AC05, lornoxicam, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Lornoxicam.]
[R03DA02, oxtriphylline, Magnesium sulfate may increase the excretion rate of Oxtriphylline which could result in a lower serum level and potentially a reduction in efficacy.]
[M03BA02, carisoprodol, The therapeutic efficacy of Carisoprodol can be increased when used in combination with Magnesium sulfate.]
[R03BB08, revefenacin, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Revefenacin.]
[A06AX05, prucalopride, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Magnesium sulfate.]
[C01BG07, cifenline, Magnesium sulfate may increase the arrhythmogenic activities of Cibenzoline.]
[C09AA08, cilazapril, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Cilazapril.]
[A03FA08, cinitapride, The therapeutic efficacy of Cinitapride can be increased when used in combination with Magnesium sulfate.]
[S01ED05, carteolol, Magnesium sulfate may increase the arrhythmogenic activities of Carteolol.]
[N06AX27, esketamine, The therapeutic efficacy of Esketamine can be increased when used in combination with Magnesium sulfate.]
[J01FA09, clarithromycin, The risk or severity of QTc prolongation and hypotension can be increased when Clarithromycin is combined with Magnesium sulfate.]
[N06BA14, solriamfetol, The therapeutic efficacy of Solriamfetol can be increased when used in combination with Magnesium sulfate.]
[N06AX29, brexanolone, The therapeutic efficacy of Brexanolone can be increased when used in combination with Magnesium sulfate.]
[N05BA09, clobazam, The therapeutic efficacy of Clobazam can be increased when used in combination with Magnesium sulfate.]
[J01AA11, clomocycline, Magnesium sulfate can cause a decrease in the absorption of Clomocycline resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A06AB05, castor oil, The therapeutic efficacy of Castor oil can be decreased when used in combination with Magnesium sulfate.]
[N05BA22, cloxazolam, The therapeutic efficacy of Cloxazolam can be increased when used in combination with Magnesium sulfate.]
[V03AE07, calcium acetate, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Calcium acetate.]
[C09CA06, candesartan, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Candesartan.]
[A12CC06, magnesium lactate, The risk or severity of hypotension can be increased when Magnesium lactate is combined with Magnesium sulfate.]
[J01DD01, cefotaxime, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Cefotaxime.]
[N05AA06, cyamemazine, The therapeutic efficacy of Cyamemazine can be increased when used in combination with Magnesium sulfate.]
[C03BX03, cicletanine, Magnesium sulfate may increase the arrhythmogenic activities of Cicletanine.]
[M03BX08, cyclobenzaprine, The therapeutic efficacy of Cyclobenzaprine can be increased when used in combination with Magnesium sulfate.]
[C03AA09, cyclothiazide, The risk or severity of adverse effects can be increased when Cyclothiazide is combined with Magnesium sulfate.]
[G04BE04, yohimbine, The therapeutic efficacy of Yohimbine can be increased when used in combination with Magnesium sulfate.]
[A10AE03, insulin, regular, pork, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Insulin pork.]
[A06AB03, danthron, The therapeutic efficacy of Dantron can be decreased when used in combination with Magnesium sulfate.]
[J01DB03, cephalothin, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Cefalotin.]
[G03DB05, demegestone, The metabolism of Demegestone can be increased when combined with Magnesium sulfate.]
[N02CC08, lasmiditan, The therapeutic efficacy of Lasmiditan can be increased when used in combination with Magnesium sulfate.]
[G03AC09, desogestrel, The metabolism of Desogestrel can be increased when combined with Magnesium sulfate.]
[R06AB06, dexbrompheniramine, The therapeutic efficacy of Dexbrompheniramine can be increased when used in combination with Magnesium sulfate.]
[R06AB02, dexchlorpheniramine, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Dexchlorpheniramine.]
[S01XA12, dexpanthenol, The serum concentration of Magnesium sulfate can be increased when it is combined with Dexpanthenol.]
[N02AX03, dezocine, The therapeutic efficacy of Dezocine can be increased when used in combination with Magnesium sulfate.]
[N05CM21, lemborexant, The therapeutic efficacy of Lemborexant can be increased when used in combination with Magnesium sulfate.]
[N05AD10, lumateperone, The therapeutic efficacy of Lumateperone can be increased when used in combination with Magnesium sulfate.]
[S01AE06, gatifloxacin, Magnesium sulfate can cause a decrease in the absorption of Gatifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N02CC07, frovatriptan, The therapeutic efficacy of Frovatriptan can be increased when used in combination with Magnesium sulfate.]
[N05CC04, dichloralphenazone, The therapeutic efficacy of Dichloralphenazone can be increased when used in combination with Magnesium sulfate.]
[G03DB08, dienogest, The metabolism of Dienogest can be increased when combined with Magnesium sulfate.]
[A07DA04, difenoxin, The therapeutic efficacy of Difenoxin can be increased when used in combination with Magnesium sulfate.]
[N02AA08, dihydrocodeine, The therapeutic efficacy of Dihydrocodeine can be increased when used in combination with Magnesium sulfate.]
[N02CC06, eletriptan, The therapeutic efficacy of Eletriptan can be increased when used in combination with Magnesium sulfate.]
[M01AH02, rofecoxib, The risk or severity of hyperkalemia can be increased when Rofecoxib is combined with Magnesium sulfate.]
[C08CA16, clevidipine, Magnesium sulfate may increase the arrhythmogenic activities of Clevidipine.]
[C01BD07, dronedarone, Magnesium sulfate may increase the arrhythmogenic activities of Dronedarone.]
[N03AG02, dipropylacetamide, The therapeutic efficacy of Valpromide can be increased when used in combination with Magnesium sulfate.]
[L01AA02, chlorambucil, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Chlorambucil.]
[N05BA02, chlordiazepoxide, The therapeutic efficacy of Chlordiazepoxide can be increased when used in combination with Magnesium sulfate.]
[A03AA08, dihexyverine, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Dihexyverine.]
[G04BD09, trospium, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Trospium.]
[M01AC04, droxicam, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Droxicam.]
[M02AA27, dexketoprofen, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Dexketoprofen.]
[N05CM02, chlormethiazole, The therapeutic efficacy of Clomethiazole can be increased when used in combination with Magnesium sulfate.]
[M03BB02, chlormezanone, The therapeutic efficacy of Chlormezanone can be increased when used in combination with Magnesium sulfate.]
[R02AD04, dyclonine, The therapeutic efficacy of Dyclonine can be increased when used in combination with Magnesium sulfate.]
[C08CA17, levamlodipine, The risk or severity of hypotension can be increased when Magnesium sulfate is combined with Levamlodipine.]
[N05CD14, remimazolam, The risk or severity of sedation can be increased when Magnesium sulfate is combined with Remimazolam.]
[N07XX04, sodium oxybate, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.]
[N02AX07, oliceridine, The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Magnesium sulfate is combined with Oliceridine.]
[P01BA01, chloroquine, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Chloroquine.]
[C03AA04, chlorothiazide, The risk or severity of adverse effects can be increased when Chlorothiazide is combined with Magnesium sulfate.]
[R06AB04, chlorpheniramine, The therapeutic efficacy of Chlorpheniramine can be increased when used in combination with Magnesium sulfate.]
[N05AA01, chlorpromazine, The therapeutic efficacy of Chlorpromazine can be increased when used in combination with Magnesium sulfate.]
[A10BB02, chlorpropamide, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Chlorpropamide.]
[N05AF03, chlorprothixene, The therapeutic efficacy of Chlorprothixene can be increased when used in combination with Magnesium sulfate.]
[C03BA04, chlorthalidone, The risk or severity of adverse effects can be increased when Chlorthalidone is combined with Magnesium sulfate.]
[M03BB03, chlorzoxazone, The therapeutic efficacy of Chlorzoxazone can be increased when used in combination with Magnesium sulfate.]
[N05BX03, etifoxine, The therapeutic efficacy of Etifoxine can be increased when used in combination with Magnesium sulfate.]
[N02BA07, ethenzamide, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Ethenzamide.]
[N06BX18, vinpocetine, The therapeutic efficacy of Vinpocetine can be increased when used in combination with Magnesium sulfate.]
[N05BA18, ethyl loflazepate, The therapeutic efficacy of Ethyl loflazepate can be increased when used in combination with Magnesium sulfate.]
[G03DC06, ethynodiol, The metabolism of Etynodiol can be increased when combined with Magnesium sulfate.]
[M01AB08, etodolac, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Etodolac.]
[M02AA06, etofenamate, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Etofenamate.]
[M09AA01, hydroquinine, Magnesium sulfate may increase the arrhythmogenic activities of Hydroquinine.]
[M03BA05, febarbamate, The therapeutic efficacy of Febarbamate can be increased when used in combination with Magnesium sulfate.]
[N03AX10, felbamate, The therapeutic efficacy of Felbamate can be increased when used in combination with Magnesium sulfate.]
[M01AE05, fenbufen, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Fenbufen.]
[N06BA10, fenethylline, Magnesium sulfate may increase the excretion rate of Fenethylline which could result in a lower serum level and potentially a reduction in efficacy.]
[J01MB07, flumequine, Magnesium sulfate can cause a decrease in the absorption of Flumequine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A10AF01, insulin, regular, human, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Insulin human.]
[L04AA50, ponesimod, The risk or severity of bradycardia can be increased when Ponesimod is combined with Magnesium sulfate.]
[N01AB05, trichloroethylene, The therapeutic efficacy of Trichloroethylene can be increased when used in combination with Magnesium sulfate.]
[A02BA01, cimetidine, The serum concentration of Magnesium sulfate can be increased when it is combined with Cimetidine.]
[N02BF01, gabapentin, The therapeutic efficacy of Gabapentin can be increased when used in combination with Magnesium sulfate.]
[N07CA02, cinnarizine, Cinnarizine may increase the arrhythmogenic activities of Magnesium sulfate.]
[J01MB06, cinoxacin, Magnesium sulfate can cause a decrease in the absorption of Cinoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[S03AA07, ciprofloxacin, Magnesium sulfate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N06AB04, citalopram, The therapeutic efficacy of Citalopram can be increased when used in combination with Magnesium sulfate.]
[C03DA05, finerenone, The risk or severity of adverse effects can be increased when Finerenone is combined with Magnesium sulfate.]
[P01CA03, fexinidazole, The risk or severity of adverse effects can be increased when Magnesium sulfate is combined with Fexinidazole.]
[R06AA04, clemastine, The therapeutic efficacy of Clemastine can be increased when used in combination with Magnesium sulfate.]
[M01AG01, mefenamic acid, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Mefenamic acid.]
[A10BB12, glimepiride, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Glimepiride.]
[A10BB08, gliquidone, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Gliquidone.]
[A12AA02, calcium glubionate, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Calcium glubionate anhydrous.]
[J01FF01, clindamycin, The risk or severity of neuromuscular blockade can be increased when Magnesium sulfate is combined with Clindamycin.]
[N06AX25, St. John's wort extract, The therapeutic efficacy of St. John's Wort can be increased when used in combination with Magnesium sulfate.]
[L03AB15, ropeginterferon alfa-2b, The risk or severity of neuropsychiatric effects can be increased when Ropeginterferon alfa-2b is combined with Magnesium sulfate.]
[N01BB10, levobupivacaine, The therapeutic efficacy of Levobupivacaine can be increased when used in combination with Magnesium sulfate.]
[N06AA04, clomipramine, The therapeutic efficacy of Clomipramine can be increased when used in combination with Magnesium sulfate.]
[N03AE01, clonazepam, The therapeutic efficacy of Clonazepam can be increased when used in combination with Magnesium sulfate.]
[S01EA04, clonidine, The risk or severity of sedation can be increased when Clonidine is combined with Magnesium sulfate.]
[A10BX16, tirzepatide, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Tirzepatide.]
[J02AC06, oteseconazole, The therapeutic efficacy of Oteseconazole can be increased when used in combination with Magnesium sulfate.]
[C03BA03, clopamide, The risk or severity of adverse effects can be increased when Clopamide is combined with Magnesium sulfate.]
[N05AH06, clothiapine, The therapeutic efficacy of Clothiapine can be increased when used in combination with Magnesium sulfate.]
[N05BA21, clotiazepam, The therapeutic efficacy of Clotiazepam can be increased when used in combination with Magnesium sulfate.]
[A04AA01, ondansetron, The therapeutic efficacy of Ondansetron can be increased when used in combination with Magnesium sulfate.]
[A04AA02, granisetron, The therapeutic efficacy of Granisetron can be increased when used in combination with Magnesium sulfate.]
[N05AH02, clozapine, The therapeutic efficacy of Clozapine can be increased when used in combination with Magnesium sulfate.]
[A10BX01, guar gum, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Guar gum.]
[A10BK06, sotagliflozin, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Sotagliflozin.]
[J01GB12, arbekacin, The risk or severity of neuromuscular blockade can be increased when Magnesium sulfate is combined with Arbekacin.]
[N05BA13, halazepam, The therapeutic efficacy of Halazepam can be increased when used in combination with Magnesium sulfate.]
[S02DA02, cocaine, The risk or severity of methemoglobinemia can be increased when Magnesium sulfate is combined with Cocaine.]
[C02KB01, metyrosine, Magnesium sulfate may increase the sedative activities of Metyrosine.]
[M01AX13, proquazone, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Proquazone.]
[R05DA04, codeine, The therapeutic efficacy of Codeine can be increased when used in combination with Magnesium sulfate.]
[M03AC05, hexafluorenium, The therapeutic efficacy of Hexafluronium can be increased when used in combination with Magnesium sulfate.]
[A03AB10, hexocyclium, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Hexocyclium.]
[A03BB06, homatropine methylbromide, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Homatropine methylbromide.]
[S01FA05, homatropine, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Homatropine.]
[J01XB01, colistin, The risk or severity of neuromuscular blockade can be increased when Magnesium sulfate is combined with Colistin.]
[C01BA13, hydroquinidine, Magnesium sulfate may increase the arrhythmogenic activities of Hydroquinidine.]
[A02AD04, hydrotalcite, The risk or severity of hypotension can be increased when Hydrotalcite is combined with Magnesium sulfate.]
[N01AB07, desflurane, The therapeutic efficacy of Desflurane can be increased when used in combination with Magnesium sulfate.]
[A04AA03, tropisetron, The therapeutic efficacy of Tropisetron can be increased when used in combination with Magnesium sulfate.]
[C04AX28, ifenprodil, The therapeutic efficacy of Ifenprodil can be increased when used in combination with Magnesium sulfate.]
[A10BX03, nateglinide, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Nateglinide.]
[N02BA16, imidazole-2-hydroxybenzoate, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Imidazole salicylate.]
[H01AC03, mecasermin, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Mecasermin.]
[A10AE04, insulin glargine, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Insulin glargine.]
[J01FA15, telithromycin, The risk or severity of QTc prolongation and hypotension can be increased when Telithromycin is combined with Magnesium sulfate.]
[B01AC10, indobufen, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Indobufen.]
[R06AX27, desloratadine, The therapeutic efficacy of Desloratadine can be increased when used in combination with Magnesium sulfate.]
[J05AB14, valganciclovir, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Valganciclovir.]
[M01AH03, valdecoxib, The risk or severity of hyperkalemia can be increased when Valdecoxib is combined with Magnesium sulfate.]
[C01AA06, lanatoside C, The serum concentration of Lanatoside C can be increased when it is combined with Magnesium sulfate.]
[N02CC05, almotriptan, The therapeutic efficacy of Almotriptan can be increased when used in combination with Magnesium sulfate.]
[M01AH04, parecoxib, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Parecoxib.]
[J02AC02, itraconazole, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Itraconazole.]
[B01AB12, bemiparin, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Bemiparin.]
[N05BA10, ketazolam, The therapeutic efficacy of Ketazolam can be increased when used in combination with Magnesium sulfate.]
[M01AA06, kebuzone, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Kebuzone.]
[J02AC04, posaconazole, The therapeutic efficacy of Posaconazole can be increased when used in combination with Magnesium sulfate.]
[C08CA09, lacidipine, Magnesium sulfate may increase the arrhythmogenic activities of Lacidipine.]
[A06AD12, lactitol, The therapeutic efficacy of Lactitol can be decreased when used in combination with Magnesium sulfate.]
[N03AX09, lamotrigine, The therapeutic efficacy of Lamotrigine can be increased when used in combination with Magnesium sulfate.]
[S01GX02, levocabastine, The therapeutic efficacy of Levocabastine can be increased when used in combination with Magnesium sulfate.]
[N07BC04, lofexidine, The therapeutic efficacy of Lofexidine can be increased when used in combination with Magnesium sulfate.]
[S01AE04, lomefloxacin, Magnesium sulfate can cause a decrease in the absorption of Lomefloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[M01AB09, lonazolac, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Lonazolac.]
[N05CD06, lormetazepam, The therapeutic efficacy of Lormetazepam can be increased when used in combination with Magnesium sulfate.]
[H01AA02, cosyntropin, The risk or severity of liver damage can be increased when Tetracosactide is combined with Magnesium sulfate.]
[M02AA31, loxoprofen, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Loxoprofen.]
[C09AA03, lisinopril, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Lisinopril.]
[A02AD02, magaldrate, The risk or severity of hypotension can be increased when Magaldrate is combined with Magnesium sulfate.]
[B05XA10, magnesium phosphate, The risk or severity of neuromuscular blockade can be increased when Magnesium sulfate is combined with Magnesium phosphate.]
[C08CA11, manidipine, Magnesium sulfate may increase the arrhythmogenic activities of Manidipine.]
[A03AA04, mebeverine, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Mebeverine.]
[N06AX13, medifoxamine, The therapeutic efficacy of Medifoxamine can be increased when used in combination with Magnesium sulfate.]
[C07AA14, mepindolol, The risk or severity of bradycardia can be increased when Magnesium sulfate is combined with Mepindolol.]
[C01EB10, adenosine, Adenosine may increase the arrhythmogenic activities of Magnesium sulfate.]
[R06AD04, methdilazine, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Methdilazine.]
[N04AA03, methixene, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Metixene.]
[C04AX01, cyclandelate, Magnesium sulfate may increase the arrhythmogenic activities of Cyclandelate.]
[R06AE03, cyclizine, The therapeutic efficacy of Cyclizine can be increased when used in combination with Magnesium sulfate.]
[N05CA10, cyclobarbital, The therapeutic efficacy of Cyclobarbital can be increased when used in combination with Magnesium sulfate.]
[C03DA04, eplerenone, The risk or severity of adverse effects can be increased when Eplerenone is combined with Magnesium sulfate.]
[N05AD03, metylperon, The therapeutic efficacy of Melperone can be increased when used in combination with Magnesium sulfate.]
[C03AA07, cyclopenthiazide, The risk or severity of adverse effects can be increased when Cyclopenthiazide is combined with Magnesium sulfate.]
[A10BF02, miglitol, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Miglitol.]
[S01FA04, cyclopentolate, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Cyclopentolate.]
[N06AX07, minaprine, The therapeutic efficacy of Minaprine can be increased when used in combination with Magnesium sulfate.]
[S01XA18, cyclosporine, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Cyclosporine.]
[N06AG02, moclobemide, The therapeutic efficacy of Moclobemide can be increased when used in combination with Magnesium sulfate.]
[R06AX02, cyproheptadine, The therapeutic efficacy of Cyproheptadine can be increased when used in combination with Magnesium sulfate.]
[C09AA13, moexipril, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Moexipril.]
[M02AA02, mofebutazone, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Mofebutazone.]
[M01AX22, morniflumate, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Morniflumate.]
[C03XA02, conivaptan, The risk or severity of adverse effects can be increased when Conivaptan is combined with Magnesium sulfate.]
[M01AH05, etoricoxib, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Etoricoxib.]
[M03CA01, dantrolene, The risk or severity of hyperkalemia can be increased when Dantrolene is combined with Magnesium sulfate.]
[N06BX04, deanol, The therapeutic efficacy of Deanol can be increased when used in combination with Magnesium sulfate.]
[A04AD11, nabilone, The therapeutic efficacy of Nabilone can be increased when used in combination with Magnesium sulfate.]
[M01AX01, nabumetone, The risk or severity of hyperkalemia can be increased when Nabumetone is combined with Magnesium sulfate.]
[B05XA15, potassium lactate, Potassium lactate may increase the hyperkalemic activities of Magnesium sulfate.]
[J01AA01, demeclocycline, Magnesium sulfate can cause a decrease in the absorption of Demeclocycline resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N05BA16, nordazepam, The therapeutic efficacy of Nordazepam can be increased when used in combination with Magnesium sulfate.]
[C07AB12, nebivolol, Magnesium sulfate may increase the arrhythmogenic activities of Nebivolol.]
[N06AX06, nefazodone, The therapeutic efficacy of Nefazodone can be increased when used in combination with Magnesium sulfate.]
[N05CM16, niaprazine, The therapeutic efficacy of Niaprazine can be increased when used in combination with Magnesium sulfate.]
[C01DX16, nicorandil, Magnesium sulfate may increase the arrhythmogenic activities of Nicorandil.]
[N03AG06, tiagabine, The therapeutic efficacy of Tiagabine can be increased when used in combination with Magnesium sulfate.]
[G03DB04, nomegestrol, The metabolism of Nomegestrol can be increased when combined with Magnesium sulfate.]
[C01CA23, theodrenaline, Magnesium sulfate may increase the excretion rate of Theodrenaline which could result in a lower serum level and potentially a reduction in efficacy.]
[M03AC11, cisatracurium, The therapeutic efficacy of Cisatracurium can be increased when used in combination with Magnesium sulfate.]
[R05DA06, normethadone, The therapeutic efficacy of Normethadone can be increased when used in combination with Magnesium sulfate.]
[N06AB10, escitalopram, The therapeutic efficacy of Escitalopram can be increased when used in combination with Magnesium sulfate.]
[G04BD08, solifenacin, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Solifenacin.]
[A07EC03, olsalazine, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Olsalazine.]
[N06AA01, desipramine, The therapeutic efficacy of Desipramine can be increased when used in combination with Magnesium sulfate.]
[C01AA07, deslanoside, Magnesium sulfate may increase the arrhythmogenic activities of Deslanoside.]
[C09XA02, aliskiren, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Aliskiren.]
[M01AE12, oxaprozin, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Oxaprozin.]
[N03AF02, oxcarbazepine, The therapeutic efficacy of Oxcarbazepine can be increased when used in combination with Magnesium sulfate.]
[N06BX07, oxiracetam, The therapeutic efficacy of Oxiracetam can be increased when used in combination with Magnesium sulfate.]
[N04AA08, dexetimide, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Dexetimide.]
[G04BD04, oxybutynin, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Oxybutynin.]
[A03AA01, oxyphencyclimine, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Oxyphencyclimine.]
[N06BA02, dextroamphetamine, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Amphetamine.]
[R05DA09, dextromethorphan, The therapeutic efficacy of Dextromethorphan can be increased when used in combination with Magnesium sulfate.]
[N03AC01, paramethadione, The therapeutic efficacy of Paramethadione can be increased when used in combination with Magnesium sulfate.]
[N02AC01, dextromoramide, The therapeutic efficacy of Dextromoramide can be increased when used in combination with Magnesium sulfate.]
[N06AB05, paroxetine, The therapeutic efficacy of Paroxetine can be increased when used in combination with Magnesium sulfate.]
[B01AC04, clopidogrel, The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Magnesium sulfate.]
[N07BC06, heroin, The therapeutic efficacy of Diamorphine can be increased when used in combination with Magnesium sulfate.]
[C01DA05, pentaerythritol tetranitrate, Magnesium sulfate may increase the vasodilatory activities of Pentaerythritol tetranitrate.]
[C04AD01, pentifylline, Magnesium sulfate may increase the excretion rate of Pentifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[N05BA01, diazepam, The therapeutic efficacy of Diazepam can be increased when used in combination with Magnesium sulfate.]
[N03AX07, phenacemide, The therapeutic efficacy of Phenacemide can be increased when used in combination with Magnesium sulfate.]
[R02AA19, phenol, The risk or severity of methemoglobinemia can be increased when Magnesium sulfate is combined with Phenol.]
[N03AD02, phensuximide, The therapeutic efficacy of Phensuximide can be increased when used in combination with Magnesium sulfate.]
[N06AA08, dibenzepin, The therapeutic efficacy of Dibenzepin can be increased when used in combination with Magnesium sulfate.]
[S02DA04, dibucaine, The therapeutic efficacy of Cinchocaine can be increased when used in combination with Magnesium sulfate.]
[M05BA02, clodronic acid, Magnesium sulfate can cause a decrease in the absorption of Clodronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[S01EC02, dichlorphenamide, The risk or severity of adverse effects can be increased when Diclofenamide is combined with Magnesium sulfate.]
[S01BC03, diclofenac, The risk or severity of hyperkalemia can be increased when Diclofenac is combined with Magnesium sulfate.]
[A03AA07, dicyclomine, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.]
[A03AX04, pinaverium, Magnesium sulfate may increase the arrhythmogenic activities of Pinaverium.]
[A10BG03, pioglitazone, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Pioglitazone.]
[N05AD05, pipamperone, The therapeutic efficacy of Pipamperone can be increased when used in combination with Magnesium sulfate.]
[A03AB14, pipenzolate, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Pipenzolate.]
[C03CA03, piretanide, The risk or severity of adverse effects can be increased when Piretanide is combined with Magnesium sulfate.]
[A08AA03, diethylpropion, The therapeutic efficacy of Diethylpropion can be increased when used in combination with Magnesium sulfate.]
[L02AA01, diethylstilbestrol, The metabolism of Diethylstilbestrol can be increased when combined with Magnesium sulfate.]
[C08CA03, isradipine, Isradipine may increase the arrhythmogenic activities of Magnesium sulfate.]
[A03AB11, poldine, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Poldine.]
[N02BA11, diflunisal, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Diflunisal.]
[C01AA04, digitoxin, Magnesium sulfate may increase the arrhythmogenic activities of Digitoxin.]
[C01AA05, digoxin, Digoxin may increase the arrhythmogenic activities of Magnesium sulfate.]
[N02CA01, dihydroergotamine, The therapeutic efficacy of Dihydroergotamine can be increased when used in combination with Magnesium sulfate.]
[N02AA03, hydromorphone, The therapeutic efficacy of Hydromorphone can be increased when used in combination with Magnesium sulfate.]
[A11CC02, dihydrotachysterol, The serum concentration of Magnesium sulfate can be increased when it is combined with Dihydrotachysterol.]
[H03BC01, potassium perchlorate, Potassium perchlorate may increase the hyperkalemic activities of Magnesium sulfate.]
[D04AB07, pramoxine, The therapeutic efficacy of Pramocaine can be increased when used in combination with Magnesium sulfate.]
[C08DB01, diltiazem, Diltiazem may increase the arrhythmogenic activities of Magnesium sulfate.]
[R06AA11, dimenhydrinate, The therapeutic efficacy of Dimenhydrinate can be increased when used in combination with Magnesium sulfate.]
[M03BX03, pridinol, The therapeutic efficacy of Pridinol can be increased when used in combination with Magnesium sulfate.]
[R06AB03, dimethindene, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Dimetindene.]
[N03AG05, progabide, The therapeutic efficacy of Progabide can be increased when used in combination with Magnesium sulfate.]
[N06BC02, propentofylline, Magnesium sulfate may increase the excretion rate of Propentofylline which could result in a lower serum level and potentially a reduction in efficacy.]
[N02BB04, propyphenazone, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Propyphenazone.]
[M01AB14, proglumetacin, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Proglumetacin.]
[S01HA04, proparacaine, The risk or severity of methemoglobinemia can be increased when Magnesium sulfate is combined with Proparacaine.]
[R03DA03, proxyphylline, Magnesium sulfate may increase the excretion rate of Proxyphylline which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AA02, diphenhydramine, The therapeutic efficacy of Diphenhydramine can be increased when used in combination with Magnesium sulfate.]
[A07DA01, diphenoxylate, The therapeutic efficacy of Diphenoxylate can be increased when used in combination with Magnesium sulfate.]
[N05CD10, quazepam, The therapeutic efficacy of Quazepam can be increased when used in combination with Magnesium sulfate.]
[C09AA06, quinapril, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Quinapril.]
[N06BA11, dexmethylphenidate, The therapeutic efficacy of Dexmethylphenidate can be increased when used in combination with Magnesium sulfate.]
[N06AA23, quinupramine, The therapeutic efficacy of Quinupramine can be increased when used in combination with Magnesium sulfate.]
[A03FA02, cisapride, The therapeutic efficacy of Cisapride can be increased when used in combination with Magnesium sulfate.]
[C09AA05, ramipril, The risk or severity of hyperkalemia can be increased when Ramipril is combined with Magnesium sulfate.]
[S01XA23, sirolimus, Magnesium sulfate may increase the immunosuppressive activities of Sirolimus.]
[N05AL04, remoxipride, The therapeutic efficacy of Remoxipride can be increased when used in combination with Magnesium sulfate.]
[C01BA03, disopyramide, Disopyramide may increase the arrhythmogenic activities of Magnesium sulfate.]
[P03AA04, disulfiram, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Disulfiram.]
[N07XX02, riluzole, The therapeutic efficacy of Riluzole can be increased when used in combination with Magnesium sulfate.]
[N05AX08, risperidone, The therapeutic efficacy of Risperidone can be increased when used in combination with Magnesium sulfate.]
[R06AE09, levocetirizine, The therapeutic efficacy of Levocetirizine can be increased when used in combination with Magnesium sulfate.]
[N01BB09, ropivacaine, The therapeutic efficacy of Ropivacaine can be increased when used in combination with Magnesium sulfate.]
[J01MB01, rosoxacin, Magnesium sulfate can cause a decrease in the absorption of Rosoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L01EX01, sunitinib, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Sunitinib.]
[C03XA01, tolvaptan, The risk or severity of adverse effects can be increased when Tolvaptan is combined with Magnesium sulfate.]
[S01BC05, ketorolac, The risk or severity of hyperkalemia can be increased when Ketorolac is combined with Magnesium sulfate.]
[N02BA06, salsalate, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Salsalate.]
[N06AA16, dothiepin, The therapeutic efficacy of Dosulepin can be increased when used in combination with Magnesium sulfate.]
[N06AA12, doxepin, The therapeutic efficacy of Doxepin can be increased when used in combination with Magnesium sulfate.]
[A06AB06, sennosides, USP, The therapeutic efficacy of Senna leaf can be decreased when used in combination with Magnesium sulfate.]
[J01AA02, doxycycline, The absorption of Doxycycline can be decreased when combined with Magnesium sulfate.]
[R06AA09, doxylamine, Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Magnesium sulfate.]
[N06AB06, sertraline, The therapeutic efficacy of Sertraline can be increased when used in combination with Magnesium sulfate.]
[N01AB08, sevoflurane, The therapeutic efficacy of Sevoflurane can be increased when used in combination with Magnesium sulfate.]
[N05AD08, droperidol, The therapeutic efficacy of Droperidol can be increased when used in combination with Magnesium sulfate.]
[A08AA10, sibutramine, The therapeutic efficacy of Sibutramine can be increased when used in combination with Magnesium sulfate.]
[C09AA11, spirapril, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Spirapril.]
[R03DA01, dyphylline, Magnesium sulfate may increase the excretion rate of Dyphylline which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AL02, sultopride, The therapeutic efficacy of Sultopride can be increased when used in combination with Magnesium sulfate.]
[N02CC01, sumatriptan, The therapeutic efficacy of Sumatriptan can be increased when used in combination with Magnesium sulfate.]
[C07AB13, talinolol, Magnesium sulfate may increase the arrhythmogenic activities of Talinolol.]
[J01MA05, temafloxacin, Magnesium sulfate can cause a decrease in the absorption of Temafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[M01AC02, tenoxicam, The risk or severity of hyperkalemia can be increased when Tenoxicam is combined with Magnesium sulfate.]
[G04CA03, terazosin, The risk or severity of hypotension can be increased when Terazosin is combined with Magnesium sulfate.]
[G04BD05, terodiline, Magnesium sulfate may increase the arrhythmogenic activities of Terodiline.]
[C07AA16, tertatolol, Magnesium sulfate may increase the arrhythmogenic activities of Tertatolol.]
[A08AB01, orlistat, Orlistat can cause a decrease in the absorption of Magnesium sulfate resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[M03BX07, tetrazepam, The therapeutic efficacy of Tetrazepam can be increased when used in combination with Magnesium sulfate.]
[M03BX05, thiocolchicoside, The therapeutic efficacy of Thiocolchicoside can be increased when used in combination with Magnesium sulfate.]
[N05AB05, thiopropazate, The therapeutic efficacy of Thiopropazate can be increased when used in combination with Magnesium sulfate.]
[G04BD01, emepronium, The therapeutic efficacy of Emepronium can be increased when used in combination with Magnesium sulfate.]
[N06AX14, tianeptine, The therapeutic efficacy of Tianeptine can be increased when used in combination with Magnesium sulfate.]
[C09AA02, enalapril, The risk or severity of hyperkalemia can be increased when Enalapril is combined with Magnesium sulfate.]
[N05BA23, tofisopam, The therapeutic efficacy of Tofisopam can be increased when used in combination with Magnesium sulfate.]
[M01AG02, tolfenamic acid, Magnesium sulfate may increase the bradycardic activities of Tolfenamic acid.]
[N06AG03, toloxatone, The therapeutic efficacy of Toloxatone can be increased when used in combination with Magnesium sulfate.]
[N03AX11, topiramate, The therapeutic efficacy of Topiramate can be increased when used in combination with Magnesium sulfate.]
[C03CA04, torsemide, The risk or severity of adverse effects can be increased when Torasemide is combined with Magnesium sulfate.]
[J01AA12, tigecycline, The risk or severity of neuromuscular blockade can be increased when Tigecycline is combined with Magnesium sulfate.]
[C09AA10, trandolapril, The risk or severity of hyperkalemia can be increased when Trandolapril is combined with Magnesium sulfate.]
[N05CD11, triazulenone, The therapeutic efficacy of Loprazolam can be increased when used in combination with Magnesium sulfate.]
[N05CC01, chloral hydrate, The therapeutic efficacy of Chloral hydrate can be increased when used in combination with Magnesium sulfate.]
[N05CM07, triclofos, The therapeutic efficacy of Triclofos can be increased when used in combination with Magnesium sulfate.]
[A03AB08, tridihexethyl, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Tridihexethyl.]
[R06AA10, trimethobenzamide, The therapeutic efficacy of Trimethobenzamide can be increased when used in combination with Magnesium sulfate.]
[N04AA12, tropatepine, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Tropatepine.]
[N01AB04, enflurane, The therapeutic efficacy of Enflurane can be increased when used in combination with Magnesium sulfate.]
[C02CA06, urapidil, The therapeutic efficacy of Urapidil can be increased when used in combination with Magnesium sulfate.]
[J01MA04, enoxacin, Magnesium sulfate can cause a decrease in the absorption of Enoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N05AL06, veralipride, The therapeutic efficacy of Veralipride can be increased when used in combination with Magnesium sulfate.]
[S01GX10, epinastine, The therapeutic efficacy of Epinastine can be increased when used in combination with Magnesium sulfate.]
[N06AX16, venlafaxine, The therapeutic efficacy of Venlafaxine can be increased when used in combination with Magnesium sulfate.]
[S01GA03, xylometazoline, Magnesium sulfate may increase the arrhythmogenic activities of Xylometazoline.]
[C08CA12, mepirodipine, Magnesium sulfate may increase the arrhythmogenic activities of Barnidipine.]
[C09AA15, zofenopril, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Zofenopril.]
[N05CF02, zolpidem, The therapeutic efficacy of Zolpidem can be increased when used in combination with Magnesium sulfate.]
[M01AB04, zomepirac, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Zomepirac.]
[N03AX15, zonisamide, The therapeutic efficacy of Zonisamide can be increased when used in combination with Magnesium sulfate.]
[A10AB06, insulin glulisine, human, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Insulin glulisine.]
[N05CF01, zopiclone, The therapeutic efficacy of Zopiclone can be increased when used in combination with Magnesium sulfate.]
[N05AX11, zotepine, The therapeutic efficacy of Zotepine can be increased when used in combination with Magnesium sulfate.]
[C02AC02, guanfacine, The therapeutic efficacy of Guanfacine can be increased when used in combination with Magnesium sulfate.]
[C01BG01, moricizine, The therapeutic efficacy of Moricizine can be increased when used in combination with Magnesium sulfate.]
[A11CC01, ergocalciferol, The serum concentration of Magnesium sulfate can be increased when it is combined with Ergocalciferol.]
[G02AB03, ergonovine, The therapeutic efficacy of Ergometrine can be increased when used in combination with Magnesium sulfate.]
[C04AE01, ergoloid mesylates, USP, The therapeutic efficacy of Ergoloid mesylate can be increased when used in combination with Magnesium sulfate.]
[N02CA02, ergotamine, The therapeutic efficacy of Ergotamine can be increased when used in combination with Magnesium sulfate.]
[C01DA13, erythrityl tetranitrate, Magnesium sulfate may increase the vasodilatory activities of Erythrityl tetranitrate.]
[S01AA17, erythromycin, The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Magnesium sulfate.]
[N05CD04, estazolam, The therapeutic efficacy of Estazolam can be increased when used in combination with Magnesium sulfate.]
[G03CA03, estradiol, The metabolism of Estradiol can be increased when combined with Magnesium sulfate.]
[N05CM08, ethchlorvynol, The therapeutic efficacy of Ethchlorvynol can be increased when used in combination with Magnesium sulfate.]
[L02AA03, ethinyl estradiol, The metabolism of Ethinylestradiol can be increased when combined with Magnesium sulfate.]
[C01BD05, ibutilide, Ibutilide may increase the arrhythmogenic activities of Magnesium sulfate.]
[N04AA05, profenamine, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Profenamine.]
[N03AD01, ethosuximide, The therapeutic efficacy of Ethosuximide can be increased when used in combination with Magnesium sulfate.]
[N03AB01, ethotoin, The therapeutic efficacy of Ethotoin can be increased when used in combination with Magnesium sulfate.]
[N01BX01, ethyl chloride, The risk or severity of methemoglobinemia can be increased when Magnesium sulfate is combined with Ethyl chloride.]
[M01AC06, meloxicam, The risk or severity of methemoglobinemia can be increased when Magnesium sulfate is combined with Meloxicam.]
[S01XA06, ethylmorphine, The therapeutic efficacy of Ethylmorphine can be increased when used in combination with Magnesium sulfate.]
[N01BB07, etidocaine, The risk or severity of methemoglobinemia can be increased when Magnesium sulfate is combined with Etidocaine.]
[N01AX07, etomidate, The therapeutic efficacy of Etomidate can be increased when used in combination with Magnesium sulfate.]
[N05AE03, sertindole, The therapeutic efficacy of Sertindole can be increased when used in combination with Magnesium sulfate.]
[C01BA05, ajmaline, Magnesium sulfate may increase the arrhythmogenic activities of Ajmaline.]
[L04AD02, tacrolimus, Magnesium sulfate may increase the immunosuppressive activities of Tacrolimus.]
[J01MA08, fleroxacin, Magnesium sulfate can cause a decrease in the absorption of Fleroxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[R06AX12, terfenadine, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Terfenadine.]
[G02AD06, misoprostol, The risk or severity of adverse effects can be increased when Magnesium sulfate is combined with Misoprostol.]
[N06AX12, bupropion, The therapeutic efficacy of Bupropion can be increased when used in combination with Magnesium sulfate.]
[N06AB08, fluvoxamine, The therapeutic efficacy of Fluvoxamine can be increased when used in combination with Magnesium sulfate.]
[C01BB03, tocainide, Magnesium sulfate may increase the arrhythmogenic activities of Tocainide.]
[C01BC08, encainide, Magnesium sulfate may increase the arrhythmogenic activities of Encainide.]
[M05BA01, etidronic acid, Magnesium sulfate can cause a decrease in the absorption of Etidronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[C08CA02, felodipine, Magnesium sulfate may increase the arrhythmogenic activities of Felodipine.]
[C08EA01, fendiline, Magnesium sulfate may increase the arrhythmogenic activities of Fendiline.]
[N03AX26, fenfluramine, The therapeutic efficacy of Fenfluramine can be increased when used in combination with Magnesium sulfate.]
[M01AE04, fenoprofen, The risk or severity of hyperkalemia can be increased when Fenoprofen is combined with Magnesium sulfate.]
[R03CC04, fenoterol, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Fenoterol.]
[N02AB03, fentanyl, The therapeutic efficacy of Fentanyl can be increased when used in combination with Magnesium sulfate.]
[G04BD02, flavoxate, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Flavoxate.]
[C01BC04, flecainide, Magnesium sulfate may increase the arrhythmogenic activities of Flecainide.]
[N02BG04, floctafenine, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Floctafenine.]
[J02AC01, fluconazole, The risk or severity of hyperkalemia can be increased when Fluconazole is combined with Magnesium sulfate.]
[N07CA03, flunarizine, The therapeutic efficacy of Flunarizine can be increased when used in combination with Magnesium sulfate.]
[N05CD03, flunitrazepam, The therapeutic efficacy of Flunitrazepam can be increased when used in combination with Magnesium sulfate.]
[N06AA14, melitracen, The therapeutic efficacy of Melitracen can be increased when used in combination with Magnesium sulfate.]
[V03AZ01, ethanol, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Ethanol.]
[N06AB03, fluoxetine, The therapeutic efficacy of Fluoxetine can be increased when used in combination with Magnesium sulfate.]
[N05AF01, flupenthixol, The therapeutic efficacy of Flupentixol can be increased when used in combination with Magnesium sulfate.]
[N05AB02, fluphenazine, The therapeutic efficacy of Fluphenazine can be increased when used in combination with Magnesium sulfate.]
[N05CD01, flurazepam, The therapeutic efficacy of Flurazepam can be increased when used in combination with Magnesium sulfate.]
[S01BC04, flurbiprofen, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Flurbiprofen.]
[N05AG01, fluspirilene, The therapeutic efficacy of Fluspirilene can be increased when used in combination with Magnesium sulfate.]
[S01AA07, framycetin, The risk or severity of neuromuscular blockade can be increased when Framycetin is combined with Magnesium sulfate.]
[M03AA01, alcuronium, The therapeutic efficacy of Alcuronium can be increased when used in combination with Magnesium sulfate.]
[G01AX06, furazolidone, The therapeutic efficacy of Furazolidone can be increased when used in combination with Magnesium sulfate.]
[J05AE10, darunavir, The serum concentration of Magnesium sulfate can be increased when it is combined with Darunavir.]
[C03CA01, furosemide, The risk or severity of adverse effects can be increased when Furosemide is combined with Magnesium sulfate.]
[M05BA04, alendronic acid, Magnesium sulfate can cause a decrease in the absorption of Alendronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N05CF04, eszopiclone, The therapeutic efficacy of Eszopiclone can be increased when used in combination with Magnesium sulfate.]
[N05AL05, amisulpride, The therapeutic efficacy of Amisulpride can be increased when used in combination with Magnesium sulfate.]
[N06DA04, galantamine, Magnesium sulfate may increase the bradycardic activities of Galantamine.]
[M03AC02, gallamine, The therapeutic efficacy of Gallamine can be increased when used in combination with Magnesium sulfate.]
[C08DA02, gallopamil, Magnesium sulfate may increase the arrhythmogenic activities of Gallopamil.]
[S01AD09, ganciclovir, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Ganciclovir.]
[N03AA04, barbexaclone, The therapeutic efficacy of Barbexaclone can be increased when used in combination with Magnesium sulfate.]
[N06AX08, bifemelane, The therapeutic efficacy of Bifemelane can be increased when used in combination with Magnesium sulfate.]
[N04BC06, cabergoline, The therapeutic efficacy of Cabergoline can be increased when used in combination with Magnesium sulfate.]
[C01CA21, cafedrine, Magnesium sulfate may increase the excretion rate of Cafedrine which could result in a lower serum level and potentially a reduction in efficacy.]
[A10BJ02, liraglutide, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Liraglutide.]
[A12AA10, calcium gluceptate, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Calcium glucoheptonate.]
[A12AA30, calcium levulinate, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Calcium levulinate.]
[N03AD03, methsuximide, The therapeutic efficacy of Methsuximide can be increased when used in combination with Magnesium sulfate.]
[G03XA02, gestrinone, The metabolism of Gestrinone can be increased when combined with Magnesium sulfate.]
[N01AH02, alfentanil, The therapeutic efficacy of Alfentanil can be increased when used in combination with Magnesium sulfate.]
[A10BB01, glyburide, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Glyburide.]
[A10BB09, gliclazide, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Gliclazide.]
[A10BB07, glipizide, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Glipizide.]
[N05CM18, dexmedetomidine, The therapeutic efficacy of Dexmedetomidine can be increased when used in combination with Magnesium sulfate.]
[N05CE01, glutethimide, The therapeutic efficacy of Glutethimide can be increased when used in combination with Magnesium sulfate.]
[C05AE01, nitroglycerin, Magnesium sulfate may increase the vasodilatory activities of Nitroglycerin.]
[C01BD04, dofetilide, Dofetilide may increase the arrhythmogenic activities of Magnesium sulfate.]
[C02CA04, doxazosin, The risk or severity of hypotension can be increased when Doxazosin is combined with Magnesium sulfate.]
[C07AB09, esmolol, Esmolol may increase the arrhythmogenic activities of Magnesium sulfate.]
[C09AA09, fosinopril, The risk or severity of hyperkalemia can be increased when Fosinopril is combined with Magnesium sulfate.]
[P01BX01, halofantrine, Magnesium sulfate can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N05AD01, haloperidol, The therapeutic efficacy of Haloperidol can be increased when used in combination with Magnesium sulfate.]
[N01AB01, halothane, The therapeutic efficacy of Halothane can be increased when used in combination with Magnesium sulfate.]
[N05AH04, quetiapine, The therapeutic efficacy of Quetiapine can be increased when used in combination with Magnesium sulfate.]
[A10AD05, insulin aspart, human, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Insulin aspart.]
[N02CX03, iprazochrome, The therapeutic efficacy of Iprazochrome can be increased when used in combination with Magnesium sulfate.]
[N05CA21, allobarbital, The therapeutic efficacy of Allobarbital can be increased when used in combination with Magnesium sulfate.]
[C09CA01, losartan, Magnesium sulfate may increase the arrhythmogenic activities of Losartan.]
[S01XA14, heparin, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Heparin.]
[B05CB03, magnesium citrate, The risk or severity of hypotension can be increased when Magnesium citrate is combined with Magnesium sulfate.]
[A12CC03, magnesium gluconate, The risk or severity of hypotension can be increased when Magnesium gluconate is combined with Magnesium sulfate.]
[A07EC02, mesalamine, The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Magnesium sulfate.]
[A12CD02, sodium monofluorophosphate, The therapeutic efficacy of Sodium fluorophosphate can be decreased when used in combination with Magnesium sulfate.]
[N05CA16, hexobarbital, The therapeutic efficacy of Hexobarbital can be increased when used in combination with Magnesium sulfate.]
[C08CA10, nilvadipine, Magnesium sulfate may increase the arrhythmogenic activities of Nilvadipine.]
[M02AA26, nimesulide, Magnesium sulfate may increase the arrhythmogenic activities of Nimesulide.]
[C09AA04, perindopril, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Perindopril.]
[C03AA03, hydrochlorothiazide, The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Magnesium sulfate.]
[R05DA03, hydrocodone, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.]
[C03AA02, hydroflumethiazide, The risk or severity of adverse effects can be increased when Hydroflumethiazide is combined with Magnesium sulfate.]
[S01XA07, aluminum potassium sulfate, Potassium alum may increase the hyperkalemic activities of Magnesium sulfate.]
[A12BA02, potassium citrate, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Magnesium sulfate.]
[G04BD06, propiverine, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Propiverine.]
[P01BA02, hydroxychloroquine, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Hydroxychloroquine.]
[N05AX07, prothipendyl, The therapeutic efficacy of Prothipendyl can be increased when used in combination with Magnesium sulfate.]
[N05BB01, hydroxyzine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Magnesium sulfate.]
[M05BA07, risedronic acid, Magnesium sulfate can cause a decrease in the absorption of Risedronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[R02AX02, ibuprofen, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Ibuprofen.]
[A06AD21, sodium tartrate, The therapeutic efficacy of Sodium tartrate can be decreased when used in combination with Magnesium sulfate.]
[N01AH03, sufentanil, The therapeutic efficacy of Sufentanil can be increased when used in combination with Magnesium sulfate.]
[N06AA02, imipramine, The therapeutic efficacy of Imipramine can be increased when used in combination with Magnesium sulfate.]
[M03BX02, tizanidine, The therapeutic efficacy of Tizanidine can be increased when used in combination with Magnesium sulfate.]
[L01CE01, topotecan, Magnesium sulfate may increase the excretion rate of Topotecan which could result in a lower serum level and potentially a reduction in efficacy.]
[C03BA11, indapamide, The risk or severity of adverse effects can be increased when Indapamide is combined with Magnesium sulfate.]
[S01BC01, indomethacin, The risk or severity of hyperkalemia can be increased when Indomethacin is combined with Magnesium sulfate.]
[C02CA02, indoramin, The risk or severity of hypotension can be increased when Indoramin is combined with Magnesium sulfate.]
[N06AX17, milnacipran, The therapeutic efficacy of Milnacipran can be increased when used in combination with Magnesium sulfate.]
[A03AA30, piperidolate, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Piperidolate.]
[R01AA02, cyclopentamine, The risk or severity of adverse effects can be increased when Magnesium sulfate is combined with Cyclopentamine.]
[N01BB08, articaine, The therapeutic efficacy of Articaine can be increased when used in combination with Magnesium sulfate.]
[A10BH01, sitagliptin, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Sitagliptin.]
[V08AB02, iohexol, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Iohexol.]
[N05BA12, alprazolam, The therapeutic efficacy of Alprazolam can be increased when used in combination with Magnesium sulfate.]
[N05CH02, ramelteon, The therapeutic efficacy of Ramelteon can be increased when used in combination with Magnesium sulfate.]
[R06AE01, buclizine, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Buclizine.]
[A10BH02, vildagliptin, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Vildagliptin.]
[C07AA01, alprenolol, The therapeutic efficacy of Alprenolol can be increased when used in combination with Magnesium sulfate.]
[C03BA02, quinethazone, The risk or severity of adverse effects can be increased when Quinethazone is combined with Magnesium sulfate.]
[N06AA13, iprindole, The therapeutic efficacy of Iprindole can be increased when used in combination with Magnesium sulfate.]
[N06AF05, iproniazid, The therapeutic efficacy of Iproniazid can be increased when used in combination with Magnesium sulfate.]
[N05AA07, chlorproethazine, The therapeutic efficacy of Chlorproethazine can be increased when used in combination with Magnesium sulfate.]
[N06AF01, isocarboxazid, The therapeutic efficacy of Isocarboxazid can be increased when used in combination with Magnesium sulfate.]
[C09AA16, imidapril, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Imidapril.]
[N01AB06, isoflurane, The therapeutic efficacy of Isoflurane can be increased when used in combination with Magnesium sulfate.]
[N04BX02, entacapone, The therapeutic efficacy of Entacapone can be increased when used in combination with Magnesium sulfate.]
[J04AC01, isoniazid, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Isoniazid.]
[A10BJ01, exenatide, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Exenatide.]
[C01DA14, isosorbide mononitrate, Magnesium sulfate may increase the vasodilatory activities of Isosorbide mononitrate.]
[C05AE02, isosorbide dinitrate, Magnesium sulfate may increase the vasodilatory activities of Isosorbide dinitrate.]
[N06AX18, reboxetine, The therapeutic efficacy of Reboxetine can be increased when used in combination with Magnesium sulfate.]
[S01AA24, kanamycin, The risk or severity of neuromuscular blockade can be increased when Magnesium sulfate is combined with Kanamycin.]
[N01AX03, ketamine, The therapeutic efficacy of Ketamine can be increased when used in combination with Magnesium sulfate.]
[C02KD01, ketanserin, The therapeutic efficacy of Ketanserin can be increased when used in combination with Magnesium sulfate.]
[J02AB02, ketoconazole, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Ketoconazole.]
[H02CA04, levoketoconazole, The therapeutic efficacy of Levoketoconazole can be increased when used in combination with Magnesium sulfate.]
[N05AH03, olanzapine, The therapeutic efficacy of Olanzapine can be increased when used in combination with Magnesium sulfate.]
[M02AA10, ketoprofen, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Ketoprofen.]
[V03AC03, deferasirox, Magnesium sulfate can cause a decrease in the absorption of Deferasirox resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N04BC09, rotigotine, The therapeutic efficacy of Rotigotine can be increased when used in combination with Magnesium sulfate.]
[J01MB02, nalidixic acid, Magnesium sulfate can cause a decrease in the absorption of Nalidixic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[M01AE11, tiaprofenic acid, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Tiaprofenic acid.]
[D11AX02, gamma-linolenic acid, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Gamolenic acid.]
[C07AG01, labetalol, The risk or severity of bradycardia can be increased when Magnesium sulfate is combined with Labetalol.]
[N04BB01, amantadine, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Amantadine.]
[A06AD11, lactulose, The therapeutic efficacy of Lactulose can be decreased when used in combination with Magnesium sulfate.]
[A06AX03, lubiprostone, The therapeutic efficacy of Lubiprostone can be decreased when used in combination with Magnesium sulfate.]
[N03AX18, lacosamide, The therapeutic efficacy of Lacosamide can be increased when used in combination with Magnesium sulfate.]
[C03CC01, ethacrynic acid, The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Magnesium sulfate.]
[G03AD01, levonorgestrel, The metabolism of Levonorgestrel can be increased when combined with Magnesium sulfate.]
[N04BA01, levodopa, The therapeutic efficacy of Levodopa can be increased when used in combination with Magnesium sulfate.]
[S02DA01, lidocaine, The therapeutic efficacy of Lidocaine can be increased when used in combination with Magnesium sulfate.]
[C08EX01, lidoflazine, Magnesium sulfate may increase the arrhythmogenic activities of Lidoflazine.]
[J01FF02, lincomycin, The risk or severity of neuromuscular blockade can be increased when Magnesium sulfate is combined with Lincomycin.]
[C03DB01, amiloride, The risk or severity of adverse effects can be increased when Amiloride is combined with Magnesium sulfate.]
[N02CA07, lisuride, The therapeutic efficacy of Lisuride can be increased when used in combination with Magnesium sulfate.]
[N06AA07, lofepramine, The therapeutic efficacy of Lofepramine can be increased when used in combination with Magnesium sulfate.]
[A07DA03, loperamide, Magnesium sulfate may increase the arrhythmogenic activities of Loperamide.]
[A12AA11, calcium pangamate, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Calcium pangamate.]
[N05BA06, lorazepam, The therapeutic efficacy of Lorazepam can be increased when used in combination with Magnesium sulfate.]
[N05AH01, loxapine, The therapeutic efficacy of Loxapine can be increased when used in combination with Magnesium sulfate.]
[J01AA04, lymecycline, Magnesium sulfate can cause a decrease in the absorption of Lymecycline resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[G03DC03, lynestrenol, The metabolism of Lynestrenol can be increased when combined with Magnesium sulfate.]
[B05XA11, magnesium chloride, The risk or severity of hypotension can be increased when Magnesium chloride is combined with Magnesium sulfate.]
[G04BX01, magnesium hydroxide, The risk or severity of hypotension can be increased when Magnesium hydroxide is combined with Magnesium sulfate.]
[V04CX04, mannitol, The risk or severity of adverse effects can be increased when Mannitol is combined with Magnesium sulfate.]
[N06AA21, maprotiline, The therapeutic efficacy of Maprotiline can be increased when used in combination with Magnesium sulfate.]
[A08AA05, mazindol, The therapeutic efficacy of Mazindol can be increased when used in combination with Magnesium sulfate.]
[C02BB01, mecamylamine, The risk or severity of adverse effects can be increased when Magnesium sulfate is combined with Mecamylamine.]
[R06AE05, meclizine, The therapeutic efficacy of Meclizine can be increased when used in combination with Magnesium sulfate.]
[M02AA18, meclofenamic acid, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Meclofenamic acid.]
[N05BA03, medazepam, The therapeutic efficacy of Medazepam can be increased when used in combination with Magnesium sulfate.]
[C01AA08, medigoxin, Magnesium sulfate may increase the arrhythmogenic activities of Metildigoxin.]
[P01BC02, mefloquine, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Mefloquine.]
[C03BA05, mefruside, The risk or severity of adverse effects can be increased when Mefruside is combined with Magnesium sulfate.]
[B01AB06, nadroparin, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Nadroparin.]
[B01AB05, enoxaparin, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Enoxaparin.]
[B01AB04, dalteparin, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Dalteparin.]
[N05CH01, melatonin, The therapeutic efficacy of Melatonin can be increased when used in combination with Magnesium sulfate.]
[N02AB02, meperidine, The therapeutic efficacy of Meperidine can be increased when used in combination with Magnesium sulfate.]
[N03AB04, mephenytoin, The therapeutic efficacy of Mephenytoin can be increased when used in combination with Magnesium sulfate.]
[N03AA01, mephobarbital, The therapeutic efficacy of Methylphenobarbital can be increased when used in combination with Magnesium sulfate.]
[N01BB03, mepivacaine, The therapeutic efficacy of Mepivacaine can be increased when used in combination with Magnesium sulfate.]
[N05BC01, meprobamate, The therapeutic efficacy of Meprobamate can be increased when used in combination with Magnesium sulfate.]
[N02AX05, meptazinol, The therapeutic efficacy of Meptazinol can be increased when used in combination with Magnesium sulfate.]
[C03BC01, mersalyl, The risk or severity of adverse effects can be increased when Mersalyl is combined with Magnesium sulfate.]
[N05AC03, mesoridazine, The therapeutic efficacy of Mesoridazine can be increased when used in combination with Magnesium sulfate.]
[N05AX13, paliperidone, The therapeutic efficacy of Paliperidone can be increased when used in combination with Magnesium sulfate.]
[A10BA02, metformin, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Metformin.]
[A04AA04, dolasetron, The therapeutic efficacy of Dolasetron can be increased when used in combination with Magnesium sulfate.]
[H01CB03, lanreotide, Magnesium sulfate may increase the bradycardic activities of Lanreotide.]
[J01AA05, methacycline, Magnesium sulfate can cause a decrease in the absorption of Metacycline resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N07BC02, methadone, The risk or severity of adverse effects can be increased when Methadone is combined with Magnesium sulfate.]
[N06BA03, methamphetamine, The therapeutic efficacy of Metamfetamine can be increased when used in combination with Magnesium sulfate.]
[A03AB07, methantheline, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Methantheline.]
[R06AC05, methapyrilene, The therapeutic efficacy of Methapyrilene can be increased when used in combination with Magnesium sulfate.]
[N05CM01, methaqualone, The therapeutic efficacy of Methaqualone can be increased when used in combination with Magnesium sulfate.]
[N03AA30, metharbital, The therapeutic efficacy of Metharbital can be increased when used in combination with Magnesium sulfate.]
[S01EC05, methazolamide, The risk or severity of adverse effects can be increased when Methazolamide is combined with Magnesium sulfate.]
[G02CB05, metergoline, The therapeutic efficacy of Metergoline can be increased when used in combination with Magnesium sulfate.]
[M03BA03, methocarbamol, The therapeutic efficacy of Methocarbamol can be increased when used in combination with Magnesium sulfate.]
[N05CA15, methohexital, The therapeutic efficacy of Methohexital can be increased when used in combination with Magnesium sulfate.]
[N02BG08, ziconotide, The therapeutic efficacy of Ziconotide can be increased when used in combination with Magnesium sulfate.]
[N05AA02, methotrimeprazine, The therapeutic efficacy of Methotrimeprazine can be increased when used in combination with Magnesium sulfate.]
[N02BG09, methoxyflurane, The therapeutic efficacy of Methoxyflurane can be increased when used in combination with Magnesium sulfate.]
[C03AA08, methyclothiazide, The risk or severity of adverse effects can be increased when Methyclothiazide is combined with Magnesium sulfate.]
[A06AC06, methylcellulose, The therapeutic efficacy of Methylcellulose can be decreased when used in combination with Magnesium sulfate.]
[C02AB01, methyldopa, Magnesium sulfate may increase the bradycardic activities of Methyldopa.]
[V04CG05, methylene blue, The therapeutic efficacy of Methylene blue can be increased when used in combination with Magnesium sulfate.]
[R03DA05, aminophylline, Magnesium sulfate may increase the excretion rate of Aminophylline which could result in a lower serum level and potentially a reduction in efficacy.]
[N06BA04, methylphenidate, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Methylphenidate.]
[N03AF03, rufinamide, The therapeutic efficacy of Rufinamide can be increased when used in combination with Magnesium sulfate.]
[N05CE02, methyprylon, The therapeutic efficacy of Methyprylon can be increased when used in combination with Magnesium sulfate.]
[N02CA04, methysergide, The therapeutic efficacy of Methysergide can be increased when used in combination with Magnesium sulfate.]
[A03FA01, metoclopramide, The risk or severity of sedation can be increased when Metoclopramide is combined with Magnesium sulfate.]
[C03BA08, metolazone, The risk or severity of adverse effects can be increased when Metolazone is combined with Magnesium sulfate.]
[C07AB02, metoprolol, Metoprolol may increase the arrhythmogenic activities of Magnesium sulfate.]
[P01AB01, metronidazole, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Metronidazole.]
[C01BB02, mexiletine, Mexiletine may increase the arrhythmogenic activities of Magnesium sulfate.]
[N06AX03, mianserin, The therapeutic efficacy of Mianserin can be increased when used in combination with Magnesium sulfate.]
[S02AA13, miconazole, The therapeutic efficacy of Miconazole can be increased when used in combination with Magnesium sulfate.]
[N02BB03, aminopyrine, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Aminophenazone.]
[B01AB07, parnaparin, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Parnaparin.]
[N05CD08, midazolam, The therapeutic efficacy of Midazolam can be increased when used in combination with Magnesium sulfate.]
[C01CA17, midodrine, Midodrine may increase the bradycardic activities of Magnesium sulfate.]
[G03XB01, mifepristone, The metabolism of Mifepristone can be increased when combined with Magnesium sulfate.]
[B01AB10, tinzaparin, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Tinzaparin.]
[A06AA01, mineral oil, The therapeutic efficacy of Mineral oil can be decreased when used in combination with Magnesium sulfate.]
[C09CA03, valsartan, The risk or severity of hyperkalemia can be increased when Valsartan is combined with Magnesium sulfate.]
[J01AA08, minocycline, Minocycline may increase the central nervous system depressant (CNS depressant) activities of Magnesium sulfate.]
[N05AE02, molindone, The therapeutic efficacy of Molindone can be increased when used in combination with Magnesium sulfate.]
[C01BD01, amiodarone, The risk or severity of adverse effects can be increased when Amiodarone is combined with Magnesium sulfate.]
[N06AA09, amitriptyline, The therapeutic efficacy of Amitriptyline can be increased when used in combination with Magnesium sulfate.]
[N02AA01, morphine, The therapeutic efficacy of Morphine can be increased when used in combination with Magnesium sulfate.]
[A04AA05, palonosetron, The therapeutic efficacy of Palonosetron can be increased when used in combination with Magnesium sulfate.]
[B02BX05, eltrombopag, Magnesium sulfate can cause a decrease in the absorption of Eltrombopag resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[G04BA01, ammonium chloride, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Ammonium chloride.]
[M03AC03, vecuronium, The therapeutic efficacy of Vecuronium can be increased when used in combination with Magnesium sulfate.]
[N05CA02, amobarbital, The therapeutic efficacy of Amobarbital can be increased when used in combination with Magnesium sulfate.]
[J05AJ01, raltegravir, Magnesium sulfate can cause a decrease in the absorption of Raltegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[G04CA04, silodosin, The risk or severity of hypotension can be increased when Silodosin is combined with Magnesium sulfate.]
[R03BB01, ipratropium bromide, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Ipratropium.]
[N06AA17, amoxapine, The therapeutic efficacy of Amoxapine can be increased when used in combination with Magnesium sulfate.]
[N03AB05, fosphenytoin, The therapeutic efficacy of Fosphenytoin can be increased when used in combination with Magnesium sulfate.]
[C07AA12, nadolol, Magnesium sulfate may increase the arrhythmogenic activities of Nadolol.]
[N04BC04, ropinirole, Magnesium sulfate may increase the sedative activities of Ropinirole.]
[J01CF06, nafcillin, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Nafcillin.]
[C04AX21, nafronyl, The therapeutic efficacy of Naftidrofuryl can be increased when used in combination with Magnesium sulfate.]
[N02AF02, nalbuphine, The therapeutic efficacy of Nalbuphine can be increased when used in combination with Magnesium sulfate.]
[N07BB04, naltrexone, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Naltrexone.]
[N06BA01, amphetamine, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Amphetamine.]
[M02AA12, naproxen, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Naproxen.]
[A10BG01, troglitazone, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Troglitazone.]
[N06AX21, duloxetine, The therapeutic efficacy of Duloxetine can be increased when used in combination with Magnesium sulfate.]
[N04BX01, tolcapone, The therapeutic efficacy of Tolcapone can be increased when used in combination with Magnesium sulfate.]
[S03AA01, neomycin, The risk or severity of neuromuscular blockade can be increased when Magnesium sulfate is combined with Neomycin.]
[N01AH06, remifentanil, The therapeutic efficacy of Remifentanil can be increased when used in combination with Magnesium sulfate.]
[A10BX02, repaglinide, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Repaglinide.]
[C01CX08, levosimendan, Magnesium sulfate may increase the arrhythmogenic activities of Levosimendan.]
[N05AX14, iloperidone, The therapeutic efficacy of Iloperidone can be increased when used in combination with Magnesium sulfate.]
[J02AA01, amphotericin B, Magnesium sulfate may decrease the nephrotoxic activities of Amphotericin B.]
[S01AA23, netilmicin, The risk or severity of neuromuscular blockade can be increased when Magnesium sulfate is combined with Netilmicin.]
[N06AX23, desvenlafaxine, The therapeutic efficacy of Desvenlafaxine can be increased when used in combination with Magnesium sulfate.]
[C09CA07, telmisartan, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Telmisartan.]
[H05BX02, paricalcitol, The serum concentration of Magnesium sulfate can be increased when it is combined with Paricalcitol.]
[N06AF02, nialamide, The therapeutic efficacy of Nialamide can be increased when used in combination with Magnesium sulfate.]
[C08CA04, nicardipine, Nicardipine may increase the arrhythmogenic activities of Magnesium sulfate.]
[C04AE02, nicergoline, The risk or severity of hypotension can be increased when Nicergoline is combined with Magnesium sulfate.]
[N07BA01, nicotine, The risk or severity of adverse effects can be increased when Magnesium sulfate is combined with Nicotine.]
[C08CA05, nifedipine, Magnesium sulfate may increase the arrhythmogenic activities of Nifedipine.]
[M02AA17, niflumic acid, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Niflumic acid.]
[V03AB22, amyl nitrite, Magnesium sulfate may increase the vasodilatory activities of Amyl Nitrite.]
[C08CA06, nimodipine, Nimodipine may increase the arrhythmogenic activities of Magnesium sulfate.]
[C08CA07, nisoldipine, Nisoldipine may increase the arrhythmogenic activities of Magnesium sulfate.]
[N05CD02, nitrazepam, The therapeutic efficacy of Nitrazepam can be increased when used in combination with Magnesium sulfate.]
[C08CA08, nitrendipine, Magnesium sulfate may increase the arrhythmogenic activities of Nitrendipine.]
[J01XE01, nitrofurantoin, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Nitrofurantoin.]
[N05CF03, zaleplon, The therapeutic efficacy of Zaleplon can be increased when used in combination with Magnesium sulfate.]
[N04BC05, pramipexole, Magnesium sulfate may increase the sedative activities of Pramipexole.]
[C02DD01, nitroprusside, Magnesium sulfate may increase the hypotensive activities of Nitroprusside.]
[N01AX13, nitrous oxide, The therapeutic efficacy of Nitrous oxide can be increased when used in combination with Magnesium sulfate.]
[N06AX04, nomifensine, The therapeutic efficacy of Nomifensine can be increased when used in combination with Magnesium sulfate.]
[G03DC02, norethindrone, The metabolism of Norethisterone can be increased when combined with Magnesium sulfate.]
[S01AE02, norfloxacin, Magnesium sulfate can cause a decrease in the absorption of Norfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[G03AC07, norgestrienone, The metabolism of Norgestrienone can be increased when combined with Magnesium sulfate.]
[N06AA10, nortriptyline, The therapeutic efficacy of Nortriptyline can be increased when used in combination with Magnesium sulfate.]
[G02CA02, nylidrin, Magnesium sulfate may increase the arrhythmogenic activities of Nylidrin.]
[B01AB08, reviparin, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Reviparin.]
[H01CB02, octreotide, The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Magnesium sulfate.]
[S02AA16, ofloxacin, Magnesium sulfate can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N06AA05, opipramol, The therapeutic efficacy of Opipramol can be increased when used in combination with Magnesium sulfate.]
[N02AA02, opium, The therapeutic efficacy of Opium can be increased when used in combination with Magnesium sulfate.]
[G04CA02, tamsulosin, The risk or severity of hypotension can be increased when Tamsulosin is combined with Magnesium sulfate.]
[C01AC01, ouabain, The serum concentration of Ouabain can be increased when it is combined with Magnesium sulfate.]
[N05BA04, oxazepam, The therapeutic efficacy of Oxazepam can be increased when used in combination with Magnesium sulfate.]
[J01MB05, oxolinic acid, Magnesium sulfate can cause a decrease in the absorption of Oxolinic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[C07AA02, oxprenolol, The therapeutic efficacy of Oxprenolol can be increased when used in combination with Magnesium sulfate.]
[N02AA05, oxycodone, The therapeutic efficacy of Oxycodone can be increased when used in combination with Magnesium sulfate.]
[N02AA11, oxymorphone, The therapeutic efficacy of Oxymorphone can be increased when used in combination with Magnesium sulfate.]
[N05AE01, oxypertine, The therapeutic efficacy of Oxypertine can be increased when used in combination with Magnesium sulfate.]
[S01BC02, oxyphenbutazone, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Oxyphenbutazone.]
[A03AB03, oxyphenonium, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.]
[S01AA04, oxytetracycline, Magnesium sulfate can cause a decrease in the absorption of Oxytetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N05AH05, asenapine, The therapeutic efficacy of Asenapine can be increased when used in combination with Magnesium sulfate.]
[B01AB09, danaparoid, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Danaparoid.]
[N02AX06, tapentadol, The therapeutic efficacy of Tapentadol can be increased when used in combination with Magnesium sulfate.]
[M03AC01, pancuronium, The therapeutic efficacy of Pancuronium can be increased when used in combination with Magnesium sulfate.]
[J04AB30, capreomycin, The risk or severity of neuromuscular blockade can be increased when Capreomycin is combined with Magnesium sulfate.]
[G03DB06, chlormadinone, The metabolism of Chlormadinone can be increased when combined with Magnesium sulfate.]
[N05CC05, paraldehyde, The therapeutic efficacy of Paraldehyde can be increased when used in combination with Magnesium sulfate.]
[C02KC01, pargyline, The therapeutic efficacy of Pargyline can be increased when used in combination with Magnesium sulfate.]
[A07AA06, paromomycin, The risk or severity of neuromuscular blockade can be increased when Magnesium sulfate is combined with Paromomycin.]
[J01MA03, pefloxacin, Magnesium sulfate can cause a decrease in the absorption of Pefloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[G04BD11, fesoterodine, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Fesoterodine.]
[C07AA23, penbutolol, The therapeutic efficacy of Penbutolol can be increased when used in combination with Magnesium sulfate.]
[N05AG03, penfluridol, The therapeutic efficacy of Penfluridol can be increased when used in combination with Magnesium sulfate.]
[N02AD01, pentazocine, The therapeutic efficacy of Pentazocine can be increased when used in combination with Magnesium sulfate.]
[N05CA01, pentobarbital, The therapeutic efficacy of Pentobarbital can be increased when used in combination with Magnesium sulfate.]
[C04AD03, pentoxifylline, Magnesium sulfate may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AB10, perazine, The therapeutic efficacy of Perazine can be increased when used in combination with Magnesium sulfate.]
[N04BC02, pergolide, The therapeutic efficacy of Pergolide can be increased when used in combination with Magnesium sulfate.]
[C08EX02, perhexiline, Magnesium sulfate may increase the arrhythmogenic activities of Perhexiline.]
[N05AB03, perphenazine, The therapeutic efficacy of Perphenazine can be increased when used in combination with Magnesium sulfate.]
[N02AD02, phenazocine, The therapeutic efficacy of Phenazocine can be increased when used in combination with Magnesium sulfate.]
[N06AF03, phenelzine, The therapeutic efficacy of Phenelzine can be increased when used in combination with Magnesium sulfate.]
[A10BA01, phenformin, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Phenformin.]
[N03AA02, phenobarbital, The therapeutic efficacy of Phenobarbital can be increased when used in combination with Magnesium sulfate.]
[A06AB01, oxyphenisatin, The therapeutic efficacy of Oxyphenisatin can be decreased when used in combination with Magnesium sulfate.]
[N01AH04, phenoperidine, The therapeutic efficacy of Phenoperidine can be increased when used in combination with Magnesium sulfate.]
[C04AX02, phenoxybenzamine, The risk or severity of hypotension can be increased when Phenoxybenzamine is combined with Magnesium sulfate.]
[V03AB36, phentolamine, The risk or severity of hypotension can be increased when Phentolamine is combined with Magnesium sulfate.]
[M02AA01, phenylbutazone, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Phenylbutazone.]
[S01GA05, phenylephrine, The risk or severity of hypertension can be decreased when Magnesium sulfate is combined with Phenylephrine.]
[R01BA01, phenylpropanolamine, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Phenylpropanolamine.]
[N03AB02, phenytoin, The therapeutic efficacy of Phenytoin can be increased when used in combination with Magnesium sulfate.]
[S01AE05, levofloxacin, Magnesium sulfate can cause a decrease in the absorption of Levofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[C08CX01, mibefradil, Magnesium sulfate may increase the arrhythmogenic activities of Mibefradil.]
[N05AG02, pimozide, The therapeutic efficacy of Pimozide can be increased when used in combination with Magnesium sulfate.]
[C07AA03, pindolol, The therapeutic efficacy of Pindolol can be increased when used in combination with Magnesium sulfate.]
[J01CA12, piperacillin, The risk or severity of neuromuscular blockade can be increased when Piperacillin is combined with Magnesium sulfate.]
[N05AC04, pipothiazine, The therapeutic efficacy of Pipotiazine can be increased when used in combination with Magnesium sulfate.]
[C09CA02, eprosartan, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Eprosartan.]
[A02BX03, pirenzepine, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Pirenzepine.]
[N02AC03, pirinitramide, The therapeutic efficacy of Piritramide can be increased when used in combination with Magnesium sulfate.]
[S01BC06, piroxicam, The risk or severity of hyperkalemia can be increased when Piroxicam is combined with Magnesium sulfate.]
[J01MA11, grepafloxacin, Magnesium sulfate can cause a decrease in the absorption of Grepafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N02CX01, pizotyline, The therapeutic efficacy of Pizotifen can be increased when used in combination with Magnesium sulfate.]
[C09CA04, irbesartan, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Irbesartan.]
[N05CA22, proxibarbal, The therapeutic efficacy of Proxibarbal can be increased when used in combination with Magnesium sulfate.]
[A10BG02, rosiglitazone, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Rosiglitazone.]
[A06AD15, polyethylene glycols, The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Magnesium sulfate.]
[A03AE01, alosetron, The therapeutic efficacy of Alosetron can be increased when used in combination with Magnesium sulfate.]
[C03AA05, polythiazide, The risk or severity of adverse effects can be increased when Polythiazide is combined with Magnesium sulfate.]
[A10BH03, saxagliptin, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Saxagliptin.]
[V03AB21, potassium iodide, Potassium Iodide may increase the hyperkalemic activities of Magnesium sulfate.]
[A10AD04, insulin lispro, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Insulin lispro.]
[C07AB01, practolol, Magnesium sulfate may increase the arrhythmogenic activities of Practolol.]
[C01BA08, prajmaline, Magnesium sulfate may increase the arrhythmogenic activities of Prajmaline.]
[N05BA11, prazepam, The therapeutic efficacy of Prazepam can be increased when used in combination with Magnesium sulfate.]
[C02CA01, prazosin, The risk or severity of hypotension can be increased when Prazosin is combined with Magnesium sulfate.]
[C01DX02, prenylamine, Magnesium sulfate may increase the arrhythmogenic activities of Prenylamine.]
[N01BB04, prilocaine, The therapeutic efficacy of Prilocaine can be increased when used in combination with Magnesium sulfate.]
[N03AA03, primidone, The therapeutic efficacy of Primidone can be increased when used in combination with Magnesium sulfate.]
[C01BA02, procainamide, Magnesium sulfate may increase the arrhythmogenic activities of Procainamide.]
[S01HA05, procaine, The therapeutic efficacy of Procaine can be increased when used in combination with Magnesium sulfate.]
[L01XB01, procarbazine, The therapeutic efficacy of Procarbazine can be increased when used in combination with Magnesium sulfate.]
[N05AB04, prochlorperazine, The therapeutic efficacy of Prochlorperazine can be increased when used in combination with Magnesium sulfate.]
[N04AA04, procyclidine, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Procyclidine.]
[G03DA04, progesterone, The metabolism of Progesterone can be increased when combined with Magnesium sulfate.]
[N05AA03, promazine, The therapeutic efficacy of Promazine can be increased when used in combination with Magnesium sulfate.]
[R06AD02, promethazine, The therapeutic efficacy of Promethazine can be increased when used in combination with Magnesium sulfate.]
[C01BC03, propafenone, Magnesium sulfate may increase the arrhythmogenic activities of Propafenone.]
[N01AX04, propanidid, The therapeutic efficacy of Propanidid can be increased when used in combination with Magnesium sulfate.]
[A03AB05, propantheline, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Propantheline.]
[N05AC01, periciazine, The therapeutic efficacy of Periciazine can be increased when used in combination with Magnesium sulfate.]
[N05CM06, propiomazine, The therapeutic efficacy of Propiomazine can be increased when used in combination with Magnesium sulfate.]
[N01AX10, propofol, The therapeutic efficacy of Propofol can be increased when used in combination with Magnesium sulfate.]
[N02AC04, propoxyphene, The therapeutic efficacy of Dextropropoxyphene can be increased when used in combination with Magnesium sulfate.]
[C07AA05, propranolol, Propranolol may increase the arrhythmogenic activities of Magnesium sulfate.]
[C01AB01, proscillaridin, The serum concentration of Proscillaridin can be increased when it is combined with Magnesium sulfate.]
[N02CC04, rizatriptan, The therapeutic efficacy of Rizatriptan can be increased when used in combination with Magnesium sulfate.]
[N06AA11, protriptyline, The therapeutic efficacy of Protriptyline can be increased when used in combination with Magnesium sulfate.]
[N05AX12, aripiprazole, The therapeutic efficacy of Aripiprazole can be increased when used in combination with Magnesium sulfate.]
[A03AB15, diphemanil, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Diphemanil.]
[A03AB09, isopropamide, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Isopropamide.]
[S01FA03, methscopolamine, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Methscopolamine.]
[N05CA07, talbutal, The therapeutic efficacy of Talbutal can be increased when used in combination with Magnesium sulfate.]
[N05CA09, vinbarbital, The therapeutic efficacy of Vinbarbital can be increased when used in combination with Magnesium sulfate.]
[N05BB02, captodiamine, The therapeutic efficacy of Captodiame can be increased when used in combination with Magnesium sulfate.]
[M03BA04, styramate, The therapeutic efficacy of Styramate can be increased when used in combination with Magnesium sulfate.]
[P02CC01, pyrantel, The therapeutic efficacy of Pyrantel can be increased when used in combination with Magnesium sulfate.]
[A12BA05, potassium gluconate, Potassium gluconate may increase the hyperkalemic activities of Magnesium sulfate.]
[R06AC01, pyrilamine, The therapeutic efficacy of Mepyramine can be increased when used in combination with Magnesium sulfate.]
[C01BA01, quinidine, Magnesium sulfate may increase the arrhythmogenic activities of Quinidine.]
[P01BC01, quinine, The therapeutic efficacy of Quinine can be increased when used in combination with Magnesium sulfate.]
[C02AA01, rescinnamine, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Rescinnamine.]
[C02AA02, reserpine, The therapeutic efficacy of Reserpine can be increased when used in combination with Magnesium sulfate.]
[N06AX01, 5-hydroxytryptophan, The therapeutic efficacy of Oxitriptan can be increased when used in combination with Magnesium sulfate.]
[J01AA09, rolitetracycline, The risk or severity of neuromuscular blockade can be increased when Magnesium sulfate is combined with Rolitetracycline.]
[N02BA05, salicylamide, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Salicylamide.]
[A07EC01, sulfasalazine, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Sulfasalazine.]
[S01BC08, salicylic acid, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Salicylic acid.]
[S01FA02, scopolamine, The therapeutic efficacy of Scopolamine can be increased when used in combination with Magnesium sulfate.]
[N05CA06, secobarbital, The therapeutic efficacy of Secobarbital can be increased when used in combination with Magnesium sulfate.]
[N04BD01, selegiline, The therapeutic efficacy of Selegiline can be increased when used in combination with Magnesium sulfate.]
[J01GB08, sisomicin, The risk or severity of neuromuscular blockade can be increased when Magnesium sulfate is combined with Sisomicin.]
[V04CC01, sorbitol, The therapeutic efficacy of Sorbitol can be decreased when used in combination with Magnesium sulfate.]
[C07AA07, sotalol, Sotalol may increase the arrhythmogenic activities of Magnesium sulfate.]
[C03DA01, spironolactone, The risk or severity of adverse effects can be increased when Spironolactone is combined with Magnesium sulfate.]
[S02DA03, antipyrine, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Antipyrine.]
[G03XB02, ulipristal, The metabolism of Ulipristal can be increased when combined with Magnesium sulfate.]
[J01GA01, streptomycin, The risk or severity of neuromuscular blockade can be increased when Magnesium sulfate is combined with Streptomycin.]
[L04AA27, fingolimod, Magnesium sulfate may increase the bradycardic activities of Fingolimod.]
[M03AB01, succinylcholine, The therapeutic efficacy of Succinylcholine can be increased when used in combination with Magnesium sulfate.]
[J01EC02, sulfadiazine, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Sulfadiazine.]
[J01EC01, sulfamethoxazole, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Sulfamethoxazole.]
[S01AB02, sulfisoxazole, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Sulfisoxazole.]
[M01AB02, sulindac, The risk or severity of hyperkalemia can be increased when Sulindac is combined with Magnesium sulfate.]
[N05AL01, sulpiride, The therapeutic efficacy of Sulpiride can be increased when used in combination with Magnesium sulfate.]
[N03AX03, sulthiame, The therapeutic efficacy of Sulthiame can be increased when used in combination with Magnesium sulfate.]
[A10BB04, glibornuride, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Glibornuride.]
[A10BC01, glymidine, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Glymidine.]
[M01AX04, apazone, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Azapropazone.]
[L01BB02, mercaptopurine, Magnesium sulfate may increase the excretion rate of Mercaptopurine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CD07, temazepam, The therapeutic efficacy of Temazepam can be increased when used in combination with Magnesium sulfate.]
[S01HA03, tetracaine, The therapeutic efficacy of Tetracaine can be increased when used in combination with Magnesium sulfate.]
[S03AA02, tetracycline, Magnesium sulfate can cause a decrease in the absorption of Tetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N05AE05, lurasidone, The therapeutic efficacy of Lurasidone can be increased when used in combination with Magnesium sulfate.]
[A04AD10, dronabinol, The therapeutic efficacy of Dronabinol can be increased when used in combination with Magnesium sulfate.]
[N04BC07, apomorphine, The therapeutic efficacy of Apomorphine can be increased when used in combination with Magnesium sulfate.]
[L04AX02, thalidomide, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.]
[R03DA07, theobromine, Magnesium sulfate may increase the excretion rate of Theobromine which could result in a lower serum level and potentially a reduction in efficacy.]
[R03DA04, theophylline, Magnesium sulfate may increase the excretion rate of Theophylline which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AD03, thiethylperazine, The therapeutic efficacy of Thiethylperazine can be increased when used in combination with Magnesium sulfate.]
[N05CA19, thiopental, The therapeutic efficacy of Thiopental can be increased when used in combination with Magnesium sulfate.]
[N05AB08, thioproperazine, The therapeutic efficacy of Thioproperazine can be increased when used in combination with Magnesium sulfate.]
[N05AC02, thioridazine, The therapeutic efficacy of Thioridazine can be increased when used in combination with Magnesium sulfate.]
[N05AF04, thiothixene, The therapeutic efficacy of Thiothixene can be increased when used in combination with Magnesium sulfate.]
[C01BB04, aprindine, Magnesium sulfate may increase the arrhythmogenic activities of Aprindine.]
[N05AL03, tiapride, The therapeutic efficacy of Tiapride can be increased when used in combination with Magnesium sulfate.]
[N02AX01, tilidine, The therapeutic efficacy of Tilidine can be increased when used in combination with Magnesium sulfate.]
[S01ED01, timolol, The risk or severity of adverse effects can be increased when Magnesium sulfate is combined with Timolol.]
[S01AA12, tobramycin, The risk or severity of neuromuscular blockade can be increased when Magnesium sulfate is combined with Tobramycin.]
[A10BB05, tolazamide, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Tolazamide.]
[M02AX02, tolazoline, The risk or severity of hypotension can be increased when Tolazoline is combined with Magnesium sulfate.]
[V04CA01, tolbutamide, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Tolbutamide.]
[M02AA21, tolmetin, The risk or severity of hyperkalemia can be increased when Tolmetin is combined with Magnesium sulfate.]
[M03BX04, tolperisone, The therapeutic efficacy of Tolperisone can be increased when used in combination with Magnesium sulfate.]
[N02AX02, tramadol, The therapeutic efficacy of Tramadol can be increased when used in combination with Magnesium sulfate.]
[N06AF04, tranylcypromine, The therapeutic efficacy of Tranylcypromine can be increased when used in combination with Magnesium sulfate.]
[N06AX05, trazodone, The therapeutic efficacy of Trazodone can be increased when used in combination with Magnesium sulfate.]
[C03DB02, triamterene, The risk or severity of adverse effects can be increased when Triamterene is combined with Magnesium sulfate.]
[N05CD05, triazolam, The therapeutic efficacy of Triazolam can be increased when used in combination with Magnesium sulfate.]
[C03AA06, trichlormethiazide, The risk or severity of adverse effects can be increased when Trichlormethiazide is combined with Magnesium sulfate.]
[A03AB12, mepenzolate, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Mepenzolate.]
[A16AX12, trientine, Magnesium sulfate can cause a decrease in the absorption of Triethylenetetramine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N05AB06, trifluoperazine, The therapeutic efficacy of Trifluoperazine can be increased when used in combination with Magnesium sulfate.]
[N05AD02, trifluperidol, The therapeutic efficacy of Trifluperidol can be increased when used in combination with Magnesium sulfate.]
[N05AA05, triflupromazine, The therapeutic efficacy of Triflupromazine can be increased when used in combination with Magnesium sulfate.]
[N04AA01, trihexyphenidyl, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Trihexyphenidyl.]
[A03AA05, trimebutine, Magnesium sulfate may increase the arrhythmogenic activities of Trimebutine.]
[S01ED04, metipranolol, Magnesium sulfate may increase the arrhythmogenic activities of Metipranolol.]
[R06AD01, trimeprazine, The therapeutic efficacy of Alimemazine can be increased when used in combination with Magnesium sulfate.]
[N03AC02, trimethadione, The therapeutic efficacy of Trimethadione can be increased when used in combination with Magnesium sulfate.]
[C02BA01, trimethaphan, The risk or severity of adverse effects can be increased when Magnesium sulfate is combined with Trimethaphan.]
[J01EA01, trimethoprim, The risk or severity of hyperkalemia can be increased when Trimethoprim is combined with Magnesium sulfate.]
[N06AA06, trimipramine, The therapeutic efficacy of Trimipramine can be increased when used in combination with Magnesium sulfate.]
[R06AX07, triprolidine, The therapeutic efficacy of Triprolidine can be increased when used in combination with Magnesium sulfate.]
[A03BB01, butylscopolamine, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Butylscopolamine.]
[N06AX24, vilazodone, The therapeutic efficacy of Vilazodone can be increased when used in combination with Magnesium sulfate.]
[S01FA06, tropicamide, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Tropicamide.]
[C09CA09, azilsartan medoxomil, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Azilsartan medoxomil.]
[M03AA02, tubocurarine, The therapeutic efficacy of Tubocurarine can be increased when used in combination with Magnesium sulfate.]
[A10BH05, linagliptin, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Linagliptin.]
[J05AP03, boceprevir, The serum concentration of Magnesium sulfate can be increased when it is combined with Boceprevir.]
[S01AA28, vancomycin, The risk or severity of neuromuscular blockade can be increased when Vancomycin is combined with Magnesium sulfate.]
[N03AX21, ezogabine, The therapeutic efficacy of Ezogabine can be increased when used in combination with Magnesium sulfate.]
[C08DA01, verapamil, Magnesium sulfate may increase the arrhythmogenic activities of Verapamil.]
[N06AX09, viloxazine, The therapeutic efficacy of Viloxazine can be increased when used in combination with Magnesium sulfate.]
[C03BA10, xipamide, The risk or severity of adverse effects can be increased when Xipamide is combined with Magnesium sulfate.]
[N05AF05, zuclopenthixol, The therapeutic efficacy of Zuclopenthixol can be increased when used in combination with Magnesium sulfate.]
[N03AX14, levetiracetam, The therapeutic efficacy of Levetiracetam can be increased when used in combination with Magnesium sulfate.]
[M05BA05, tiludronic acid, Magnesium sulfate can cause a decrease in the absorption of Tiludronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L01ED01, crizotinib, Crizotinib may increase the bradycardic activities of Magnesium sulfate.]
[H05BX03, doxercalciferol, The serum concentration of Magnesium sulfate can be increased when it is combined with Doxercalciferol.]
[M05BA06, ibandronic acid, Magnesium sulfate can cause a decrease in the absorption of Ibandronate resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[J01MA13, trovafloxacin, Magnesium sulfate can cause a decrease in the absorption of Trovafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N05AE04, ziprasidone, The therapeutic efficacy of Ziprasidone can be increased when used in combination with Magnesium sulfate.]
[G03AC10, drospirenone, The metabolism of Drospirenone can be increased when combined with Magnesium sulfate.]
[V03AC02, deferiprone, Magnesium sulfate can cause a decrease in the absorption of Deferiprone resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N02BA01, aspirin, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Acetylsalicylic acid.]
[L01EJ01, ruxolitinib, Ruxolitinib may increase the bradycardic activities of Magnesium sulfate.]
[G04BD07, tolterodine, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Tolterodine.]
[C07AB03, atenolol, Atenolol may increase the arrhythmogenic activities of Magnesium sulfate.]
[A11CC03, alfacalcidol, The serum concentration of Magnesium sulfate can be increased when it is combined with Alfacalcidol.]
[J02AC03, voriconazole, The therapeutic efficacy of Voriconazole can be increased when used in combination with Magnesium sulfate.]
[M03AC04, atracurium, The therapeutic efficacy of Atracurium can be increased when used in combination with Magnesium sulfate.]
[S01FA01, atropine, Atropine may increase the arrhythmogenic activities of Magnesium sulfate.]
[J01CA09, azlocillin, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Azlocillin.]
[M03BX01, baclofen, The therapeutic efficacy of Baclofen can be increased when used in combination with Magnesium sulfate.]
[A08AA11, lorcaserin, The therapeutic efficacy of Lorcaserin can be increased when used in combination with Magnesium sulfate.]
[A06AX04, linaclotide, The therapeutic efficacy of Linaclotide can be decreased when used in combination with Magnesium sulfate.]
[A02AA05, magnesium silicate, The risk or severity of hypotension can be increased when Magnesium silicate is combined with Magnesium sulfate.]
[L01EX05, regorafenib, Magnesium sulfate may increase the bradycardic activities of Regorafenib.]
[N05CA04, barbital, The therapeutic efficacy of Barbital can be increased when used in combination with Magnesium sulfate.]
[C01AA01, acetyldigitoxin, Acetyldigitoxin may increase the arrhythmogenic activities of Magnesium sulfate.]
[S01GA07, brimonidine, Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Magnesium sulfate.]
[N04BD02, rasagiline, The therapeutic efficacy of Rasagiline can be increased when used in combination with Magnesium sulfate.]
[C08CA13, lercanidipine, Lercanidipine may increase the arrhythmogenic activities of Magnesium sulfate.]
[A03FA09, mosapride, The therapeutic efficacy of Mosapride can be increased when used in combination with Magnesium sulfate.]
[N06DA02, donepezil, The therapeutic efficacy of Donepezil can be increased when used in combination with Magnesium sulfate.]
[N03AX22, perampanel, The therapeutic efficacy of Perampanel can be increased when used in combination with Magnesium sulfate.]
[L04AA29, tofacitinib, Magnesium sulfate may increase the bradycardic activities of Tofacitinib.]
[N02CC03, zolmitriptan, The therapeutic efficacy of Zolmitriptan can be increased when used in combination with Magnesium sulfate.]
[R06AC06, thonzylamine, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Thonzylamine.]
[G04BD10, darifenacin, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Darifenacin.]
[N01AA01, ethyl ether, The therapeutic efficacy of Diethyl ether can be increased when used in combination with Magnesium sulfate.]
[H01CB05, pasireotide, Magnesium sulfate may increase the bradycardic activities of Pasireotide.]
[C04AX11, bencyclane, Magnesium sulfate may increase the arrhythmogenic activities of Bencyclane.]
[A10BH04, alogliptin, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Alogliptin.]
[C03AA01, bendroflumethiazide, The risk or severity of adverse effects can be increased when Bendroflumethiazide is combined with Magnesium sulfate.]
[L04AX06, pomalidomide, The therapeutic efficacy of Pomalidomide can be increased when used in combination with Magnesium sulfate.]
[N02BA10, benorilate, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Benorilate.]
[N05AD07, benperidol, The therapeutic efficacy of Benperidol can be increased when used in combination with Magnesium sulfate.]
[A10BK02, canagliflozin, The risk or severity of adverse effects can be increased when Canagliflozin is combined with Magnesium sulfate.]
[J01MA15, gemifloxacin, The absorption of Gemifloxacin can be decreased when combined with Magnesium sulfate.]
[A12CC09, magnesium orotate, The risk or severity of hypotension can be increased when Magnesium orotate is combined with Magnesium sulfate.]
[S01AE07, moxifloxacin, Magnesium sulfate can cause a decrease in the absorption of Moxifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A06AX06, tegaserod, The therapeutic efficacy of Tegaserod can be decreased when used in combination with Magnesium sulfate.]
[A10AE05, insulin detemir, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Insulin detemir.]
[R02AD01, benzocaine, The therapeutic efficacy of Benzocaine can be increased when used in combination with Magnesium sulfate.]
[A10BX05, pramlintide, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Pramlintide.]
[M01AH01, celecoxib, The risk or severity of hyperkalemia can be increased when Celecoxib is combined with Magnesium sulfate.]
[N02CC02, naratriptan, The therapeutic efficacy of Naratriptan can be increased when used in combination with Magnesium sulfate.]
[A12CC05, magnesium aspartate, The risk or severity of hypotension can be increased when Magnesium aspartate is combined with Magnesium sulfate.]
[N04AC01, benztropine, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.]
[R02AX03, benzydamine, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Benzydamine.]
[P03AX06, benzyl alcohol, The therapeutic efficacy of Benzyl alcohol can be increased when used in combination with Magnesium sulfate.]
[N06AX28, levomilnacipran, The therapeutic efficacy of Levomilnacipran can be increased when used in combination with Magnesium sulfate.]
[C08EA02, bepridil, Magnesium sulfate may increase the arrhythmogenic activities of Bepridil.]
[A10BJ03, lixisenatide, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Lixisenatide.]
[N06AX26, vortioxetine, The therapeutic efficacy of Vortioxetine can be increased when used in combination with Magnesium sulfate.]
[G03AC08, etonogestrel, The metabolism of Etonogestrel can be increased when combined with Magnesium sulfate.]
[N03AF04, eslicarbazepine, The therapeutic efficacy of Eslicarbazepine can be increased when used in combination with Magnesium sulfate.]
[N03AG04, vigabatrin, The therapeutic efficacy of Vigabatrin can be increased when used in combination with Magnesium sulfate.]
[A10BK01, dapagliflozin, The risk or severity of adverse effects can be increased when Dapagliflozin is combined with Magnesium sulfate.]
[C07AB04, acebutolol, Magnesium sulfate may increase the arrhythmogenic activities of Acebutolol.]
[N05CH03, tasimelteon, The therapeutic efficacy of Tasimelteon can be increased when used in combination with Magnesium sulfate.]
[S01ED02, betaxolol, Betaxolol may increase the arrhythmogenic activities of Magnesium sulfate.]
[A10BJ04, albiglutide, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Albiglutide.]
[L01ED02, ceritinib, Magnesium sulfate may increase the bradycardic activities of Ceritinib.]
[A03BA03, hyoscyamine, Hyoscyamine may increase the arrhythmogenic activities of Magnesium sulfate.]
[N01AX05, alfaxalone, The therapeutic efficacy of Alfaxalone can be increased when used in combination with Magnesium sulfate.]
[A10BK03, empagliflozin, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Empagliflozin.]
[D11AA01, glycopyrronium, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Glycopyrronium.]
[N05CM19, suvorexant, The therapeutic efficacy of Suvorexant can be increased when used in combination with Magnesium sulfate.]
[S01AA15, dihydrostreptomycin, The risk or severity of neuromuscular blockade can be increased when Magnesium sulfate is combined with Dihydrostreptomycin.]
[N05AA04, acepromazine, The therapeutic efficacy of Acepromazine can be increased when used in combination with Magnesium sulfate.]
[A06AB04, phenolphthalein, The therapeutic efficacy of Phenolphthalein can be decreased when used in combination with Magnesium sulfate.]
[A10BJ05, dulaglutide, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Dulaglutide.]
[A06AH03, naloxegol, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Naloxegol.]
[N04AA02, biperiden, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Biperiden.]
[A06AG02, bisacodyl, The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Magnesium sulfate.]
[S03AA06, gentamicin, The risk or severity of neuromuscular blockade can be increased when Magnesium sulfate is combined with Gentamicin.]
[N06AX11, mirtazapine, The therapeutic efficacy of Mirtazapine can be increased when used in combination with Magnesium sulfate.]
[A03AA09, difemerine, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Difemerine.]
[C01EB17, ivabradine, Magnesium sulfate may increase the bradycardic activities of Ivabradine.]
[A07DA06, eluxadoline, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Eluxadoline.]
[N05AX16, brexpiprazole, The therapeutic efficacy of Brexpiprazole can be increased when used in combination with Magnesium sulfate.]
[G02CX02, flibanserin, The therapeutic efficacy of Flibanserin can be increased when used in combination with Magnesium sulfate.]
[A06AD03, magnesium peroxide, The risk or severity of hypotension can be increased when Magnesium peroxide is combined with Magnesium sulfate.]
[N05AX15, cariprazine, The therapeutic efficacy of Cariprazine can be increased when used in combination with Magnesium sulfate.]
[A10BF01, acarbose, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Acarbose.]
[M02AA25, aceclofenac, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Aceclofenac.]
[M01AB11, acemetacin, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Acemetacin.]
[S01EC01, acetazolamide, The therapeutic efficacy of Acetazolamide can be increased when used in combination with Magnesium sulfate.]
[A10AE06, insulin degludec, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Insulin degludec.]
[N05AB07, acetophenazine, The therapeutic efficacy of Acetophenazine can be increased when used in combination with Magnesium sulfate.]
[J02AC05, isavuconazole, The therapeutic efficacy of Isavuconazole can be increased when used in combination with Magnesium sulfate.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be decreased when it is combined with Magnesium sulfate.]
[A10BB31, acetohexamide, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Acetohexamide.]
[G04CA01, alfuzosin, The risk or severity of hypotension can be increased when Alfuzosin is combined with Magnesium sulfate.]
[N05CA05, aprobarbital, The therapeutic efficacy of Aprobarbital can be increased when used in combination with Magnesium sulfate.]
[M01AE16, alminoprofen, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Alminoprofen.]
[N03AX23, brivaracetam, The therapeutic efficacy of Brivaracetam can be increased when used in combination with Magnesium sulfate.]
[N05BA08, bromazepam, The therapeutic efficacy of Bromazepam can be increased when used in combination with Magnesium sulfate.]
[N04BC01, bromocriptine, The therapeutic efficacy of Bromocriptine can be increased when used in combination with Magnesium sulfate.]
[A02AD05, aluminum magnesium silicate, The risk or severity of neuromuscular blockade can be increased when Magnesium sulfate is combined with Magnesium Aluminum Silicate.]
[A03AX08, alverine, The therapeutic efficacy of Alverine can be increased when used in combination with Magnesium sulfate.]
[R06AB01, brompheniramine, The therapeutic efficacy of Dexbrompheniramine can be increased when used in combination with Magnesium sulfate.]
[N06AA19, amineptin, The therapeutic efficacy of Amineptine can be increased when used in combination with Magnesium sulfate.]
[C08CA01, amlodipine, Amlodipine may increase the arrhythmogenic activities of Magnesium sulfate.]
[N06BX11, aniracetam, The therapeutic efficacy of Aniracetam can be increased when used in combination with Magnesium sulfate.]
[C03CA02, bumetanide, The risk or severity of adverse effects can be increased when Bumetanide is combined with Magnesium sulfate.]
[N01BB01, bupivacaine, The therapeutic efficacy of Bupivacaine can be increased when used in combination with Magnesium sulfate.]
[C07AA19, bupranolol, Magnesium sulfate may increase the arrhythmogenic activities of Bupranolol.]
[N07BC01, buprenorphine, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.]
[N05BE01, buspirone, The therapeutic efficacy of Buspirone can be increased when used in combination with Magnesium sulfate.]
[N06DA03, rivastigmine, Magnesium sulfate may increase the bradycardic activities of Rivastigmine.]
[N02AF01, butorphanol, The therapeutic efficacy of Butorphanol can be increased when used in combination with Magnesium sulfate.]
[J01MA09, sparfloxacin, Magnesium sulfate can cause a decrease in the absorption of Sparfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[R06AX09, azatadine, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Azatadine.]
[S01GX07, azelastine, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Azelastine.]
[A06AX07, plecanatide, The therapeutic efficacy of Plecanatide can be decreased when used in combination with Magnesium sulfate.]
[A07EC04, balsalazide, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Balsalazide.]
[R03DA08, bamifylline, Magnesium sulfate may increase the excretion rate of Bamifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[N02BF02, pregabalin, The therapeutic efficacy of Pregabalin can be increased when used in combination with Magnesium sulfate.]
[N03AX30, beclamide, The therapeutic efficacy of Beclamide can be increased when used in combination with Magnesium sulfate.]
[N06BC01, caffeine, Magnesium sulfate may increase the excretion rate of Caffeine which could result in a lower serum level and potentially a reduction in efficacy.]
[C09AA07, benazepril, The risk or severity of hyperkalemia can be increased when Benazepril is combined with Magnesium sulfate.]
[A10BX06, benfluorex, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Benfluorex.]
[S01HA02, benoxinate, The therapeutic efficacy of Oxybuprocaine can be increased when used in combination with Magnesium sulfate.]
[H05BX05, calcifediol, The serum concentration of Magnesium sulfate can be increased when it is combined with Calcifediol.]
[D05AX03, calcitriol, The serum concentration of Magnesium sulfate can be increased when it is combined with Calcitriol.]
[J01XX08, linezolid, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Linezolid.]
[A12AA01, calcium phosphate, Magnesium sulfate can cause a decrease in the absorption of Calcium Phosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N04BD03, safinamide, The therapeutic efficacy of Safinamide can be increased when used in combination with Magnesium sulfate.]
[J01MA23, delafloxacin, Magnesium sulfate can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[D01AC10, bifonazole, The therapeutic efficacy of Bifonazole can be increased when used in combination with Magnesium sulfate.]
[P03AC02, bioallethrin, Magnesium sulfate may increase the arrhythmogenic activities of Bioallethrin.]
[C07AB07, bisoprolol, The therapeutic efficacy of Magnesium sulfate can be increased when used in combination with Bisoprolol.]
[J05AG03, efavirenz, The therapeutic efficacy of Efavirenz can be increased when used in combination with Magnesium sulfate.]
[C07AA17, bopindolol, The risk or severity of bradycardia can be increased when Magnesium sulfate is combined with Bopindolol.]
[N04AA11, bornaprine, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Bornaprine.]
[N05AD06, bromperidol, The therapeutic efficacy of Bromperidol can be increased when used in combination with Magnesium sulfate.]
[N05CD09, brotizolam, The therapeutic efficacy of Brotizolam can be increased when used in combination with Magnesium sulfate.]
[C03DA03, canrenone, The risk or severity of adverse effects can be increased when Canrenone is combined with Magnesium sulfate.]
[M01AB07, bumadizone, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Bumadizone.]
[N05CA03, butobarbital, The therapeutic efficacy of Butobarbital can be increased when used in combination with Magnesium sulfate.]
[N06AA15, butriptyline, The therapeutic efficacy of Butriptyline can be increased when used in combination with Magnesium sulfate.]
[C01AA02, acetyldigoxins, Magnesium sulfate may increase the arrhythmogenic activities of Acetyldigoxin.]
[A10BJ06, semaglutide, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Semaglutide.]
[N01BX04, capsaicin, The risk or severity of methemoglobinemia can be increased when Magnesium sulfate is combined with Capsaicin.]
[A10BK04, ertugliflozin, The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Magnesium sulfate.]
[N05CA08, butylvinal, The therapeutic efficacy of Vinylbital can be increased when used in combination with Magnesium sulfate.]
[C09AA01, captopril, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Captopril.]
[N03AF01, carbamazepine, The therapeutic efficacy of Carbamazepine can be increased when used in combination with Magnesium sulfate.]
[A06AC08, calcium polycarbophil, The therapeutic efficacy of Calcium polycarbophil can be decreased when used in combination with Magnesium sulfate.]
[A03AA03, camylofine, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Camylofin.]
[R06AA08, carbinoxamine, The therapeutic efficacy of Carbinoxamine can be increased when used in combination with Magnesium sulfate.]
[C07AG02, carvedilol, Magnesium sulfate may increase the arrhythmogenic activities of Carvedilol.]
[N03AX24, cannabidiol, The therapeutic efficacy of Cannabidiol can be increased when used in combination with Magnesium sulfate.]
[J01GB14, plazomicin, The risk or severity of neuromuscular blockade can be increased when Magnesium sulfate is combined with Plazomicin.]
[C07AB08, celiprolol, Magnesium sulfate may increase the arrhythmogenic activities of Celiprolol.]
[N03AX17, stiripentol, The therapeutic efficacy of Stiripentol can be increased when used in combination with Magnesium sulfate.]
[J01AA14, sarecycline, Magnesium sulfate can cause a decrease in the absorption of Sarecycline resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[J01AA15, omadacycline, Magnesium sulfate can cause a decrease in the absorption of Omadacycline resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[S01GX12, cetirizine, The therapeutic efficacy of Cetirizine can be increased when used in combination with Magnesium sulfate.]
[N05CM04, carbromal, The therapeutic efficacy of Carbromal can be increased when used in combination with Magnesium sulfate.]
[A10BB06, carbutamide, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Carbutamide.]
[N01BA04, chloroprocaine, The therapeutic efficacy of Chloroprocaine can be increased when used in combination with Magnesium sulfate.]
[R06AA06, chlorphenoxamine, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Chlorphenoxamine.]
[M01AC05, lornoxicam, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Lornoxicam.]
[R03DA02, oxtriphylline, Magnesium sulfate may increase the excretion rate of Oxtriphylline which could result in a lower serum level and potentially a reduction in efficacy.]
[M03BA02, carisoprodol, The therapeutic efficacy of Carisoprodol can be increased when used in combination with Magnesium sulfate.]
[R03BB08, revefenacin, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Revefenacin.]
[A06AX05, prucalopride, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Magnesium sulfate.]
[C01BG07, cifenline, Magnesium sulfate may increase the arrhythmogenic activities of Cibenzoline.]
[C09AA08, cilazapril, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Cilazapril.]
[A03FA08, cinitapride, The therapeutic efficacy of Cinitapride can be increased when used in combination with Magnesium sulfate.]
[S01ED05, carteolol, Magnesium sulfate may increase the arrhythmogenic activities of Carteolol.]
[N06AX27, esketamine, The therapeutic efficacy of Esketamine can be increased when used in combination with Magnesium sulfate.]
[J01FA09, clarithromycin, The risk or severity of QTc prolongation and hypotension can be increased when Clarithromycin is combined with Magnesium sulfate.]
[N06BA14, solriamfetol, The therapeutic efficacy of Solriamfetol can be increased when used in combination with Magnesium sulfate.]
[N06AX29, brexanolone, The therapeutic efficacy of Brexanolone can be increased when used in combination with Magnesium sulfate.]
[N05BA09, clobazam, The therapeutic efficacy of Clobazam can be increased when used in combination with Magnesium sulfate.]
[J01AA11, clomocycline, Magnesium sulfate can cause a decrease in the absorption of Clomocycline resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A06AB05, castor oil, The therapeutic efficacy of Castor oil can be decreased when used in combination with Magnesium sulfate.]
[N05BA22, cloxazolam, The therapeutic efficacy of Cloxazolam can be increased when used in combination with Magnesium sulfate.]
[V03AE07, calcium acetate, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Calcium acetate.]
[C09CA06, candesartan, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Candesartan.]
[A12CC06, magnesium lactate, The risk or severity of hypotension can be increased when Magnesium lactate is combined with Magnesium sulfate.]
[J01DD01, cefotaxime, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Cefotaxime.]
[N05AA06, cyamemazine, The therapeutic efficacy of Cyamemazine can be increased when used in combination with Magnesium sulfate.]
[C03BX03, cicletanine, Magnesium sulfate may increase the arrhythmogenic activities of Cicletanine.]
[M03BX08, cyclobenzaprine, The therapeutic efficacy of Cyclobenzaprine can be increased when used in combination with Magnesium sulfate.]
[C03AA09, cyclothiazide, The risk or severity of adverse effects can be increased when Cyclothiazide is combined with Magnesium sulfate.]
[G04BE04, yohimbine, The therapeutic efficacy of Yohimbine can be increased when used in combination with Magnesium sulfate.]
[A10AE03, insulin, regular, pork, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Insulin pork.]
[A06AB03, danthron, The therapeutic efficacy of Dantron can be decreased when used in combination with Magnesium sulfate.]
[J01DB03, cephalothin, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Cefalotin.]
[G03DB05, demegestone, The metabolism of Demegestone can be increased when combined with Magnesium sulfate.]
[N02CC08, lasmiditan, The therapeutic efficacy of Lasmiditan can be increased when used in combination with Magnesium sulfate.]
[G03AC09, desogestrel, The metabolism of Desogestrel can be increased when combined with Magnesium sulfate.]
[R06AB06, dexbrompheniramine, The therapeutic efficacy of Dexbrompheniramine can be increased when used in combination with Magnesium sulfate.]
[R06AB02, dexchlorpheniramine, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Dexchlorpheniramine.]
[S01XA12, dexpanthenol, The serum concentration of Magnesium sulfate can be increased when it is combined with Dexpanthenol.]
[N02AX03, dezocine, The therapeutic efficacy of Dezocine can be increased when used in combination with Magnesium sulfate.]
[N05CM21, lemborexant, The therapeutic efficacy of Lemborexant can be increased when used in combination with Magnesium sulfate.]
[N05AD10, lumateperone, The therapeutic efficacy of Lumateperone can be increased when used in combination with Magnesium sulfate.]
[S01AE06, gatifloxacin, Magnesium sulfate can cause a decrease in the absorption of Gatifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N02CC07, frovatriptan, The therapeutic efficacy of Frovatriptan can be increased when used in combination with Magnesium sulfate.]
[N05CC04, dichloralphenazone, The therapeutic efficacy of Dichloralphenazone can be increased when used in combination with Magnesium sulfate.]
[G03DB08, dienogest, The metabolism of Dienogest can be increased when combined with Magnesium sulfate.]
[A07DA04, difenoxin, The therapeutic efficacy of Difenoxin can be increased when used in combination with Magnesium sulfate.]
[N02AA08, dihydrocodeine, The therapeutic efficacy of Dihydrocodeine can be increased when used in combination with Magnesium sulfate.]
[N02CC06, eletriptan, The therapeutic efficacy of Eletriptan can be increased when used in combination with Magnesium sulfate.]
[M01AH02, rofecoxib, The risk or severity of hyperkalemia can be increased when Rofecoxib is combined with Magnesium sulfate.]
[C08CA16, clevidipine, Magnesium sulfate may increase the arrhythmogenic activities of Clevidipine.]
[C01BD07, dronedarone, Magnesium sulfate may increase the arrhythmogenic activities of Dronedarone.]
[N03AG02, dipropylacetamide, The therapeutic efficacy of Valpromide can be increased when used in combination with Magnesium sulfate.]
[L01AA02, chlorambucil, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Chlorambucil.]
[N05BA02, chlordiazepoxide, The therapeutic efficacy of Chlordiazepoxide can be increased when used in combination with Magnesium sulfate.]
[A03AA08, dihexyverine, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Dihexyverine.]
[G04BD09, trospium, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Trospium.]
[M01AC04, droxicam, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Droxicam.]
[M02AA27, dexketoprofen, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Dexketoprofen.]
[N05CM02, chlormethiazole, The therapeutic efficacy of Clomethiazole can be increased when used in combination with Magnesium sulfate.]
[M03BB02, chlormezanone, The therapeutic efficacy of Chlormezanone can be increased when used in combination with Magnesium sulfate.]
[R02AD04, dyclonine, The therapeutic efficacy of Dyclonine can be increased when used in combination with Magnesium sulfate.]
[C08CA17, levamlodipine, The risk or severity of hypotension can be increased when Magnesium sulfate is combined with Levamlodipine.]
[N05CD14, remimazolam, The risk or severity of sedation can be increased when Magnesium sulfate is combined with Remimazolam.]
[N02AX07, oliceridine, The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Magnesium sulfate is combined with Oliceridine.]
[P01BA01, chloroquine, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Chloroquine.]
[C03AA04, chlorothiazide, The risk or severity of adverse effects can be increased when Chlorothiazide is combined with Magnesium sulfate.]
[R06AB04, chlorpheniramine, The therapeutic efficacy of Chlorpheniramine can be increased when used in combination with Magnesium sulfate.]
[N05AA01, chlorpromazine, The therapeutic efficacy of Chlorpromazine can be increased when used in combination with Magnesium sulfate.]
[A10BB02, chlorpropamide, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Chlorpropamide.]
[N05AF03, chlorprothixene, The therapeutic efficacy of Chlorprothixene can be increased when used in combination with Magnesium sulfate.]
[C03BA04, chlorthalidone, The risk or severity of adverse effects can be increased when Chlorthalidone is combined with Magnesium sulfate.]
[M03BB03, chlorzoxazone, The therapeutic efficacy of Chlorzoxazone can be increased when used in combination with Magnesium sulfate.]
[N05BX03, etifoxine, The therapeutic efficacy of Etifoxine can be increased when used in combination with Magnesium sulfate.]
[N02BA07, ethenzamide, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Ethenzamide.]
[N06BX18, vinpocetine, The therapeutic efficacy of Vinpocetine can be increased when used in combination with Magnesium sulfate.]
[N05BA18, ethyl loflazepate, The therapeutic efficacy of Ethyl loflazepate can be increased when used in combination with Magnesium sulfate.]
[G03DC06, ethynodiol, The metabolism of Etynodiol can be increased when combined with Magnesium sulfate.]
[M01AB08, etodolac, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Etodolac.]
[M02AA06, etofenamate, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Etofenamate.]
[M09AA01, hydroquinine, Magnesium sulfate may increase the arrhythmogenic activities of Hydroquinine.]
[M03BA05, febarbamate, The therapeutic efficacy of Febarbamate can be increased when used in combination with Magnesium sulfate.]
[N03AX10, felbamate, The therapeutic efficacy of Felbamate can be increased when used in combination with Magnesium sulfate.]
[M01AE05, fenbufen, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Fenbufen.]
[N06BA10, fenethylline, Magnesium sulfate may increase the excretion rate of Fenethylline which could result in a lower serum level and potentially a reduction in efficacy.]
[J01MB07, flumequine, Magnesium sulfate can cause a decrease in the absorption of Flumequine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A10AF01, insulin, regular, human, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Insulin human.]
[L04AA50, ponesimod, The risk or severity of bradycardia can be increased when Ponesimod is combined with Magnesium sulfate.]
[N01AB05, trichloroethylene, The therapeutic efficacy of Trichloroethylene can be increased when used in combination with Magnesium sulfate.]
[A02BA01, cimetidine, The serum concentration of Magnesium sulfate can be increased when it is combined with Cimetidine.]
[N02BF01, gabapentin, The therapeutic efficacy of Gabapentin can be increased when used in combination with Magnesium sulfate.]
[N07CA02, cinnarizine, Cinnarizine may increase the arrhythmogenic activities of Magnesium sulfate.]
[J01MB06, cinoxacin, Magnesium sulfate can cause a decrease in the absorption of Cinoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[S03AA07, ciprofloxacin, Magnesium sulfate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N06AB04, citalopram, The therapeutic efficacy of Citalopram can be increased when used in combination with Magnesium sulfate.]
[C03DA05, finerenone, The risk or severity of adverse effects can be increased when Finerenone is combined with Magnesium sulfate.]
[P01CA03, fexinidazole, The risk or severity of adverse effects can be increased when Magnesium sulfate is combined with Fexinidazole.]
[R06AA04, clemastine, The therapeutic efficacy of Clemastine can be increased when used in combination with Magnesium sulfate.]
[A10BB12, glimepiride, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Glimepiride.]
[A10BB08, gliquidone, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Gliquidone.]
[A12AA02, calcium glubionate, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Calcium glubionate anhydrous.]
[J01FF01, clindamycin, The risk or severity of neuromuscular blockade can be increased when Magnesium sulfate is combined with Clindamycin.]
[N06AX25, St. John's wort extract, The therapeutic efficacy of St. John's Wort can be increased when used in combination with Magnesium sulfate.]
[L03AB15, ropeginterferon alfa-2b, The risk or severity of neuropsychiatric effects can be increased when Ropeginterferon alfa-2b is combined with Magnesium sulfate.]
[N01BB10, levobupivacaine, The therapeutic efficacy of Levobupivacaine can be increased when used in combination with Magnesium sulfate.]
[N06AA04, clomipramine, The therapeutic efficacy of Clomipramine can be increased when used in combination with Magnesium sulfate.]
[N03AE01, clonazepam, The therapeutic efficacy of Clonazepam can be increased when used in combination with Magnesium sulfate.]
[S01EA04, clonidine, The risk or severity of sedation can be increased when Clonidine is combined with Magnesium sulfate.]
[A10BX16, tirzepatide, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Tirzepatide.]
[J02AC06, oteseconazole, The therapeutic efficacy of Oteseconazole can be increased when used in combination with Magnesium sulfate.]
[C03BA03, clopamide, The risk or severity of adverse effects can be increased when Clopamide is combined with Magnesium sulfate.]
[N05AH06, clothiapine, The therapeutic efficacy of Clothiapine can be increased when used in combination with Magnesium sulfate.]
[N05BA21, clotiazepam, The therapeutic efficacy of Clotiazepam can be increased when used in combination with Magnesium sulfate.]
[A04AA01, ondansetron, The therapeutic efficacy of Ondansetron can be increased when used in combination with Magnesium sulfate.]
[A04AA02, granisetron, The therapeutic efficacy of Granisetron can be increased when used in combination with Magnesium sulfate.]
[N05AH02, clozapine, The therapeutic efficacy of Clozapine can be increased when used in combination with Magnesium sulfate.]
[A10BX01, guar gum, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Guar gum.]
[A10BK06, sotagliflozin, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Sotagliflozin.]
[J01GB12, arbekacin, The risk or severity of neuromuscular blockade can be increased when Magnesium sulfate is combined with Arbekacin.]
[N05BA13, halazepam, The therapeutic efficacy of Halazepam can be increased when used in combination with Magnesium sulfate.]
[S02DA02, cocaine, The risk or severity of methemoglobinemia can be increased when Magnesium sulfate is combined with Cocaine.]
[C02KB01, metyrosine, Magnesium sulfate may increase the sedative activities of Metyrosine.]
[M01AX13, proquazone, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Proquazone.]
[R05DA04, codeine, The therapeutic efficacy of Codeine can be increased when used in combination with Magnesium sulfate.]
[M03AC05, hexafluorenium, The therapeutic efficacy of Hexafluronium can be increased when used in combination with Magnesium sulfate.]
[A03AB10, hexocyclium, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Hexocyclium.]
[A03BB06, homatropine methylbromide, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Homatropine methylbromide.]
[S01FA05, homatropine, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Homatropine.]
[J01XB01, colistin, The risk or severity of neuromuscular blockade can be increased when Magnesium sulfate is combined with Colistin.]
[C01BA13, hydroquinidine, Magnesium sulfate may increase the arrhythmogenic activities of Hydroquinidine.]
[A02AD04, hydrotalcite, The risk or severity of hypotension can be increased when Hydrotalcite is combined with Magnesium sulfate.]
[N01AB07, desflurane, The therapeutic efficacy of Desflurane can be increased when used in combination with Magnesium sulfate.]
[A04AA03, tropisetron, The therapeutic efficacy of Tropisetron can be increased when used in combination with Magnesium sulfate.]
[C04AX28, ifenprodil, The therapeutic efficacy of Ifenprodil can be increased when used in combination with Magnesium sulfate.]
[A10BX03, nateglinide, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Nateglinide.]
[N02BA16, imidazole-2-hydroxybenzoate, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Imidazole salicylate.]
[H01AC03, mecasermin, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Mecasermin.]
[A10AE04, insulin glargine, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Insulin glargine.]
[J01FA15, telithromycin, The risk or severity of QTc prolongation and hypotension can be increased when Telithromycin is combined with Magnesium sulfate.]
[B01AC10, indobufen, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Indobufen.]
[R06AX27, desloratadine, The therapeutic efficacy of Desloratadine can be increased when used in combination with Magnesium sulfate.]
[J05AB14, valganciclovir, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Valganciclovir.]
[M01AH03, valdecoxib, The risk or severity of hyperkalemia can be increased when Valdecoxib is combined with Magnesium sulfate.]
[C01AA06, lanatoside C, The serum concentration of Lanatoside C can be increased when it is combined with Magnesium sulfate.]
[N02CC05, almotriptan, The therapeutic efficacy of Almotriptan can be increased when used in combination with Magnesium sulfate.]
[M01AH04, parecoxib, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Parecoxib.]
[J02AC02, itraconazole, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Itraconazole.]
[B01AB12, bemiparin, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Bemiparin.]
[N05BA10, ketazolam, The therapeutic efficacy of Ketazolam can be increased when used in combination with Magnesium sulfate.]
[M01AA06, kebuzone, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Kebuzone.]
[J02AC04, posaconazole, The therapeutic efficacy of Posaconazole can be increased when used in combination with Magnesium sulfate.]
[C08CA09, lacidipine, Magnesium sulfate may increase the arrhythmogenic activities of Lacidipine.]
[A06AD12, lactitol, The therapeutic efficacy of Lactitol can be decreased when used in combination with Magnesium sulfate.]
[N03AX09, lamotrigine, The therapeutic efficacy of Lamotrigine can be increased when used in combination with Magnesium sulfate.]
[S01GX02, levocabastine, The therapeutic efficacy of Levocabastine can be increased when used in combination with Magnesium sulfate.]
[N07BC04, lofexidine, The therapeutic efficacy of Lofexidine can be increased when used in combination with Magnesium sulfate.]
[S01AE04, lomefloxacin, Magnesium sulfate can cause a decrease in the absorption of Lomefloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[M01AB09, lonazolac, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Lonazolac.]
[N05CD06, lormetazepam, The therapeutic efficacy of Lormetazepam can be increased when used in combination with Magnesium sulfate.]
[H01AA02, cosyntropin, The risk or severity of liver damage can be increased when Tetracosactide is combined with Magnesium sulfate.]
[M02AA31, loxoprofen, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Loxoprofen.]
[C09AA03, lisinopril, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Lisinopril.]
[A02AD02, magaldrate, The risk or severity of hypotension can be increased when Magaldrate is combined with Magnesium sulfate.]
[B05XA10, magnesium phosphate, The risk or severity of neuromuscular blockade can be increased when Magnesium sulfate is combined with Magnesium phosphate.]
[C08CA11, manidipine, Magnesium sulfate may increase the arrhythmogenic activities of Manidipine.]
[A03AA04, mebeverine, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Mebeverine.]
[N06AX13, medifoxamine, The therapeutic efficacy of Medifoxamine can be increased when used in combination with Magnesium sulfate.]
[C07AA14, mepindolol, The risk or severity of bradycardia can be increased when Magnesium sulfate is combined with Mepindolol.]
[C01EB10, adenosine, Adenosine may increase the arrhythmogenic activities of Magnesium sulfate.]
[R06AD04, methdilazine, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Methdilazine.]
[N04AA03, methixene, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Metixene.]
[C04AX01, cyclandelate, Magnesium sulfate may increase the arrhythmogenic activities of Cyclandelate.]
[R06AE03, cyclizine, The therapeutic efficacy of Cyclizine can be increased when used in combination with Magnesium sulfate.]
[N05CA10, cyclobarbital, The therapeutic efficacy of Cyclobarbital can be increased when used in combination with Magnesium sulfate.]
[C03DA04, eplerenone, The risk or severity of adverse effects can be increased when Eplerenone is combined with Magnesium sulfate.]
[N05AD03, metylperon, The therapeutic efficacy of Melperone can be increased when used in combination with Magnesium sulfate.]
[C03AA07, cyclopenthiazide, The risk or severity of adverse effects can be increased when Cyclopenthiazide is combined with Magnesium sulfate.]
[A10BF02, miglitol, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Miglitol.]
[S01FA04, cyclopentolate, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Cyclopentolate.]
[N06AX07, minaprine, The therapeutic efficacy of Minaprine can be increased when used in combination with Magnesium sulfate.]
[S01XA18, cyclosporine, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Cyclosporine.]
[N06AG02, moclobemide, The therapeutic efficacy of Moclobemide can be increased when used in combination with Magnesium sulfate.]
[R06AX02, cyproheptadine, The therapeutic efficacy of Cyproheptadine can be increased when used in combination with Magnesium sulfate.]
[C09AA13, moexipril, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Moexipril.]
[M02AA02, mofebutazone, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Mofebutazone.]
[M01AX22, morniflumate, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Morniflumate.]
[C03XA02, conivaptan, The risk or severity of adverse effects can be increased when Conivaptan is combined with Magnesium sulfate.]
[M01AH05, etoricoxib, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Etoricoxib.]
[M03CA01, dantrolene, The risk or severity of hyperkalemia can be increased when Dantrolene is combined with Magnesium sulfate.]
[N06BX04, deanol, The therapeutic efficacy of Deanol can be increased when used in combination with Magnesium sulfate.]
[A04AD11, nabilone, The therapeutic efficacy of Nabilone can be increased when used in combination with Magnesium sulfate.]
[M01AX01, nabumetone, The risk or severity of hyperkalemia can be increased when Nabumetone is combined with Magnesium sulfate.]
[B05XA15, potassium lactate, Potassium lactate may increase the hyperkalemic activities of Magnesium sulfate.]
[J01AA01, demeclocycline, Magnesium sulfate can cause a decrease in the absorption of Demeclocycline resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N05BA16, nordazepam, The therapeutic efficacy of Nordazepam can be increased when used in combination with Magnesium sulfate.]
[C07AB12, nebivolol, Magnesium sulfate may increase the arrhythmogenic activities of Nebivolol.]
[N06AX06, nefazodone, The therapeutic efficacy of Nefazodone can be increased when used in combination with Magnesium sulfate.]
[N05CM16, niaprazine, The therapeutic efficacy of Niaprazine can be increased when used in combination with Magnesium sulfate.]
[C01DX16, nicorandil, Magnesium sulfate may increase the arrhythmogenic activities of Nicorandil.]
[N03AG06, tiagabine, The therapeutic efficacy of Tiagabine can be increased when used in combination with Magnesium sulfate.]
[G03DB04, nomegestrol, The metabolism of Nomegestrol can be increased when combined with Magnesium sulfate.]
[C01CA23, theodrenaline, Magnesium sulfate may increase the excretion rate of Theodrenaline which could result in a lower serum level and potentially a reduction in efficacy.]
[M03AC11, cisatracurium, The therapeutic efficacy of Cisatracurium can be increased when used in combination with Magnesium sulfate.]
[R05DA06, normethadone, The therapeutic efficacy of Normethadone can be increased when used in combination with Magnesium sulfate.]
[N06AB10, escitalopram, The therapeutic efficacy of Escitalopram can be increased when used in combination with Magnesium sulfate.]
[G04BD08, solifenacin, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Solifenacin.]
[A07EC03, olsalazine, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Olsalazine.]
[N06AA01, desipramine, The therapeutic efficacy of Desipramine can be increased when used in combination with Magnesium sulfate.]
[C01AA07, deslanoside, Magnesium sulfate may increase the arrhythmogenic activities of Deslanoside.]
[C09XA02, aliskiren, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Aliskiren.]
[M01AE12, oxaprozin, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Oxaprozin.]
[N03AF02, oxcarbazepine, The therapeutic efficacy of Oxcarbazepine can be increased when used in combination with Magnesium sulfate.]
[N06BX07, oxiracetam, The therapeutic efficacy of Oxiracetam can be increased when used in combination with Magnesium sulfate.]
[N04AA08, dexetimide, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Dexetimide.]
[G04BD04, oxybutynin, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Oxybutynin.]
[A03AA01, oxyphencyclimine, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Oxyphencyclimine.]
[N06BA02, dextroamphetamine, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Amphetamine.]
[R05DA09, dextromethorphan, The therapeutic efficacy of Dextromethorphan can be increased when used in combination with Magnesium sulfate.]
[N03AC01, paramethadione, The therapeutic efficacy of Paramethadione can be increased when used in combination with Magnesium sulfate.]
[N02AC01, dextromoramide, The therapeutic efficacy of Dextromoramide can be increased when used in combination with Magnesium sulfate.]
[N06AB05, paroxetine, The therapeutic efficacy of Paroxetine can be increased when used in combination with Magnesium sulfate.]
[B01AC04, clopidogrel, The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Magnesium sulfate.]
[N07BC06, heroin, The therapeutic efficacy of Diamorphine can be increased when used in combination with Magnesium sulfate.]
[C04AD01, pentifylline, Magnesium sulfate may increase the excretion rate of Pentifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[N05BA01, diazepam, The therapeutic efficacy of Diazepam can be increased when used in combination with Magnesium sulfate.]
[N03AX07, phenacemide, The therapeutic efficacy of Phenacemide can be increased when used in combination with Magnesium sulfate.]
[R02AA19, phenol, The risk or severity of methemoglobinemia can be increased when Magnesium sulfate is combined with Phenol.]
[N03AD02, phensuximide, The therapeutic efficacy of Phensuximide can be increased when used in combination with Magnesium sulfate.]
[N06AA08, dibenzepin, The therapeutic efficacy of Dibenzepin can be increased when used in combination with Magnesium sulfate.]
[S02DA04, dibucaine, The therapeutic efficacy of Cinchocaine can be increased when used in combination with Magnesium sulfate.]
[M05BA02, clodronic acid, Magnesium sulfate can cause a decrease in the absorption of Clodronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[S01EC02, dichlorphenamide, The risk or severity of adverse effects can be increased when Diclofenamide is combined with Magnesium sulfate.]
[S01BC03, diclofenac, The risk or severity of hyperkalemia can be increased when Diclofenac is combined with Magnesium sulfate.]
[A03AA07, dicyclomine, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.]
[A03AX04, pinaverium, Magnesium sulfate may increase the arrhythmogenic activities of Pinaverium.]
[A10BG03, pioglitazone, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Pioglitazone.]
[N05AD05, pipamperone, The therapeutic efficacy of Pipamperone can be increased when used in combination with Magnesium sulfate.]
[A03AB14, pipenzolate, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Pipenzolate.]
[C03CA03, piretanide, The risk or severity of adverse effects can be increased when Piretanide is combined with Magnesium sulfate.]
[A08AA03, diethylpropion, The therapeutic efficacy of Diethylpropion can be increased when used in combination with Magnesium sulfate.]
[L02AA01, diethylstilbestrol, The metabolism of Diethylstilbestrol can be increased when combined with Magnesium sulfate.]
[C08CA03, isradipine, Isradipine may increase the arrhythmogenic activities of Magnesium sulfate.]
[A03AB11, poldine, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Poldine.]
[N02BA11, diflunisal, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Diflunisal.]
[C01AA04, digitoxin, Magnesium sulfate may increase the arrhythmogenic activities of Digitoxin.]
[C01AA05, digoxin, Digoxin may increase the arrhythmogenic activities of Magnesium sulfate.]
[N02CA01, dihydroergotamine, The therapeutic efficacy of Dihydroergotamine can be increased when used in combination with Magnesium sulfate.]
[N02AA03, hydromorphone, The therapeutic efficacy of Hydromorphone can be increased when used in combination with Magnesium sulfate.]
[A11CC02, dihydrotachysterol, The serum concentration of Magnesium sulfate can be increased when it is combined with Dihydrotachysterol.]
[H03BC01, potassium perchlorate, Potassium perchlorate may increase the hyperkalemic activities of Magnesium sulfate.]
[D04AB07, pramoxine, The therapeutic efficacy of Pramocaine can be increased when used in combination with Magnesium sulfate.]
[C08DB01, diltiazem, Diltiazem may increase the arrhythmogenic activities of Magnesium sulfate.]
[R06AA11, dimenhydrinate, The therapeutic efficacy of Dimenhydrinate can be increased when used in combination with Magnesium sulfate.]
[M03BX03, pridinol, The therapeutic efficacy of Pridinol can be increased when used in combination with Magnesium sulfate.]
[R06AB03, dimethindene, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Dimetindene.]
[N03AG05, progabide, The therapeutic efficacy of Progabide can be increased when used in combination with Magnesium sulfate.]
[N06BC02, propentofylline, Magnesium sulfate may increase the excretion rate of Propentofylline which could result in a lower serum level and potentially a reduction in efficacy.]
[N02BB04, propyphenazone, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Propyphenazone.]
[M01AB14, proglumetacin, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Proglumetacin.]
[S01HA04, proparacaine, The risk or severity of methemoglobinemia can be increased when Magnesium sulfate is combined with Proparacaine.]
[R03DA03, proxyphylline, Magnesium sulfate may increase the excretion rate of Proxyphylline which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AA02, diphenhydramine, The therapeutic efficacy of Diphenhydramine can be increased when used in combination with Magnesium sulfate.]
[A07DA01, diphenoxylate, The therapeutic efficacy of Diphenoxylate can be increased when used in combination with Magnesium sulfate.]
[N05CD10, quazepam, The therapeutic efficacy of Quazepam can be increased when used in combination with Magnesium sulfate.]
[C09AA06, quinapril, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Quinapril.]
[N06BA11, dexmethylphenidate, The therapeutic efficacy of Dexmethylphenidate can be increased when used in combination with Magnesium sulfate.]
[N06AA23, quinupramine, The therapeutic efficacy of Quinupramine can be increased when used in combination with Magnesium sulfate.]
[A03FA02, cisapride, The therapeutic efficacy of Cisapride can be increased when used in combination with Magnesium sulfate.]
[C09AA05, ramipril, The risk or severity of hyperkalemia can be increased when Ramipril is combined with Magnesium sulfate.]
[S01XA23, sirolimus, Magnesium sulfate may increase the immunosuppressive activities of Sirolimus.]
[N05AL04, remoxipride, The therapeutic efficacy of Remoxipride can be increased when used in combination with Magnesium sulfate.]
[C01BA03, disopyramide, Disopyramide may increase the arrhythmogenic activities of Magnesium sulfate.]
[P03AA04, disulfiram, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Disulfiram.]
[N07XX02, riluzole, The therapeutic efficacy of Riluzole can be increased when used in combination with Magnesium sulfate.]
[N05AX08, risperidone, The therapeutic efficacy of Risperidone can be increased when used in combination with Magnesium sulfate.]
[R06AE09, levocetirizine, The therapeutic efficacy of Levocetirizine can be increased when used in combination with Magnesium sulfate.]
[N01BB09, ropivacaine, The therapeutic efficacy of Ropivacaine can be increased when used in combination with Magnesium sulfate.]
[J01MB01, rosoxacin, Magnesium sulfate can cause a decrease in the absorption of Rosoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L01EX01, sunitinib, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Sunitinib.]
[C03XA01, tolvaptan, The risk or severity of adverse effects can be increased when Tolvaptan is combined with Magnesium sulfate.]
[S01BC05, ketorolac, The risk or severity of hyperkalemia can be increased when Ketorolac is combined with Magnesium sulfate.]
[N02BA06, salsalate, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Salsalate.]
[N06AA16, dothiepin, The therapeutic efficacy of Dosulepin can be increased when used in combination with Magnesium sulfate.]
[N06AA12, doxepin, The therapeutic efficacy of Doxepin can be increased when used in combination with Magnesium sulfate.]
[A06AB06, sennosides, USP, The therapeutic efficacy of Senna leaf can be decreased when used in combination with Magnesium sulfate.]
[J01AA02, doxycycline, The absorption of Doxycycline can be decreased when combined with Magnesium sulfate.]
[R06AA09, doxylamine, Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Magnesium sulfate.]
[N06AB06, sertraline, The therapeutic efficacy of Sertraline can be increased when used in combination with Magnesium sulfate.]
[N01AB08, sevoflurane, The therapeutic efficacy of Sevoflurane can be increased when used in combination with Magnesium sulfate.]
[N05AD08, droperidol, The therapeutic efficacy of Droperidol can be increased when used in combination with Magnesium sulfate.]
[A08AA10, sibutramine, The therapeutic efficacy of Sibutramine can be increased when used in combination with Magnesium sulfate.]
[C09AA11, spirapril, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Spirapril.]
[R03DA01, dyphylline, Magnesium sulfate may increase the excretion rate of Dyphylline which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AL02, sultopride, The therapeutic efficacy of Sultopride can be increased when used in combination with Magnesium sulfate.]
[N02CC01, sumatriptan, The therapeutic efficacy of Sumatriptan can be increased when used in combination with Magnesium sulfate.]
[C07AB13, talinolol, Magnesium sulfate may increase the arrhythmogenic activities of Talinolol.]
[J01MA05, temafloxacin, Magnesium sulfate can cause a decrease in the absorption of Temafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[M01AC02, tenoxicam, The risk or severity of hyperkalemia can be increased when Tenoxicam is combined with Magnesium sulfate.]
[G04CA03, terazosin, The risk or severity of hypotension can be increased when Terazosin is combined with Magnesium sulfate.]
[G04BD05, terodiline, Magnesium sulfate may increase the arrhythmogenic activities of Terodiline.]
[C07AA16, tertatolol, Magnesium sulfate may increase the arrhythmogenic activities of Tertatolol.]
[A08AB01, orlistat, Orlistat can cause a decrease in the absorption of Magnesium sulfate resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[M03BX07, tetrazepam, The therapeutic efficacy of Tetrazepam can be increased when used in combination with Magnesium sulfate.]
[M03BX05, thiocolchicoside, The therapeutic efficacy of Thiocolchicoside can be increased when used in combination with Magnesium sulfate.]
[N05AB05, thiopropazate, The therapeutic efficacy of Thiopropazate can be increased when used in combination with Magnesium sulfate.]
[G04BD01, emepronium, The therapeutic efficacy of Emepronium can be increased when used in combination with Magnesium sulfate.]
[N06AX14, tianeptine, The therapeutic efficacy of Tianeptine can be increased when used in combination with Magnesium sulfate.]
[C09AA02, enalapril, The risk or severity of hyperkalemia can be increased when Enalapril is combined with Magnesium sulfate.]
[N05BA23, tofisopam, The therapeutic efficacy of Tofisopam can be increased when used in combination with Magnesium sulfate.]
[M01AG02, tolfenamic acid, Magnesium sulfate may increase the bradycardic activities of Tolfenamic acid.]
[N06AG03, toloxatone, The therapeutic efficacy of Toloxatone can be increased when used in combination with Magnesium sulfate.]
[N03AX11, topiramate, The therapeutic efficacy of Topiramate can be increased when used in combination with Magnesium sulfate.]
[C03CA04, torsemide, The risk or severity of adverse effects can be increased when Torasemide is combined with Magnesium sulfate.]
[J01AA12, tigecycline, The risk or severity of neuromuscular blockade can be increased when Tigecycline is combined with Magnesium sulfate.]
[C09AA10, trandolapril, The risk or severity of hyperkalemia can be increased when Trandolapril is combined with Magnesium sulfate.]
[N05CD11, triazulenone, The therapeutic efficacy of Loprazolam can be increased when used in combination with Magnesium sulfate.]
[N05CC01, chloral hydrate, The therapeutic efficacy of Chloral hydrate can be increased when used in combination with Magnesium sulfate.]
[N05CM07, triclofos, The therapeutic efficacy of Triclofos can be increased when used in combination with Magnesium sulfate.]
[A03AB08, tridihexethyl, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Tridihexethyl.]
[R06AA10, trimethobenzamide, The therapeutic efficacy of Trimethobenzamide can be increased when used in combination with Magnesium sulfate.]
[N04AA12, tropatepine, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Tropatepine.]
[N01AB04, enflurane, The therapeutic efficacy of Enflurane can be increased when used in combination with Magnesium sulfate.]
[C02CA06, urapidil, The therapeutic efficacy of Urapidil can be increased when used in combination with Magnesium sulfate.]
[J01MA04, enoxacin, Magnesium sulfate can cause a decrease in the absorption of Enoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N05AL06, veralipride, The therapeutic efficacy of Veralipride can be increased when used in combination with Magnesium sulfate.]
[S01GX10, epinastine, The therapeutic efficacy of Epinastine can be increased when used in combination with Magnesium sulfate.]
[N06AX16, venlafaxine, The therapeutic efficacy of Venlafaxine can be increased when used in combination with Magnesium sulfate.]
[S01GA03, xylometazoline, Magnesium sulfate may increase the arrhythmogenic activities of Xylometazoline.]
[C08CA12, mepirodipine, Magnesium sulfate may increase the arrhythmogenic activities of Barnidipine.]
[C09AA15, zofenopril, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Zofenopril.]
[N05CF02, zolpidem, The therapeutic efficacy of Zolpidem can be increased when used in combination with Magnesium sulfate.]
[M01AB04, zomepirac, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Zomepirac.]
[N03AX15, zonisamide, The therapeutic efficacy of Zonisamide can be increased when used in combination with Magnesium sulfate.]
[A10AB06, insulin glulisine, human, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Insulin glulisine.]
[N05CF01, zopiclone, The therapeutic efficacy of Zopiclone can be increased when used in combination with Magnesium sulfate.]
[N05AX11, zotepine, The therapeutic efficacy of Zotepine can be increased when used in combination with Magnesium sulfate.]
[C02AC02, guanfacine, The therapeutic efficacy of Guanfacine can be increased when used in combination with Magnesium sulfate.]
[C01BG01, moricizine, The therapeutic efficacy of Moricizine can be increased when used in combination with Magnesium sulfate.]
[A11CC01, ergocalciferol, The serum concentration of Magnesium sulfate can be increased when it is combined with Ergocalciferol.]
[G02AB03, ergonovine, The therapeutic efficacy of Ergometrine can be increased when used in combination with Magnesium sulfate.]
[C04AE01, ergoloid mesylates, USP, The therapeutic efficacy of Ergoloid mesylate can be increased when used in combination with Magnesium sulfate.]
[N02CA02, ergotamine, The therapeutic efficacy of Ergotamine can be increased when used in combination with Magnesium sulfate.]
[N03AG01, valproic acid, The therapeutic efficacy of Valproic acid can be increased when used in combination with Magnesium sulfate.]
[C01DA13, erythrityl tetranitrate, Magnesium sulfate may increase the vasodilatory activities of Erythrityl tetranitrate.]
[S01AA17, erythromycin, The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Magnesium sulfate.]
[N05CD04, estazolam, The therapeutic efficacy of Estazolam can be increased when used in combination with Magnesium sulfate.]
[G03CA03, estradiol, The metabolism of Estradiol can be increased when combined with Magnesium sulfate.]
[N05CM08, ethchlorvynol, The therapeutic efficacy of Ethchlorvynol can be increased when used in combination with Magnesium sulfate.]
[L02AA03, ethinyl estradiol, The metabolism of Ethinylestradiol can be increased when combined with Magnesium sulfate.]
[C01BD05, ibutilide, Ibutilide may increase the arrhythmogenic activities of Magnesium sulfate.]
[N04AA05, profenamine, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Profenamine.]
[N03AD01, ethosuximide, The therapeutic efficacy of Ethosuximide can be increased when used in combination with Magnesium sulfate.]
[N03AB01, ethotoin, The therapeutic efficacy of Ethotoin can be increased when used in combination with Magnesium sulfate.]
[N01BX01, ethyl chloride, The risk or severity of methemoglobinemia can be increased when Magnesium sulfate is combined with Ethyl chloride.]
[M01AC06, meloxicam, The risk or severity of methemoglobinemia can be increased when Magnesium sulfate is combined with Meloxicam.]
[S01XA06, ethylmorphine, The therapeutic efficacy of Ethylmorphine can be increased when used in combination with Magnesium sulfate.]
[N01BB07, etidocaine, The risk or severity of methemoglobinemia can be increased when Magnesium sulfate is combined with Etidocaine.]
[N01AX07, etomidate, The therapeutic efficacy of Etomidate can be increased when used in combination with Magnesium sulfate.]
[N05AE03, sertindole, The therapeutic efficacy of Sertindole can be increased when used in combination with Magnesium sulfate.]
[C01BA05, ajmaline, Magnesium sulfate may increase the arrhythmogenic activities of Ajmaline.]
[L04AD02, tacrolimus, Magnesium sulfate may increase the immunosuppressive activities of Tacrolimus.]
[J01MA08, fleroxacin, Magnesium sulfate can cause a decrease in the absorption of Fleroxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[R06AX12, terfenadine, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Terfenadine.]
[G02AD06, misoprostol, The risk or severity of adverse effects can be increased when Magnesium sulfate is combined with Misoprostol.]
[N06AX12, bupropion, The therapeutic efficacy of Bupropion can be increased when used in combination with Magnesium sulfate.]
[N06AB08, fluvoxamine, The therapeutic efficacy of Fluvoxamine can be increased when used in combination with Magnesium sulfate.]
[C01BB03, tocainide, Magnesium sulfate may increase the arrhythmogenic activities of Tocainide.]
[C01BC08, encainide, Magnesium sulfate may increase the arrhythmogenic activities of Encainide.]
[M05BA01, etidronic acid, Magnesium sulfate can cause a decrease in the absorption of Etidronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[C08CA02, felodipine, Magnesium sulfate may increase the arrhythmogenic activities of Felodipine.]
[C08EA01, fendiline, Magnesium sulfate may increase the arrhythmogenic activities of Fendiline.]
[N03AX26, fenfluramine, The therapeutic efficacy of Fenfluramine can be increased when used in combination with Magnesium sulfate.]
[M01AE04, fenoprofen, The risk or severity of hyperkalemia can be increased when Fenoprofen is combined with Magnesium sulfate.]
[R03CC04, fenoterol, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Fenoterol.]
[N02AB03, fentanyl, The therapeutic efficacy of Fentanyl can be increased when used in combination with Magnesium sulfate.]
[G04BD02, flavoxate, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Flavoxate.]
[C01BC04, flecainide, Magnesium sulfate may increase the arrhythmogenic activities of Flecainide.]
[N02BG04, floctafenine, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Floctafenine.]
[J02AC01, fluconazole, The risk or severity of hyperkalemia can be increased when Fluconazole is combined with Magnesium sulfate.]
[N07CA03, flunarizine, The therapeutic efficacy of Flunarizine can be increased when used in combination with Magnesium sulfate.]
[N05CD03, flunitrazepam, The therapeutic efficacy of Flunitrazepam can be increased when used in combination with Magnesium sulfate.]
[N06AA14, melitracen, The therapeutic efficacy of Melitracen can be increased when used in combination with Magnesium sulfate.]
[V03AZ01, ethanol, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Ethanol.]
[N06AB03, fluoxetine, The therapeutic efficacy of Fluoxetine can be increased when used in combination with Magnesium sulfate.]
[N05AF01, flupenthixol, The therapeutic efficacy of Flupentixol can be increased when used in combination with Magnesium sulfate.]
[N05AB02, fluphenazine, The therapeutic efficacy of Fluphenazine can be increased when used in combination with Magnesium sulfate.]
[N05CD01, flurazepam, The therapeutic efficacy of Flurazepam can be increased when used in combination with Magnesium sulfate.]
[S01BC04, flurbiprofen, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Flurbiprofen.]
[N05AG01, fluspirilene, The therapeutic efficacy of Fluspirilene can be increased when used in combination with Magnesium sulfate.]
[S01AA07, framycetin, The risk or severity of neuromuscular blockade can be increased when Framycetin is combined with Magnesium sulfate.]
[M03AA01, alcuronium, The therapeutic efficacy of Alcuronium can be increased when used in combination with Magnesium sulfate.]
[G01AX06, furazolidone, The therapeutic efficacy of Furazolidone can be increased when used in combination with Magnesium sulfate.]
[J05AE10, darunavir, The serum concentration of Magnesium sulfate can be increased when it is combined with Darunavir.]
[C03CA01, furosemide, The risk or severity of adverse effects can be increased when Furosemide is combined with Magnesium sulfate.]
[M05BA04, alendronic acid, Magnesium sulfate can cause a decrease in the absorption of Alendronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N05CF04, eszopiclone, The therapeutic efficacy of Eszopiclone can be increased when used in combination with Magnesium sulfate.]
[N05AL05, amisulpride, The therapeutic efficacy of Amisulpride can be increased when used in combination with Magnesium sulfate.]
[N06DA04, galantamine, Magnesium sulfate may increase the bradycardic activities of Galantamine.]
[M03AC02, gallamine, The therapeutic efficacy of Gallamine can be increased when used in combination with Magnesium sulfate.]
[C08DA02, gallopamil, Magnesium sulfate may increase the arrhythmogenic activities of Gallopamil.]
[S01AD09, ganciclovir, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Ganciclovir.]
[N03AA04, barbexaclone, The therapeutic efficacy of Barbexaclone can be increased when used in combination with Magnesium sulfate.]
[N06AX08, bifemelane, The therapeutic efficacy of Bifemelane can be increased when used in combination with Magnesium sulfate.]
[N04BC06, cabergoline, The therapeutic efficacy of Cabergoline can be increased when used in combination with Magnesium sulfate.]
[C01CA21, cafedrine, Magnesium sulfate may increase the excretion rate of Cafedrine which could result in a lower serum level and potentially a reduction in efficacy.]
[A10BJ02, liraglutide, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Liraglutide.]
[A12AA10, calcium gluceptate, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Calcium glucoheptonate.]
[A12AA30, calcium levulinate, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Calcium levulinate.]
[N03AD03, methsuximide, The therapeutic efficacy of Methsuximide can be increased when used in combination with Magnesium sulfate.]
[G03XA02, gestrinone, The metabolism of Gestrinone can be increased when combined with Magnesium sulfate.]
[N01AH02, alfentanil, The therapeutic efficacy of Alfentanil can be increased when used in combination with Magnesium sulfate.]
[A10BB01, glyburide, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Glyburide.]
[A10BB09, gliclazide, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Gliclazide.]
[A10BB07, glipizide, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Glipizide.]
[N05CM18, dexmedetomidine, The therapeutic efficacy of Dexmedetomidine can be increased when used in combination with Magnesium sulfate.]
[N05CE01, glutethimide, The therapeutic efficacy of Glutethimide can be increased when used in combination with Magnesium sulfate.]
[C05AE01, nitroglycerin, Magnesium sulfate may increase the vasodilatory activities of Nitroglycerin.]
[C01BD04, dofetilide, Dofetilide may increase the arrhythmogenic activities of Magnesium sulfate.]
[C02CA04, doxazosin, The risk or severity of hypotension can be increased when Doxazosin is combined with Magnesium sulfate.]
[C07AB09, esmolol, Esmolol may increase the arrhythmogenic activities of Magnesium sulfate.]
[C09AA09, fosinopril, The risk or severity of hyperkalemia can be increased when Fosinopril is combined with Magnesium sulfate.]
[P01BX01, halofantrine, Magnesium sulfate can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N05AD01, haloperidol, The therapeutic efficacy of Haloperidol can be increased when used in combination with Magnesium sulfate.]
[N01AB01, halothane, The therapeutic efficacy of Halothane can be increased when used in combination with Magnesium sulfate.]
[N05AH04, quetiapine, The therapeutic efficacy of Quetiapine can be increased when used in combination with Magnesium sulfate.]
[A10AD05, insulin aspart, human, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Insulin aspart.]
[N02CX03, iprazochrome, The therapeutic efficacy of Iprazochrome can be increased when used in combination with Magnesium sulfate.]
[N05CA21, allobarbital, The therapeutic efficacy of Allobarbital can be increased when used in combination with Magnesium sulfate.]
[C09CA01, losartan, Magnesium sulfate may increase the arrhythmogenic activities of Losartan.]
[S01XA14, heparin, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Heparin.]
[B05CB03, magnesium citrate, The risk or severity of hypotension can be increased when Magnesium citrate is combined with Magnesium sulfate.]
[A12CC03, magnesium gluconate, The risk or severity of hypotension can be increased when Magnesium gluconate is combined with Magnesium sulfate.]
[A07EC02, mesalamine, The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Magnesium sulfate.]
[A12CD02, sodium monofluorophosphate, The therapeutic efficacy of Sodium fluorophosphate can be decreased when used in combination with Magnesium sulfate.]
[N05CA16, hexobarbital, The therapeutic efficacy of Hexobarbital can be increased when used in combination with Magnesium sulfate.]
[C08CA10, nilvadipine, Magnesium sulfate may increase the arrhythmogenic activities of Nilvadipine.]
[M02AA26, nimesulide, Magnesium sulfate may increase the arrhythmogenic activities of Nimesulide.]
[C09AA04, perindopril, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Perindopril.]
[C03AA03, hydrochlorothiazide, The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Magnesium sulfate.]
[R05DA03, hydrocodone, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.]
[C03AA02, hydroflumethiazide, The risk or severity of adverse effects can be increased when Hydroflumethiazide is combined with Magnesium sulfate.]
[S01XA07, aluminum potassium sulfate, Potassium alum may increase the hyperkalemic activities of Magnesium sulfate.]
[A12BA02, potassium citrate, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Magnesium sulfate.]
[G04BD06, propiverine, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Propiverine.]
[P01BA02, hydroxychloroquine, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Hydroxychloroquine.]
[N05AX07, prothipendyl, The therapeutic efficacy of Prothipendyl can be increased when used in combination with Magnesium sulfate.]
[N05BB01, hydroxyzine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Magnesium sulfate.]
[M05BA07, risedronic acid, Magnesium sulfate can cause a decrease in the absorption of Risedronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[R02AX02, ibuprofen, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Ibuprofen.]
[A06AD21, sodium tartrate, The therapeutic efficacy of Sodium tartrate can be decreased when used in combination with Magnesium sulfate.]
[N01AH03, sufentanil, The therapeutic efficacy of Sufentanil can be increased when used in combination with Magnesium sulfate.]
[N06AA02, imipramine, The therapeutic efficacy of Imipramine can be increased when used in combination with Magnesium sulfate.]
[M03BX02, tizanidine, The therapeutic efficacy of Tizanidine can be increased when used in combination with Magnesium sulfate.]
[L01CE01, topotecan, Magnesium sulfate may increase the excretion rate of Topotecan which could result in a lower serum level and potentially a reduction in efficacy.]
[C03BA11, indapamide, The risk or severity of adverse effects can be increased when Indapamide is combined with Magnesium sulfate.]
[S01BC01, indomethacin, The risk or severity of hyperkalemia can be increased when Indomethacin is combined with Magnesium sulfate.]
[C02CA02, indoramin, The risk or severity of hypotension can be increased when Indoramin is combined with Magnesium sulfate.]
[N06AX17, milnacipran, The therapeutic efficacy of Milnacipran can be increased when used in combination with Magnesium sulfate.]
[A03AA30, piperidolate, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Piperidolate.]
[R01AA02, cyclopentamine, The risk or severity of adverse effects can be increased when Magnesium sulfate is combined with Cyclopentamine.]
[N01BB08, articaine, The therapeutic efficacy of Articaine can be increased when used in combination with Magnesium sulfate.]
[A10BH01, sitagliptin, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Sitagliptin.]
[V08AB02, iohexol, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Iohexol.]
[N05BA12, alprazolam, The therapeutic efficacy of Alprazolam can be increased when used in combination with Magnesium sulfate.]
[N05CH02, ramelteon, The therapeutic efficacy of Ramelteon can be increased when used in combination with Magnesium sulfate.]
[R06AE01, buclizine, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Buclizine.]
[A10BH02, vildagliptin, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Vildagliptin.]
[C07AA01, alprenolol, The therapeutic efficacy of Alprenolol can be increased when used in combination with Magnesium sulfate.]
[C03BA02, quinethazone, The risk or severity of adverse effects can be increased when Quinethazone is combined with Magnesium sulfate.]
[N06AA13, iprindole, The therapeutic efficacy of Iprindole can be increased when used in combination with Magnesium sulfate.]
[N06AF05, iproniazid, The therapeutic efficacy of Iproniazid can be increased when used in combination with Magnesium sulfate.]
[N05AA07, chlorproethazine, The therapeutic efficacy of Chlorproethazine can be increased when used in combination with Magnesium sulfate.]
[N06AF01, isocarboxazid, The therapeutic efficacy of Isocarboxazid can be increased when used in combination with Magnesium sulfate.]
[C09AA16, imidapril, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Imidapril.]
[N01AB06, isoflurane, The therapeutic efficacy of Isoflurane can be increased when used in combination with Magnesium sulfate.]
[N04BX02, entacapone, The therapeutic efficacy of Entacapone can be increased when used in combination with Magnesium sulfate.]
[J04AC01, isoniazid, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Isoniazid.]
[A10BJ01, exenatide, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Exenatide.]
[C01DA14, isosorbide mononitrate, Magnesium sulfate may increase the vasodilatory activities of Isosorbide mononitrate.]
[C05AE02, isosorbide dinitrate, Magnesium sulfate may increase the vasodilatory activities of Isosorbide dinitrate.]
[N06AX18, reboxetine, The therapeutic efficacy of Reboxetine can be increased when used in combination with Magnesium sulfate.]
[S01AA24, kanamycin, The risk or severity of neuromuscular blockade can be increased when Magnesium sulfate is combined with Kanamycin.]
[N01AX03, ketamine, The therapeutic efficacy of Ketamine can be increased when used in combination with Magnesium sulfate.]
[C02KD01, ketanserin, The therapeutic efficacy of Ketanserin can be increased when used in combination with Magnesium sulfate.]
[J02AB02, ketoconazole, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Ketoconazole.]
[H02CA04, levoketoconazole, The therapeutic efficacy of Levoketoconazole can be increased when used in combination with Magnesium sulfate.]
[N05AH03, olanzapine, The therapeutic efficacy of Olanzapine can be increased when used in combination with Magnesium sulfate.]
[M02AA10, ketoprofen, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Ketoprofen.]
[V03AC03, deferasirox, Magnesium sulfate can cause a decrease in the absorption of Deferasirox resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N04BC09, rotigotine, The therapeutic efficacy of Rotigotine can be increased when used in combination with Magnesium sulfate.]
[M01AE11, tiaprofenic acid, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Tiaprofenic acid.]
[D11AX02, gamma-linolenic acid, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Gamolenic acid.]
[C07AG01, labetalol, The risk or severity of bradycardia can be increased when Magnesium sulfate is combined with Labetalol.]
[N04BB01, amantadine, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Amantadine.]
[A06AD11, lactulose, The therapeutic efficacy of Lactulose can be decreased when used in combination with Magnesium sulfate.]
[A06AX03, lubiprostone, The therapeutic efficacy of Lubiprostone can be decreased when used in combination with Magnesium sulfate.]
[N03AX18, lacosamide, The therapeutic efficacy of Lacosamide can be increased when used in combination with Magnesium sulfate.]
[C03CC01, ethacrynic acid, The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Magnesium sulfate.]
[G03AD01, levonorgestrel, The metabolism of Levonorgestrel can be increased when combined with Magnesium sulfate.]
[N04BA01, levodopa, The therapeutic efficacy of Levodopa can be increased when used in combination with Magnesium sulfate.]
[S02DA01, lidocaine, The therapeutic efficacy of Lidocaine can be increased when used in combination with Magnesium sulfate.]
[C08EX01, lidoflazine, Magnesium sulfate may increase the arrhythmogenic activities of Lidoflazine.]
[J01FF02, lincomycin, The risk or severity of neuromuscular blockade can be increased when Magnesium sulfate is combined with Lincomycin.]
[C03DB01, amiloride, The risk or severity of adverse effects can be increased when Amiloride is combined with Magnesium sulfate.]
[N02CA07, lisuride, The therapeutic efficacy of Lisuride can be increased when used in combination with Magnesium sulfate.]
[N06AA07, lofepramine, The therapeutic efficacy of Lofepramine can be increased when used in combination with Magnesium sulfate.]
[A07DA03, loperamide, Magnesium sulfate may increase the arrhythmogenic activities of Loperamide.]
[A12AA11, calcium pangamate, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Calcium pangamate.]
[N05BA06, lorazepam, The therapeutic efficacy of Lorazepam can be increased when used in combination with Magnesium sulfate.]
[N05AH01, loxapine, The therapeutic efficacy of Loxapine can be increased when used in combination with Magnesium sulfate.]
[J01AA04, lymecycline, Magnesium sulfate can cause a decrease in the absorption of Lymecycline resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[G03DC03, lynestrenol, The metabolism of Lynestrenol can be increased when combined with Magnesium sulfate.]
[B05XA11, magnesium chloride, The risk or severity of hypotension can be increased when Magnesium chloride is combined with Magnesium sulfate.]
[G04BX01, magnesium hydroxide, The risk or severity of hypotension can be increased when Magnesium hydroxide is combined with Magnesium sulfate.]
[J01MB04, pipemidic acid, Magnesium sulfate can cause a decrease in the absorption of Pipemidic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N07XX04, sodium oxybate, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.]
[M01AG01, mefenamic acid, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Mefenamic acid.]
[C01DA05, pentaerythritol tetranitrate, Magnesium sulfate may increase the vasodilatory activities of Pentaerythritol tetranitrate.]
[J01MB02, nalidixic acid, Magnesium sulfate can cause a decrease in the absorption of Nalidixic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[V04CX04, mannitol, The risk or severity of adverse effects can be increased when Mannitol is combined with Magnesium sulfate.]
[N06AA21, maprotiline, The therapeutic efficacy of Maprotiline can be increased when used in combination with Magnesium sulfate.]
[A08AA05, mazindol, The therapeutic efficacy of Mazindol can be increased when used in combination with Magnesium sulfate.]
[C02BB01, mecamylamine, The risk or severity of adverse effects can be increased when Magnesium sulfate is combined with Mecamylamine.]
[R06AE05, meclizine, The therapeutic efficacy of Meclizine can be increased when used in combination with Magnesium sulfate.]
[M02AA18, meclofenamic acid, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Meclofenamic acid.]
[N05BA03, medazepam, The therapeutic efficacy of Medazepam can be increased when used in combination with Magnesium sulfate.]
[C01AA08, medigoxin, Magnesium sulfate may increase the arrhythmogenic activities of Metildigoxin.]
[P01BC02, mefloquine, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Mefloquine.]
[C03BA05, mefruside, The risk or severity of adverse effects can be increased when Mefruside is combined with Magnesium sulfate.]
[B01AB06, nadroparin, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Nadroparin.]
[B01AB05, enoxaparin, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Enoxaparin.]
[B01AB04, dalteparin, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Dalteparin.]
[N05CH01, melatonin, The therapeutic efficacy of Melatonin can be increased when used in combination with Magnesium sulfate.]
[N02AB02, meperidine, The therapeutic efficacy of Meperidine can be increased when used in combination with Magnesium sulfate.]
[N03AB04, mephenytoin, The therapeutic efficacy of Mephenytoin can be increased when used in combination with Magnesium sulfate.]
[N03AA01, mephobarbital, The therapeutic efficacy of Methylphenobarbital can be increased when used in combination with Magnesium sulfate.]
[N01BB03, mepivacaine, The therapeutic efficacy of Mepivacaine can be increased when used in combination with Magnesium sulfate.]
[N05BC01, meprobamate, The therapeutic efficacy of Meprobamate can be increased when used in combination with Magnesium sulfate.]
[N02AX05, meptazinol, The therapeutic efficacy of Meptazinol can be increased when used in combination with Magnesium sulfate.]
[C03BC01, mersalyl, The risk or severity of adverse effects can be increased when Mersalyl is combined with Magnesium sulfate.]
[N05AC03, mesoridazine, The therapeutic efficacy of Mesoridazine can be increased when used in combination with Magnesium sulfate.]
[N05AX13, paliperidone, The therapeutic efficacy of Paliperidone can be increased when used in combination with Magnesium sulfate.]
[A10BA02, metformin, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Metformin.]
[A04AA04, dolasetron, The therapeutic efficacy of Dolasetron can be increased when used in combination with Magnesium sulfate.]
[H01CB03, lanreotide, Magnesium sulfate may increase the bradycardic activities of Lanreotide.]
[J01AA05, methacycline, Magnesium sulfate can cause a decrease in the absorption of Metacycline resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N07BC02, methadone, The risk or severity of adverse effects can be increased when Methadone is combined with Magnesium sulfate.]
[N06BA03, methamphetamine, The therapeutic efficacy of Metamfetamine can be increased when used in combination with Magnesium sulfate.]
[A03AB07, methantheline, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Methantheline.]
[R06AC05, methapyrilene, The therapeutic efficacy of Methapyrilene can be increased when used in combination with Magnesium sulfate.]
[N05CM01, methaqualone, The therapeutic efficacy of Methaqualone can be increased when used in combination with Magnesium sulfate.]
[N03AA30, metharbital, The therapeutic efficacy of Metharbital can be increased when used in combination with Magnesium sulfate.]
[S01EC05, methazolamide, The risk or severity of adverse effects can be increased when Methazolamide is combined with Magnesium sulfate.]
[G02CB05, metergoline, The therapeutic efficacy of Metergoline can be increased when used in combination with Magnesium sulfate.]
[M03BA03, methocarbamol, The therapeutic efficacy of Methocarbamol can be increased when used in combination with Magnesium sulfate.]
[N05CA15, methohexital, The therapeutic efficacy of Methohexital can be increased when used in combination with Magnesium sulfate.]
[N02BG08, ziconotide, The therapeutic efficacy of Ziconotide can be increased when used in combination with Magnesium sulfate.]
[N05AA02, methotrimeprazine, The therapeutic efficacy of Methotrimeprazine can be increased when used in combination with Magnesium sulfate.]
[N02BG09, methoxyflurane, The therapeutic efficacy of Methoxyflurane can be increased when used in combination with Magnesium sulfate.]
[C03AA08, methyclothiazide, The risk or severity of adverse effects can be increased when Methyclothiazide is combined with Magnesium sulfate.]
[A06AC06, methylcellulose, The therapeutic efficacy of Methylcellulose can be decreased when used in combination with Magnesium sulfate.]
[C02AB01, methyldopa, Magnesium sulfate may increase the bradycardic activities of Methyldopa.]
[V04CG05, methylene blue, The therapeutic efficacy of Methylene blue can be increased when used in combination with Magnesium sulfate.]
[R03DA05, aminophylline, Magnesium sulfate may increase the excretion rate of Aminophylline which could result in a lower serum level and potentially a reduction in efficacy.]
[N06BA04, methylphenidate, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Methylphenidate.]
[N03AF03, rufinamide, The therapeutic efficacy of Rufinamide can be increased when used in combination with Magnesium sulfate.]
[N05CE02, methyprylon, The therapeutic efficacy of Methyprylon can be increased when used in combination with Magnesium sulfate.]
[N02CA04, methysergide, The therapeutic efficacy of Methysergide can be increased when used in combination with Magnesium sulfate.]
[A03FA01, metoclopramide, The risk or severity of sedation can be increased when Metoclopramide is combined with Magnesium sulfate.]
[C03BA08, metolazone, The risk or severity of adverse effects can be increased when Metolazone is combined with Magnesium sulfate.]
[C07AB02, metoprolol, Metoprolol may increase the arrhythmogenic activities of Magnesium sulfate.]
[P01AB01, metronidazole, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Metronidazole.]
[C01BB02, mexiletine, Mexiletine may increase the arrhythmogenic activities of Magnesium sulfate.]
[N06AX03, mianserin, The therapeutic efficacy of Mianserin can be increased when used in combination with Magnesium sulfate.]
[S02AA13, miconazole, The therapeutic efficacy of Miconazole can be increased when used in combination with Magnesium sulfate.]
[N02BB03, aminopyrine, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Aminophenazone.]
[B01AB07, parnaparin, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Parnaparin.]
[N05CD08, midazolam, The therapeutic efficacy of Midazolam can be increased when used in combination with Magnesium sulfate.]
[C01CA17, midodrine, Midodrine may increase the bradycardic activities of Magnesium sulfate.]
[G03XB01, mifepristone, The metabolism of Mifepristone can be increased when combined with Magnesium sulfate.]
[B01AB10, tinzaparin, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Tinzaparin.]
[A06AA01, mineral oil, The therapeutic efficacy of Mineral oil can be decreased when used in combination with Magnesium sulfate.]
[C09CA03, valsartan, The risk or severity of hyperkalemia can be increased when Valsartan is combined with Magnesium sulfate.]
[J01AA08, minocycline, Minocycline may increase the central nervous system depressant (CNS depressant) activities of Magnesium sulfate.]
[N05AE02, molindone, The therapeutic efficacy of Molindone can be increased when used in combination with Magnesium sulfate.]
[C01BD01, amiodarone, The risk or severity of adverse effects can be increased when Amiodarone is combined with Magnesium sulfate.]
[N06AA09, amitriptyline, The therapeutic efficacy of Amitriptyline can be increased when used in combination with Magnesium sulfate.]
[N02AA01, morphine, The therapeutic efficacy of Morphine can be increased when used in combination with Magnesium sulfate.]
[A04AA05, palonosetron, The therapeutic efficacy of Palonosetron can be increased when used in combination with Magnesium sulfate.]
[B02BX05, eltrombopag, Magnesium sulfate can cause a decrease in the absorption of Eltrombopag resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[G04BA01, ammonium chloride, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Ammonium chloride.]
[M03AC03, vecuronium, The therapeutic efficacy of Vecuronium can be increased when used in combination with Magnesium sulfate.]
[N05CA02, amobarbital, The therapeutic efficacy of Amobarbital can be increased when used in combination with Magnesium sulfate.]
[J05AJ01, raltegravir, Magnesium sulfate can cause a decrease in the absorption of Raltegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[G04CA04, silodosin, The risk or severity of hypotension can be increased when Silodosin is combined with Magnesium sulfate.]
[N06AA17, amoxapine, The therapeutic efficacy of Amoxapine can be increased when used in combination with Magnesium sulfate.]
[N03AB05, fosphenytoin, The therapeutic efficacy of Fosphenytoin can be increased when used in combination with Magnesium sulfate.]
[C07AA12, nadolol, Magnesium sulfate may increase the arrhythmogenic activities of Nadolol.]
[N04BC04, ropinirole, Magnesium sulfate may increase the sedative activities of Ropinirole.]
[J01CF06, nafcillin, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Nafcillin.]
[C04AX21, nafronyl, The therapeutic efficacy of Naftidrofuryl can be increased when used in combination with Magnesium sulfate.]
[N02AF02, nalbuphine, The therapeutic efficacy of Nalbuphine can be increased when used in combination with Magnesium sulfate.]
[N07BB04, naltrexone, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Naltrexone.]
[N06BA01, amphetamine, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Amphetamine.]
[M02AA12, naproxen, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Naproxen.]
[A10BG01, troglitazone, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Troglitazone.]
[N06AX21, duloxetine, The therapeutic efficacy of Duloxetine can be increased when used in combination with Magnesium sulfate.]
[N04BX01, tolcapone, The therapeutic efficacy of Tolcapone can be increased when used in combination with Magnesium sulfate.]
[S03AA01, neomycin, The risk or severity of neuromuscular blockade can be increased when Magnesium sulfate is combined with Neomycin.]
[N01AH06, remifentanil, The therapeutic efficacy of Remifentanil can be increased when used in combination with Magnesium sulfate.]
[A10BX02, repaglinide, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Repaglinide.]
[C01CX08, levosimendan, Magnesium sulfate may increase the arrhythmogenic activities of Levosimendan.]
[N05AX14, iloperidone, The therapeutic efficacy of Iloperidone can be increased when used in combination with Magnesium sulfate.]
[J02AA01, amphotericin B, Magnesium sulfate may decrease the nephrotoxic activities of Amphotericin B.]
[S01AA23, netilmicin, The risk or severity of neuromuscular blockade can be increased when Magnesium sulfate is combined with Netilmicin.]
[N06AX23, desvenlafaxine, The therapeutic efficacy of Desvenlafaxine can be increased when used in combination with Magnesium sulfate.]
[C09CA07, telmisartan, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Telmisartan.]
[H05BX02, paricalcitol, The serum concentration of Magnesium sulfate can be increased when it is combined with Paricalcitol.]
[N06AF02, nialamide, The therapeutic efficacy of Nialamide can be increased when used in combination with Magnesium sulfate.]
[C08CA04, nicardipine, Nicardipine may increase the arrhythmogenic activities of Magnesium sulfate.]
[C04AE02, nicergoline, The risk or severity of hypotension can be increased when Nicergoline is combined with Magnesium sulfate.]
[N07BA01, nicotine, The risk or severity of adverse effects can be increased when Magnesium sulfate is combined with Nicotine.]
[C08CA05, nifedipine, Magnesium sulfate may increase the arrhythmogenic activities of Nifedipine.]
[M02AA17, niflumic acid, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Niflumic acid.]
[V03AB22, amyl nitrite, Magnesium sulfate may increase the vasodilatory activities of Amyl Nitrite.]
[C08CA06, nimodipine, Nimodipine may increase the arrhythmogenic activities of Magnesium sulfate.]
[C08CA07, nisoldipine, Nisoldipine may increase the arrhythmogenic activities of Magnesium sulfate.]
[N05CD02, nitrazepam, The therapeutic efficacy of Nitrazepam can be increased when used in combination with Magnesium sulfate.]
[C08CA08, nitrendipine, Magnesium sulfate may increase the arrhythmogenic activities of Nitrendipine.]
[J01XE01, nitrofurantoin, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Nitrofurantoin.]
[N05CF03, zaleplon, The therapeutic efficacy of Zaleplon can be increased when used in combination with Magnesium sulfate.]
[N04BC05, pramipexole, Magnesium sulfate may increase the sedative activities of Pramipexole.]
[C02DD01, nitroprusside, Magnesium sulfate may increase the hypotensive activities of Nitroprusside.]
[N01AX13, nitrous oxide, The therapeutic efficacy of Nitrous oxide can be increased when used in combination with Magnesium sulfate.]
[N06AX04, nomifensine, The therapeutic efficacy of Nomifensine can be increased when used in combination with Magnesium sulfate.]
[G03DC02, norethindrone, The metabolism of Norethisterone can be increased when combined with Magnesium sulfate.]
[S01AE02, norfloxacin, Magnesium sulfate can cause a decrease in the absorption of Norfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[G03AC07, norgestrienone, The metabolism of Norgestrienone can be increased when combined with Magnesium sulfate.]
[N06AA10, nortriptyline, The therapeutic efficacy of Nortriptyline can be increased when used in combination with Magnesium sulfate.]
[G02CA02, nylidrin, Magnesium sulfate may increase the arrhythmogenic activities of Nylidrin.]
[B01AB08, reviparin, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Reviparin.]
[H01CB02, octreotide, The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Magnesium sulfate.]
[S02AA16, ofloxacin, Magnesium sulfate can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N06AA05, opipramol, The therapeutic efficacy of Opipramol can be increased when used in combination with Magnesium sulfate.]
[N02AA02, opium, The therapeutic efficacy of Opium can be increased when used in combination with Magnesium sulfate.]
[G04CA02, tamsulosin, The risk or severity of hypotension can be increased when Tamsulosin is combined with Magnesium sulfate.]
[C01AC01, ouabain, The serum concentration of Ouabain can be increased when it is combined with Magnesium sulfate.]
[N05BA04, oxazepam, The therapeutic efficacy of Oxazepam can be increased when used in combination with Magnesium sulfate.]
[J01MB05, oxolinic acid, Magnesium sulfate can cause a decrease in the absorption of Oxolinic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[C07AA02, oxprenolol, The therapeutic efficacy of Oxprenolol can be increased when used in combination with Magnesium sulfate.]
[N02AA05, oxycodone, The therapeutic efficacy of Oxycodone can be increased when used in combination with Magnesium sulfate.]
[N02AA11, oxymorphone, The therapeutic efficacy of Oxymorphone can be increased when used in combination with Magnesium sulfate.]
[N05AE01, oxypertine, The therapeutic efficacy of Oxypertine can be increased when used in combination with Magnesium sulfate.]
[S01BC02, oxyphenbutazone, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Oxyphenbutazone.]
[A03AB03, oxyphenonium, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.]
[S01AA04, oxytetracycline, Magnesium sulfate can cause a decrease in the absorption of Oxytetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N05AH05, asenapine, The therapeutic efficacy of Asenapine can be increased when used in combination with Magnesium sulfate.]
[B01AB09, danaparoid, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Danaparoid.]
[N02AX06, tapentadol, The therapeutic efficacy of Tapentadol can be increased when used in combination with Magnesium sulfate.]
[M03AC01, pancuronium, The therapeutic efficacy of Pancuronium can be increased when used in combination with Magnesium sulfate.]
[J04AB30, capreomycin, The risk or severity of neuromuscular blockade can be increased when Capreomycin is combined with Magnesium sulfate.]
[G03DB06, chlormadinone, The metabolism of Chlormadinone can be increased when combined with Magnesium sulfate.]
[N05CC05, paraldehyde, The therapeutic efficacy of Paraldehyde can be increased when used in combination with Magnesium sulfate.]
[C02KC01, pargyline, The therapeutic efficacy of Pargyline can be increased when used in combination with Magnesium sulfate.]
[A07AA06, paromomycin, The risk or severity of neuromuscular blockade can be increased when Magnesium sulfate is combined with Paromomycin.]
[J01MA03, pefloxacin, Magnesium sulfate can cause a decrease in the absorption of Pefloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[G04BD11, fesoterodine, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Fesoterodine.]
[C07AA23, penbutolol, The therapeutic efficacy of Penbutolol can be increased when used in combination with Magnesium sulfate.]
[N05AG03, penfluridol, The therapeutic efficacy of Penfluridol can be increased when used in combination with Magnesium sulfate.]
[N02AD01, pentazocine, The therapeutic efficacy of Pentazocine can be increased when used in combination with Magnesium sulfate.]
[N05CA01, pentobarbital, The therapeutic efficacy of Pentobarbital can be increased when used in combination with Magnesium sulfate.]
[C04AD03, pentoxifylline, Magnesium sulfate may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AB10, perazine, The therapeutic efficacy of Perazine can be increased when used in combination with Magnesium sulfate.]
[N04BC02, pergolide, The therapeutic efficacy of Pergolide can be increased when used in combination with Magnesium sulfate.]
[C08EX02, perhexiline, Magnesium sulfate may increase the arrhythmogenic activities of Perhexiline.]
[N05AB03, perphenazine, The therapeutic efficacy of Perphenazine can be increased when used in combination with Magnesium sulfate.]
[N02AD02, phenazocine, The therapeutic efficacy of Phenazocine can be increased when used in combination with Magnesium sulfate.]
[N06AF03, phenelzine, The therapeutic efficacy of Phenelzine can be increased when used in combination with Magnesium sulfate.]
[A10BA01, phenformin, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Phenformin.]
[N03AA02, phenobarbital, The therapeutic efficacy of Phenobarbital can be increased when used in combination with Magnesium sulfate.]
[A06AB01, oxyphenisatin, The therapeutic efficacy of Oxyphenisatin can be decreased when used in combination with Magnesium sulfate.]
[N01AH04, phenoperidine, The therapeutic efficacy of Phenoperidine can be increased when used in combination with Magnesium sulfate.]
[C04AX02, phenoxybenzamine, The risk or severity of hypotension can be increased when Phenoxybenzamine is combined with Magnesium sulfate.]
[V03AB36, phentolamine, The risk or severity of hypotension can be increased when Phentolamine is combined with Magnesium sulfate.]
[M02AA01, phenylbutazone, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Phenylbutazone.]
[S01GA05, phenylephrine, The risk or severity of hypertension can be decreased when Magnesium sulfate is combined with Phenylephrine.]
[R01BA01, phenylpropanolamine, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Phenylpropanolamine.]
[N03AB02, phenytoin, The therapeutic efficacy of Phenytoin can be increased when used in combination with Magnesium sulfate.]
[S01AE05, levofloxacin, Magnesium sulfate can cause a decrease in the absorption of Levofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[C08CX01, mibefradil, Magnesium sulfate may increase the arrhythmogenic activities of Mibefradil.]
[N05AG02, pimozide, The therapeutic efficacy of Pimozide can be increased when used in combination with Magnesium sulfate.]
[C07AA03, pindolol, The therapeutic efficacy of Pindolol can be increased when used in combination with Magnesium sulfate.]
[J01CA12, piperacillin, The risk or severity of neuromuscular blockade can be increased when Piperacillin is combined with Magnesium sulfate.]
[N05AC04, pipothiazine, The therapeutic efficacy of Pipotiazine can be increased when used in combination with Magnesium sulfate.]
[C09CA02, eprosartan, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Eprosartan.]
[A02BX03, pirenzepine, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Pirenzepine.]
[N02AC03, pirinitramide, The therapeutic efficacy of Piritramide can be increased when used in combination with Magnesium sulfate.]
[S01BC06, piroxicam, The risk or severity of hyperkalemia can be increased when Piroxicam is combined with Magnesium sulfate.]
[J01MA11, grepafloxacin, Magnesium sulfate can cause a decrease in the absorption of Grepafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N02CX01, pizotyline, The therapeutic efficacy of Pizotifen can be increased when used in combination with Magnesium sulfate.]
[C09CA04, irbesartan, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Irbesartan.]
[N05CA22, proxibarbal, The therapeutic efficacy of Proxibarbal can be increased when used in combination with Magnesium sulfate.]
[A10BG02, rosiglitazone, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Rosiglitazone.]
[A06AD15, polyethylene glycols, The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Magnesium sulfate.]
[A03AE01, alosetron, The therapeutic efficacy of Alosetron can be increased when used in combination with Magnesium sulfate.]
[C03AA05, polythiazide, The risk or severity of adverse effects can be increased when Polythiazide is combined with Magnesium sulfate.]
[A10BH03, saxagliptin, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Saxagliptin.]
[V03AB21, potassium iodide, Potassium Iodide may increase the hyperkalemic activities of Magnesium sulfate.]
[A10AD04, insulin lispro, The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Insulin lispro.]
[C07AB01, practolol, Magnesium sulfate may increase the arrhythmogenic activities of Practolol.]
[C01BA08, prajmaline, Magnesium sulfate may increase the arrhythmogenic activities of Prajmaline.]
[N05BA11, prazepam, The therapeutic efficacy of Prazepam can be increased when used in combination with Magnesium sulfate.]
[C02CA01, prazosin, The risk or severity of hypotension can be increased when Prazosin is combined with Magnesium sulfate.]
[C01DX02, prenylamine, Magnesium sulfate may increase the arrhythmogenic activities of Prenylamine.]
[N01BB04, prilocaine, The therapeutic efficacy of Prilocaine can be increased when used in combination with Magnesium sulfate.]
[N03AA03, primidone, The therapeutic efficacy of Primidone can be increased when used in combination with Magnesium sulfate.]
[C01BA02, procainamide, Magnesium sulfate may increase the arrhythmogenic activities of Procainamide.]
[S01HA05, procaine, The therapeutic efficacy of Procaine can be increased when used in combination with Magnesium sulfate.]
[L01XB01, procarbazine, The therapeutic efficacy of Procarbazine can be increased when used in combination with Magnesium sulfate.]
[N05AB04, prochlorperazine, The therapeutic efficacy of Prochlorperazine can be increased when used in combination with Magnesium sulfate.]
[N04AA04, procyclidine, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Procyclidine.]
[G03DA04, progesterone, The metabolism of Progesterone can be increased when combined with Magnesium sulfate.]
[N05AA03, promazine, The therapeutic efficacy of Promazine can be increased when used in combination with Magnesium sulfate.]
[R06AD02, promethazine, The therapeutic efficacy of Promethazine can be increased when used in combination with Magnesium sulfate.]
[C01BC03, propafenone, Magnesium sulfate may increase the arrhythmogenic activities of Propafenone.]
[N01AX04, propanidid, The therapeutic efficacy of Propanidid can be increased when used in combination with Magnesium sulfate.]
[A03AB05, propantheline, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Propantheline.]
[N05AC01, periciazine, The therapeutic efficacy of Periciazine can be increased when used in combination with Magnesium sulfate.]
[N05CM06, propiomazine, The therapeutic efficacy of Propiomazine can be increased when used in combination with Magnesium sulfate.]
[N01AX10, propofol, The therapeutic efficacy of Propofol can be increased when used in combination with Magnesium sulfate.]
[N02AC04, propoxyphene, The therapeutic efficacy of Dextropropoxyphene can be increased when used in combination with Magnesium sulfate.]
[C07AA05, propranolol, Propranolol may increase the arrhythmogenic activities of Magnesium sulfate.]
[C01AB01, proscillaridin, The serum concentration of Proscillaridin can be increased when it is combined with Magnesium sulfate.]
[N02CC04, rizatriptan, The therapeutic efficacy of Rizatriptan can be increased when used in combination with Magnesium sulfate.]
[N06AA11, protriptyline, The therapeutic efficacy of Protriptyline can be increased when used in combination with Magnesium sulfate.]
[N05AX12, aripiprazole, The therapeutic efficacy of Aripiprazole can be increased when used in combination with Magnesium sulfate.]
[A03AB15, diphemanil, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Diphemanil.]
[A03AB09, isopropamide, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Isopropamide.]
[S01FA03, methscopolamine, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Methscopolamine.]
[N05CA07, talbutal, The therapeutic efficacy of Talbutal can be increased when used in combination with Magnesium sulfate.]
[N05CA09, vinbarbital, The therapeutic efficacy of Vinbarbital can be increased when used in combination with Magnesium sulfate.]
[N05BB02, captodiamine, The therapeutic efficacy of Captodiame can be increased when used in combination with Magnesium sulfate.]
[M03BA04, styramate, The therapeutic efficacy of Styramate can be increased when used in combination with Magnesium sulfate.]
[P02CC01, pyrantel, The therapeutic efficacy of Pyrantel can be increased when used in combination with Magnesium sulfate.]
[A12BA05, potassium gluconate, Potassium gluconate may increase the hyperkalemic activities of Magnesium sulfate.]
[R06AC01, pyrilamine, The therapeutic efficacy of Mepyramine can be increased when used in combination with Magnesium sulfate.]
[C01BA01, quinidine, Magnesium sulfate may increase the arrhythmogenic activities of Quinidine.]
[P01BC01, quinine, The therapeutic efficacy of Quinine can be increased when used in combination with Magnesium sulfate.]
[C02AA01, rescinnamine, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Rescinnamine.]
[C02AA02, reserpine, The therapeutic efficacy of Reserpine can be increased when used in combination with Magnesium sulfate.]
[N06AX01, 5-hydroxytryptophan, The therapeutic efficacy of Oxitriptan can be increased when used in combination with Magnesium sulfate.]
[J01AA09, rolitetracycline, The risk or severity of neuromuscular blockade can be increased when Magnesium sulfate is combined with Rolitetracycline.]
[N02BA05, salicylamide, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Salicylamide.]
[A07EC01, sulfasalazine, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Sulfasalazine.]
[S01BC08, salicylic acid, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Salicylic acid.]
[S01FA02, scopolamine, The therapeutic efficacy of Scopolamine can be increased when used in combination with Magnesium sulfate.]
[N05CA06, secobarbital, The therapeutic efficacy of Secobarbital can be increased when used in combination with Magnesium sulfate.]
[N04BD01, selegiline, The therapeutic efficacy of Selegiline can be increased when used in combination with Magnesium sulfate.]
[J01GB08, sisomicin, The risk or severity of neuromuscular blockade can be increased when Magnesium sulfate is combined with Sisomicin.]
[V04CC01, sorbitol, The therapeutic efficacy of Sorbitol can be decreased when used in combination with Magnesium sulfate.]
[C07AA07, sotalol, Sotalol may increase the arrhythmogenic activities of Magnesium sulfate.]
[C03DA01, spironolactone, The risk or severity of adverse effects can be increased when Spironolactone is combined with Magnesium sulfate.]
[R03BB01, ipratropium bromide, Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Ipratropium.]
